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Abstract 
 
Foot-and-mouth disease (FMD) is a highly infectious disease of wild and 
domestic cloven–hoofed animals such as cattle, swine and deer. It is caused by 
one of the most contagious animal diseases known; FMD virus (FMDV). Since 
the disease is endemic in many countries, transmission by international travel/ 
trade presents an on-going potential threat to the UK. Very little is known at the 
molecular level about how FMDV replicates within host cells. In this study, FMDV 
replicons have been used to investigate FMDV RNA replication and to improve 
our understanding of the viral life cycle: a process which will aid in the production 
of a new generation of live-attenuated vaccine candidate strains. Sequences 
encoding the capsid coding region of the genome have been replaced with green 
fluorescent protein (GFP) such that replication can be monitored in live cells via 
GFP fluorescence. This provides a rapid, non-invasive screen for replicative 
fitness that can be used outwith high disease security facilities. Differences 
between replicating and non-replicating forms could easily be distinguished, 
highlighting the potential of this system to screen for attenuated genomes. 
 
The FMDV replicon system was improved through a series of construct 
modifications until an optimal system was produced. A range of different methods 
were used to attenuate the replication of these genomes. Of major significance is 
the finding that increasing dinucleotide frequencies were shown to decrease 
growth kinetics of Echovirus 7 – as opposed to altering the codon-pair bias - and 
the application of this finding to construction of further replicon systems (and RNA 
viruses in general) is described. 
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Chapter 1:  Introduction 
 
1.1 Picornaviruses 
1.1.1 Classification and genome structure 
The Picornaviruses are a diverse family of pathogens which infect humans and 
animals. They are responsible for diseases such as poliomyelitis, the common 
cold, meningitis and foot-and-mouth disease (Lin et al., 2009; Stanway, 1990) 
They currently belong to 26 genera (Figure 1.1) as classified by the International 
Committee on Taxonomy of Viruses (ICTV) in 2013 (Knowles, 2013). The 
classification is based on phylogenetic properties which reflect evolutionary 
history. 
Picornavirus genomes are small icosahedral particles containing a single-
stranded, positive-sense RNA, ~7.5-8.5 kb in length. Although there is only a 
small degree of sequence homology at the nucleic acid level, picornaviruses 
share a similar genome structure and organisation (Figure 1.2). The RNA 
genome encodes a highly structured 5’ untranslated region (UTR) which contains 
a covalently attached protein (VPg) to the 5’ terminus (Crawford & Baltimore, 
1983; Nomoto et al., 1977), a large single open-reading frame (ORF); followed by 
a structured 3’ UTR that is polyadenylated at the 3’ terminus. The ORF encodes 
a single large polyprotein that consists of three main regions; P1 containing the 
structural proteins, and the P2/P3 regions which encode all the non-structural 
proteins involved in manipulation of host-cell endomembrane structures (P2), 
RNA replication (P3), and polyprotein processing (3Cpro). The polyprotein is 
processed by virally encoded proteases to produce the mature viral proteins and 
protein intermediates (Lin et al., 2009; Stanway, 1990). All picornaviruses lack a 
cap structure and perform cap-independent translation from the internal ribosome 
entry site (IRES). Despite the similar genome organisation shared, there are a 
few differences between members of this virus family. The 5’ UTRs of cardio- and 
aphthoviruses contain long polyribocytidylic acid [poly(C)] tracts and are 
characterised further by the presence of a leader protein encoded 5’ of the capsid 
region. Many picornaviruses also differ in the 2A protein they encode, as well as 
the number of 3B (VPg) copies they contain (Knowles et al., 2010; Stanway, 
1990). 
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Figure 1.1. Relationship between picornavirus 3D polymerases of the genus 
type-species of the current 26 genera. Sequences were aligned using MEGA 
(Tamura et al., 2011) and the tree visualised using FigTree (Rambaut, 2008). 
Accession numbers of genus type species and FMDV strains are listed within the 
appendices (A.4). 
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1.1.1.2 Aphthoviruses  
The Aphthoviruses consist of Foot-and-mouth disease virus (FMDV), Bovine 
rhinitis B virus (BRBV), Equine rhinitis A virus (ERAV) and a newly identified 
species, Bovine rhinitis A virus (BRAV) (Knowles, 2014; Knowles et al., 2010). 
FMDV is the genus type species and seven serotypes exist (A, O, C, Asia 1 and 
South African Territories 1, 2 and 3), with numerous subtypes within each 
serotype (Knowles et al., 2010). FMDV is the cause of foot-and-mouth disease 
(FMD), which is a highly infectious disease that affects wild and domestic cloven-
hoofed animals. ERAV contains one serotype which is of the same name and 
causes upper respiratory infections in horses. BRVs have been found in cattle 
with acute respiratory disease and their role in disease remains uncertain 
(Knowles, 2014). 
 
1.1.2 Foot-and-mouth disease virus 
FMDV is the type species of the Aphthovirus genus of the Picornaviridae family. 
The polyprotein translated from the ~8.5 kb viral mRNA genome is processed by 
FMDV-encoded proteinases, the L proteinase (Lpro) and 3C proteinase (3Cpro), as 
well as the 2A peptide (Figure 1.2; Grubman et al., 2010). These co- and post-
translational cleavages generate ‘intermediate’ and ‘mature’ structural and non-
structural proteins (see 1.2.3). Lpro and 3Cpro are also involved in the cleavage of 
a number of host cell proteins.  
The 5’ UTR of FMDV is the longest within the picornaviridae. It comprises ~ 
1,300 nucleotides (nts) or ~ 1/7 of the genome and can be subdivided into at 
least 5 distinct domains (Belsham, 2005; Grubman et al., 2010) The N-terminal 
domain of the polyprotein codes for Lpro which releases itself from the nascent 
polyprotein, cleaving at its own C-terminus, then degrades important target host-
cell proteins (see 1.1.2.6). As mentioned above, only aphthoviruses and 
cardioviruses contain a leader proteinase and the two in-frame initiation codons 
present at the beginning of the polyprotein are a unique feature of the 
aphthoviruses, as is the proteolytic activity possessed by aphthovirus leader 
proteinases (see 1.1.2.6; Grubman et al., 2010; Stanway, 1990). Five copies of 
the capsid proteins (1A-D) assemble to form a pentamer, twelve of which form 
the particle (see 1.2.1). The capsid protein precursor (P1-2A) is processed by 
3Cpro with the exception of the 1AB cleavage, which occurs with encapsidation of 
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virus RNA (Belsham, 2005). Like other members of the picornaviruses, the P2 
and P3 regions encode replication proteins, however FMDV is unique in encoding 
three copies of 3B (VPg; see 1.1.2.12; Grubman et al., 2010). 
 
1.1.2.1 5’ UTR  
The Untranslated Regions (UTRs) account for ~16 % of the FMDV genome. The 
5’ UTR of FMDV is >1kb in length, which is in stark contrast to the ~50-100 nt 
encoded by cellular mRNAs. It seems counterintuitive that a virus that can 
replicate so effectively can afford to devote so much of its genetic content to non-
coding sequences, and implies that the RNA structural features in this region 
must contribute to the efficiency of viral replication.  A number of highly structured 
elements reside within the 5’ UTR of FMDV (Figures 1.2, 1.3) and relatively little 
is known about the detailed functioning of these RNA elements. 
 
1.1.2.2 The S-fragment  
The S-Fragment is approximately 360 nucleotides in length and has been 
predicted to adopt a long, linear hairpin structure interrupted by short unpaired 
regions (Clarke et al., 1987; Witwer et al., 2001). The function of the S-fragment 
in unknown, but it is assumed that it has crucial roles in the control of RNA 
replication. A recent study demonstrated that the S-fragment can form complexes 
with cellular proteins including RNA helicase A, PABP and PCBP, together with 
the viral proteins 2C, 3A and 3Cpro (Lawrence & Rieder, 2009). In addition, it can 
bind to structural motifs in the 3’ UTR (Lawrence & Rieder, 2009; Serrano et al., 
2006). These findings suggest that multiple interactions are important for the 
mechanisms and control of viral replication, but the details of these processes are 
largely unknown. 
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Figure 1.2. Schematic representation of FMDV genome organisation. The 
secondary structure located within each non-coding region is shown. The large 
ORF is translated into a polyprotein which is processed by viral proteases. The 
primary polyprotein cleavages by Lpro, 2A and 3Cpro are shown as dashed arrows 
with major precursors annotated.  
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Figure 1.3. Structural elements within the 5’ UTR of FMDV. Detailed 
schematic representation of the structured regions predicted to be present within 
the 5’ UTR. All elements are described within the text. The five domains of the 
IRES (H-L) and the conserved motif within the cre are labelled. PPT, 
polypyrimidine tract (adapted from Belsham, 2005). 
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1.1.2.3 The poly(C) tract and pseudoknot domains  
The poly(C) tract is a distinctive feature of aphthoviruses and most cardioviruses 
(excluding Theiler’s murine encephalitis virus). In FMDV the poly(C) tract is found 
immediately 3’ of the S-fragment and is followed by a variable number of 
pseudoknot domains. The pseudoknot domain varies in number in the genomes 
of different viral isolates, but their biological roles in virus replication are 
completely unknown (Belsham, 2005; Grubman et al., 2010). Field strains of 
FMDV typically contain poly(C) tracts of around 150-200 nts in length. The length 
of the tract can dramatically influence pathogenicity within cardioviruses, but with 
respect to FMDV, some reports suggest the length is important for virulence 
(Harris & Brown, 1977; Rieder et al., 1993), and others have suggested otherwise 
(Giomi et al., 1984). Pathogenicity of mengovirus in mice can be attenuated by 
the truncation of the poly(C) tract (Duke et al., 1990). It seems that FMDV 
requires a minimum length of poly(C), the length of the tract increasing during 
passage. When a tract of just 6 C residues was present in RNA transcripts 
derived from a cDNA clone, the tract length increased through passage to contain 
tracts of around 80 C residues. However, when cDNA clones contained only 2 C 
residues, the tract was not amplified and the virus grew slower in tissue culture. 
The pathogenicity of the virus however, remained the same when tested in mice 
(Rieder et al., 1993). The longest poly(C) tract identified was found in persistently 
infected BHK cells and was 420 nt in length, but  this virus was attenuated in 
cattle and mice (Escarmís et al., 1992). Thus, the function of this region within 
FMDV, and other members of the picornavirus family, remains unclear.  
 
1.1.2.4 cis-acting replication element 
Cis-acting replication elements (cre) were first discovered when it was shown that 
HRV-14 genomes lacking the P1 region resulted in inhibition of viral RNA 
synthesis (McKnight & Lemon, 1996, 1998). This element was required to permit 
replication as an RNA entity, although it was found within a protein coding region. 
Picornavirus cres are thought to form stable stem-loop structures, with a 
conserved motif of -AAACA- located within the terminal loop region. This motif is 
proposed to act as a template for uridylation of 3BVPg - a primer for initiation of 
RNA replication (Paul et al., 1998).  Location of the cre within the genome of 
various picornaviruses has been mapped to different locations; the HRV-14 cre is 
located within 1D (VP1) (McKnight & Lemon, 1998), the PV cre  within the 2C 
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coding region (Goodfellow et al., 2000) and within the 5’ UTR of FMDV (Mason et 
al., 2002). FMDV is so far unique in having the cre located outwith the coding 
region. Mutational analyses of the cre within FMDV showed that mutations in the 
-AAACA- motif impaired replication of FMDV replicons, with mutations in the stem 
region demonstrating the importance of this structure for replication. The location 
of the cre to the 5’ UTR is not critical for replication as replicons and viruses 
encoding a cre within the 3’ UTR were functional (Mason et al., 2002). Retention 
of activity following movement of this element within the genome has also been 
demonstrated for PV (Goodfellow et al., 2000).  
 
1.1.2.5 Internal Ribosome Entry Site (IRES) 
The region essential for initiation of protein synthesis is located within the 3’-end 
of the 5’ UTR (Kühn et al., 1990). This element, an internal ribosome entry site 
(IRES), is similar to the cardiovirus IRES (group 2). The FMDV IRES is ~ 450 nt 
in length and folds into a complex secondary structure consisting of five domains 
(Pilipenko et al., 1989).  Most of the canonical translation initiation factors 
necessary for translation of cellular mRNAs are also required by the FMDV IRES 
(Pilipenko et al., 2000). A polypyrimidine tract is located at the 3’-end of the IRES 
and is conserved amongst most picornavirus IRES elements (Belsham, 2005). 
This region interacts with polypyrimidine tract binding protein (PTBP), which has 
been shown to enhance FMDV IRES activity in vitro (Pilipenko et al., 2000). 
Furthermore, both purified PTBP and IRES-specific trans-acting factor 45 
(ITAF45) have been shown to stimulate the formation of the 48S initiation complex 
on the FMDV IRES (Pilipenko et al., 2000). It is thought that the binding of these 
IRES-interacting proteins helps to facilitate IRES activity through stabilisation of 
the tertiary structure and enhancement of initiation factor binding (Belsham, 2005; 
Pilipenko et al., 2000). In FMDV, the initiation of translation occurs at two sites, 
84 nt apart, which are conserved across all seven serotypes. This results in the 
production of two forms of the first protein component of the polyprotein; the L 
proteinase (described below). The context of this arrangement remains largely 
unknown. 
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1.1.2.6 L proteinase 
The FMDV L proteinase (Lpro) is a papain-like cysteine protease, which cleaves 
itself from the viral polyprotein (Strebel & Beck, 1986). As well as cleaving itself 
from the polyprotein, Lpro is also involved in the cleavage of the eukaryotic 
translation initiation factor 4 gamma (eIF4G; Devaney et al., 1988; Kirchweger et 
al., 1994), resulting in the inhibition of host cap-dependent mRNA translation. 
FMDV translation is a cap-independent process and therefore does not require 
eIF4G for successful viral protein synthesis. As a result, host cell protein 
synthesis is rapidly inhibited without affecting FMDV translation (Belsham, 2005).  
Lpro contains two in-frame initiation codons, 84 nts apart, which are conserved in 
all natural FMDV isolates (Carrillo et al., 2005; Sangar et al., 1987) and  results in 
two forms being produced, Lab and Lb (Belsham, 2005). Mutagenesis of either 
initiation site, leading to the production of only one of these two forms, 
demonstrated that each form of proteinase behaves similarly in proteolytic 
activity: there is no effect on eIF4G cleavage or viral polyprotein processing (Cao 
et al., 1995). Despite the Lb form being the predominant form produced (Cao et 
al., 1995; Sangar et al., 1987), deletion of the Lb region is not important for virus 
viability (Piccone et al., 1995). As already mentioned, viruses containing the 84 nt 
Lab ‘spacer’ region, but lacking the Lb region, are viable; however, if this spacer 
region is then removed it is lethal for the virus (Belsham, 2013; Piccone et al., 
1995). Additionally, if the Lb start site is mutated within an infectious FMDV cDNA 
clone, allowing only the Lab form to be produced, virus cannot be rescued. When 
the reverse is performed, permitting the production of the Lb form only, viable 
virus can be obtained (Belsham, 2013; Cao et al., 1995). Furthermore, insertion 
of a 57 nucleotide sequence between the two initiation codons results in an 
attenuated phenotype in cattle, suggesting this region is important for virulence 
(Piccone et al., 2010).  
Lpro has been of particular interest in terms of vaccine development due to 
differences in replication kinetics observed with viruses encoding the differing 
forms. Piccone et al., (1995) found that viruses lacking the portion of L directly 
after the Lb initiation codon replicated less efficiently in BHK-21 cells. This 
replication was only slightly slower than the wild-type (WT)  virus, however, when 
tested in cattle the ‘partially leaderless’ virus had greatly reduced pathogenicity 
and did not spread from the initial site of infection (Brown et al., 1996). When this 
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virus was later tested in swine, similar results to those observed earlier in cattle 
were found (Chinsangaram et al., 1998). 
There is evidence that Lpro is involved in the regulation of genes associated with 
the innate immune system. Recently it was shown that interferon IFN-β and IFN 
stimulated gene (ISG) mRNA was significantly induced in cells transfected with 
leaderless FMDV compared to WT (de los Santos et al., 2006). Lpro has also 
been shown to be involved in the degradation of the p65/RelA subunit of nuclear 
factor kappaB (NF-κB) (de los Santos et al., 2007, 2009). 
 
1.1.2.7 2A protein 
The large polyprotein produced during FMDV translation is primarily cleaved into 
distinct domains through the action of virally encoded proteinases. However, 
separation of the capsid protein precursor from the downstream region encoding 
the replication proteins is achieved through the cleavage action of FMDV 2A. This 
oligopeptide is only 18 aa long and, unlike the virus-encoded 2A proteinase 
(2Apro) of the entero- and sapeloviruses, lacks protease activity (Martı́nez-Salas & 
Ryan, 2010). FMDV 2A-mediated cleavage occurs at its C-terminus, at the novel 
motif (DxExNPG
↓
P), via a novel translational recoding event termed “ribosome 
skipping” (Donnelly et al., 2001b). When the 2A region (in addition to the N-
terminal proline of FMDV 2B) was inserted into an artificial reporter system, such 
that CAT and β-glucuronidase (GUS) proteins flanked 2A, three major products 
were observed. These products consisted of uncleaved polyprotein [CAT-2A-
GUS], GUS and [CAT-2A], demonstrating that FMDV 2A was able to mediate  
cleavage in this artificial system in a similar manner to that observed during 
FMDV polyprotein processing (Ryan & Drew, 1994). The cleavage activity is 
sensitive to changes N-terminal to 2A, however, replacement of sequences 
downstream of the N-terminal proline of 2B does not affect activity (Ryan et al., 
1991). Using translation systems in vitro, a 2- to 5-fold molar excess of protein 
products encoded upstream of 2A over those downstream is routinely observed 
following quantification of cleavage products. The proposed model for this activity 
is the formation of a helix by 2A which interacts with the exit tunnel of the 
ribosome. The tight turn formed at the C-terminus of this helix, in addition to the 
interaction with the ribosome, is thought to prevent formation of the peptide bond 
at the P-site between the incoming prolyl-tRNA in the A-site. Prolyl-tRNA then 
dissociates from the ribosome and translation is ceased (Donnelly et al., 2001b). 
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Recent studies have shown the involvement of eukaryotic translation termination 
(release) factors 1 and 3 (eRF1/3) in 2A mediated cleavage. These factors 
facilitate the hydrolysis of ester bond leading to release of the nascent peptide 
(Doronina et al., 2008). 
 
1.1.2.8 2B and 2C proteins 
Infection of cells by picornaviruses leads to reorganisation of cellular membranes 
as sites for RNA replication. The enterovirus 2B protein has been shown to impair 
Golgi complex trafficking: calcium is released from the ER into the cytoplasm by 
forming pores within these membranes, reducing the ER luminal Ca2+ content 
(van Kuppeveld et al., 2005; Lin et al., 2009). The exact biological function of the 
picornavirus 2C protein remains unknown. It is thought to facilitate the 
rearrangement of membranes, along with 2B, due to the presence of a predicted 
amphipathic helix in its N-terminus. A conservd ATPase domain is located 
upstream of this predicted helix, with ATPase activity documented (Sweeney et 
al., 2010). The presence of a helicase domain has also been predicted, however, 
helicase activity has never been documented (Gorbalenya & Koonin, 1989; 
Palmenberg et al., 2010; Sweeney et al., 2010). It was demonstrated that FMDV 
3A, 2B, 2C, and 2BC expressed alone in vero cells associated with cellular 
membranes. The effect of cell trafficking was investigated and it was shown that 
2BC disrupted protein transport from the ER to the Golgi body, affecting protein 
delivery to the cell surface (Moffat et al., 2005).  
 
1.1.2.9 3A protein  
The 3A protein of picornaviruses differs in length, with the 153 aa of FMDV 3A 
being one of the largest described. Point mutations and deletions in FMDV 3A 
have been linked to altered host specificity, adaptation, attenuation and virulence. 
Repeated passage of FMDV in chicken embryos generated attenuated strains 
which contained deletions in the C-terminus of 3A (Dong-Sheng et al., 2011). A 
similar deletion was also found in the FMDV strain which caused the 1997 
outbreak in Taiwan. This outbreak only affected swine and had an abnormally 
high mortality rate. Beard & Mason, (2000) discovered that this virus contained a 
10-amino-acid deletion (aa 93-102) in the C-terminus of 3A. It has been 
suggested that mutations in the region surrounding the deletion (aa 73-143) 
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could also be a factor in the modified host range (Knowles et al., 2001). FMDV 
isolates from pigs carrying deletions in 3A (Type O aa 93-102; Asia-1 aa 133-
143) grew well in porcine cells and caused disease in swine, but displayed 
restricted growth in bovine cells in vitro and significant attenuation in bovines in 
vivo (Pacheco et al., 2003). Furthermore, a single mutation within 3A mediates 
adaptation of FMDV to the guinea pig demonstrating the involvement 3A has in 
host range (Núñez et al., 2001).  
Both FMDV and poliovirus proteins associate with the ER and both have 
hydrophobic domains that could explain this association, but the N- and C-termini 
are very different, with FMDV 3A having a C-terminal extension of ~50 aa (Moffat 
et al., 2005). Poliovirus 3A inhibits protein trafficking from the ER to the Golgi, 
and it was postulated that FMDV 3A may have a similar role. It was, however, 
shown that in FMDV, 2BC, and not 3A, has this role (Moffat et al., 2005). 
 
1.1.2.10 3B (VPg) protein 
The 3BVPg protein is covalently attached to the 5’-end of both positive and 
negative RNA genomes. This linkage is made through a conserved tyrosine 
within 3BVPg with a phosphate of the terminal uridine present at the 5’-end of the 
genome. FMDV is unique in comparison to other picornaviruses as it contains 
three copies of the 3BVPg protein in the viral genome (Forss & Schaller, 1982; 
Forss et al., 1984). Seal aquamavirus A1 and mosavirus contain two 3BVPg 
proteins (Kapoor et al., 2008; Phan et al., 2011; Reuter et al., 2014), with all other 
members of this family containing one copy of 3BVPg. All three FMDV 3BVPg 
copies have been found attached to virion RNA within infected cells, but the exact 
significance of this remains unknown. Viruses produced which lacked the normal 
number of 3BVPg copies, or contained mutated copies, were shown to produce 
decreased RNA yields and had an effect on infective particle formation (Falk et 
al., 1992). All three copies of 3BVPg are uridylated for priming of RNA transcription 
by 3Dpol (see 1.2.2); however 3BVPg3 shows the highest activity (Nayak et al., 
2005). 
 
1.1.2.11 3C and 3D proteins 
FMDV 3Cpro performs most of the polyprotein processing which generates the 
mature and intermediate protein products (see 1.2.3). It is a member of the 
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trypsin-like serine proteases, however, it was confirmed during mutagenesis 
experiments that the active site consisted of a cysteine rather than a serine 
(Grubman et al., 1995). The predominant function of FMDV 3Cpro is polyprotein 
processing, however it has also been shown to modify host cell proteins. Falk et 
al., (1990) demonstrated cleavage of histone H3 by 3Cpro during infection. Other 
cellular targets include the cap-binding components eIF4A and eIF4G. Cleavage 
of eIF4G occurs at the C-terminus of the site generated by Lpro activity (Belsham 
et al., 2000).  
Precursors containing 3Cpro retain catalytic activity (P3, 3ABC, 3CD). PV 3CDpro 
is involved in processing the capsid protein precursor (Ryan & Flint, 1997) and 
has a role in RNA replication (see 1.2.2). 
The 3D protein is an RNA-dependent polymerase, and like other RNA-dependent 
polymerases is error prone: ~1-2 nucleotides are misincorporated per genome-
copying event (Ward et al., 1988). 3Dpol is involved in catalysing the synthesis of 
positive and negative sense RNA during viral replication. Uridylated 3BVPg is 
required as a primer by 3Dpol to initiate replication of either strand (Paul et al., 
1998). The functional domain of 3Dpol is a GDD motif and is conserved within the 
picornaviruses, and similar to the YXDD motif conserved amongst other RNA 
polymerases (Stanway, 1990). 
 
1.1.2.12 3’ UTR and poly(A) tail 
The 3’ UTR of FMDV encodes two stem-loop structures (Witwer et al., 2001) 
followed by a poly(A) of varying length: the length of the poly(A) tract has been 
implicated to be important for both infectivity of PV RNA (Sarnow, 1989; Spector 
& Baltimore, 1974) and negative-strand RNA synthesis (Silvestri et al., 2006). 
 It has been shown that deletion of the 3’ UTR of FMDV abolishes viral replication 
(Saiz et al., 2001), whereas PV  replication can occur when this region is deleted, 
albeit at a reduced level (Todd et al., 1997). Deletion of SL1 within the 3’ UTR is 
tolerated, however, deletion of SL2 is lethal for virus viability. Viruses containing 
the SL1 deletion displayed reduced growth kinetics and were attenuated when 
inoculated in swine (Rodríguez Pulido et al., 2009). The 3’ UTR interacts with 
both the S-fragment and the IRES domains within the 5’ UTR (Serrano et al., 
2006). Both the SL1 and SL2 stem-loops were required to interact with the IRES, 
whereas the S-fragment could form contacts with either of these structures. 
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Additionally, the S-fragment─3’ UTR interaction was dependent on the presence 
of the poly(A) tail. When the 3’ UTR was mixed with cellular extracts, co-
precipitation occurred with both poly(rC)-binding protein 2 (PCBP2) and poly(A)-
binding protein (PABP): both of which are involved in the replication of other 
members of the picornavirus family (see 1.2.2). 
 
1.2 Viral life-cycle 
1.2.1 Virion structure and cell entry 
FMDV particles are non-enveloped, icosahedral particles with a diameter of ~25-
30 nM. The capsid is comprised of 60 copies of each of the structural proteins 
1A-D which form into capsomers (Figure 1.4). Proteins 1B-D (VP2, 3 and 1) fold 
into a wedge-shaped β-barrel structure. The loops from each β-barrel connect the 
individual proteins, with some of the loops decorating the virus surface. The 1A 
protein, however, is located within the capsid and contains a myristyl group 
attached to its N-terminus (Fry & Stuart, 2010). It is known that this myristolation 
is essential for capsid assembly within PV (see 1.2.4; Marc et al., 1991). 
Members of the picornaviruses contain a surface canyon, or pit, on the outer 
surface of the viral particle; FMDV, however, lacks this surface feature. FMDV 
capsids are relatively smooth structures with the exception of a long loop 
belonging to 1D (VP1). This GH loop contains a highly conserved RGD motif 
which is essential for cell attachment (Fox et al., 1989; Mason et al., 1994). The 
C-terminal portion of this loop (~140-160 aa) is the main antigenic site, to which 
most of the immune response is directed (Novella et al., 1993). 
FMDV binds to cell surface αvβ integrins (αvβ1, αvβ3, αvβ6, αvβ8) and enters the cell 
through clathrin mediated endocytosis (Burman et al., 2006). This is followed by 
acidification of the endosome which disrupts the particle, releasing the viral RNA 
into the cytoplasm (Levy et al., 2010). 
 
1.2.2 Genome replication 
There have been very few studies which have focused on transcription and 
replication in FMDV. This process has been studied extensively within 
enteroviruses; therefore analogies have to be made with FMDV. 
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Picornaviruses replicate their RNA in close association with host-cellular 
membranes. This results in major rearrangements of these membranes to create 
vesicular structures upon which virus genome replication takes place (Bienz et 
al., 1990; Schlegel et al., 1996). For most members of the picornaviruses these 
membrane structures cluster around the perinuclear region and occupy most of 
the cytoplasm (van Kuppeveld et al., 2010). FMDV is one of the few exceptions, 
displaying distinct membrane vesicles which do not cluster and are present in 
fewer numbers (Monaghan et al., 2004). 
Before replication can begin, the viral RNA must be translated to produce the 
viral proteins required for subsequent replication. It is postulated that translation 
of the positive strand has to end before negative strand synthesis can 
commence. Using PV as a model, it was shown that accumulation of 3CDpro 
repressed translation while PCBP, which interacts with the IRES of PV, enhanced 
translation in infected cells. It is thought that 3CDpro binds to the 5’ cloverleaf (CL) 
structure within the 5’ UTR and alters the affinity of PCBP for the IRES, causing a 
switch from translation to replication (Gamarnik & Andino, 1998). 
The first step in viral RNA synthesis is the uridylation of 3BVPg by 3Dpol. Uridylated 
3BVPg (3BVPgpUpU) then acts as a primer for initiation of transcription. It is thought 
that the cre acts as the primary site for uridylation of 3BVPg by 3Dpol. Using cell-
free assays, it was demonstrated for PV that 3BVPg could be uridylated by 3Dpol 
and this reaction was strongly stimulated by the addition of purified 3CDpro. 
Deletion of the cre abrogated the synthesis of 3BVPgpUpU in the presence or 
absence of 3CDpro (Paul et al., 2000). It has, however, been shown that the 
poly(A) RNA can also act as a site for uridylation (Paul et al., 1998). FMDV does 
not seem to need the poly(A) as a template, with the cre proving critical for 
uridylation (Nayak et al., 2005). Therefore, it seems differences occur for this 
reaction between members of the picornavirus family. 
Elongation of the negative strand commences once the primer (3BVPgpUpU) is 
translocated to the 3’-end of the positive strand. This process is unknown; 
however, it is proposed that binding of PABP to the poly(A) tail positions the 3’-
end of the positive strand in close proximity to the cre to facilitate this process 
(Grubman & Baxt, 2004). It has been shown for PV that a circular RNP complex 
forms between proteins bound to both the 5’ CL structure and the poly(A) tail. 
PCBP and 3CDpro bind to stem-loops within the cloverleaf (Gamarnik & Andino, 
2000; Parsley et al., 1997) and interact with PABP bound to the poly(A) tail 
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(Herold & Andino, 2001). Deletion of the 5’ CL abolishes negative-strand 
synthesis, and disruption of this structure leads to a decrease in synthesis 
(Barton et al., 2001; Herold & Andino, 2001). The requirement of this 5’ structure 
for negative-strand synthesis at the 3’ end supports the idea of genome 
circularisation as a necessary step in replication. As described previously, it has 
been shown that the 3’ UTR of FMDV interacts with both PCBP, PABP and the 5’ 
S-fragment (Serrano et al., 2006); therefore, although the precise mechanisms of 
negative RNA synthesis remain largely unknown, it appears that similarities exist 
amongst picornaviruses. 
Synthesis of negative-strands is thought to produce a double-stranded replicative 
form (RF) consisting of template and newly-synthesised RNA. The ratio of 
positive to negative strands is around 50:1 and essentially no ‘free’ negative 
strands are found within infected cells (Rozovics & Semler, 2010). A replicative 
intermediate (RI) is thought to exist, where a single negative strand is the 
template for the synthesis of numerous positive strands. The details involved in 
the initiation of positive-strand synthesis are not largely explained, but the cellular 
RNA binding-protein heterogeneous nuclear ribonucleoprotein C (hnRNP C) and 
viral proteins 2C and 3C/3CDpro have been implicated as important factors for this 
process (Ertel et al., 2010), as well as the 3’ UTR (Brown et al., 2004) and the 5’ 
CL (Sharma et al., 2005).  
Detailed descriptions of genome replication are described in the following book 
chapters (Kirkegaard & Semler, 2010; Rozovics & Semler, 2010). 
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Figure 1.4. FMDV virion structure. The structural proteins 1A (VP4), 1B (VP2), 
1C (VP3) and 1D (VP1) arrange into protomeric and pentameric units. These 
units assemble to form the virion containing 60 copies of each structural protein. 
1A is located internally within the capsid and is not shown. Particles lacking an 
RNA genome have been shown to occur (adapted from Jamal & Belsham, 2013). 
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1.2.3 Translation and polyprotein processing 
As mentioned above, translation of picornavirus RNA is driven by the IRES 
element. This is in contrast to cellular translation which relies on a cap structure 
(m7Gppp) at the 5’-end to initiate translation. Translation therefore proceeds in a 
cap-independent manner. This is facilitated by proteolysis of specific eukaryotic 
initiation factors (eIF), favouring IRES-driven translation, and allowing for the use 
of host cell translation machinery. Initiation of translation via the IRES involves 
recruitment of the translation machinery to an internal region on the viral RNA 
(Martı́nez-Salas & Ryan, 2010). 
Picornavirus genomes encode a long, single ORF which would be predicted to 
generate a large polyprotein once translated. This full-length translation product 
is never observed in cells during infection due to the rapid proteolytic activity of 
viral encoded proteinases which occur both co- and post-translationally (Figure 
1.5). Primary processing consists of co-translational cleavages which separate 
the capsid precursor from the downstream region encoding the replication 
proteins. FMDV (and other genera) utilises a novel translational recoding event 
encoded by the 2A oligopeptide which mediates release at the 2A/2B junction. 
Other genera within the picornavirus family achieve this through 3Cpro 
(hepatoviruses), or 2Apro (entero- and sapeloviruses) mediated cleavage 
(Martı́nez-Salas & Ryan, 2010; Ryan & Flint, 1997). A second primary processing 
event occurs at the region between 2C/3A and is performed by 3Cpro (Ryan & 
Flint, 1997). An additional processing event involves the release of Lpro from the 
polyprotein via auto-catalytic cleavage between its C-terminus and the N-
terminus of 1A. These primary cleavages result in the formation of protein 
precursors which undergo further processing. Generation of “intermediate” and 
“mature” forms is mediated by 3Cpro.  
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Figure 1.5. Polyprotein processing within the picornaviruses. Primary (black 
triangles) and secondary cleavages mediated by 3Cpro (rounded arrows) are 
shown. (A) The P1 precursor is processed by 3CDpro, rather than 3Cpro, amongst 
enteroviruses. (B) Aphthoviruses mediate [P1-2A] processing (into 1AB, 1C, 1D 
and 2A) by both 3C and 3CD proteinases. The multiple copies of 3BVPg within the 
P3 precursor makes processing a highly complex event as several alternative 
processing events occur, giving rise to many protein forms. (C) Viruses which 
lack L or 2A proteinases are processed by 3Cpro or 3CDpro. A host cell proteinase 
is responsible for cleavage of the 1D/2A site within hepatoviruses (arrow with 
dotted line; image adapted from Martı́nez-Salas & Ryan, 2010). 
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1.2.4 Encapsidation and maturation 
The processes involved in encapsidation and the maturation ‘cleavage’ remain 
largely unknown. Two proposed models of encapsidation exist. The first model 
implies that empty capsids form (by the assembly of pentamers into the capsid 
structure; Figure 1.4) and the viral RNA is inserted following this assembly. The 
second model proposes an interaction between the capsid pentamers and the 
viral RNA, forming a provirion (a viral particle which contains an uncleaved 1AB 
(VP0) protein; (Grubman & Baxt, 2004). The maturation cleavage of 1AB (VP0) is 
the final stage in encapsidation. It is believed that this cleavage is autocatalytic, 
and is usually observed during encapsidation of viral RNA. This step is thought to 
involve the activation of water molecules, which leads to nucleophilic attack at the 
scissile bond. For FMDV, a conserved histidine (2145H within 1B [VP2]) located 
close to the VP0 cleavage site is responsible for this cleavage reaction (Curry et 
al., 1997). This 1AB ‘cleavage’ event is required for particle stability, as 
interactions are made between regions of the pentamers following release of both 
1A and 1B (VP4 and VP2). Additionally, prevention of 1AB (VP0) cleavage via 
mutagenesis results in a loss of infectivity, demonstrating that this event is 
important for the generation of infectious virus (Knipe et al., 1997). 
 
Figure 1.6 shows a summary of the life cycle which has been described within 
section 1.2. 
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Figure 1.6. Picornavirus life cycle. Major events which occur during viral infection are summarised. Detailed 
descriptions are provided within the text (image adapted from Whitton et al., 2005)
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1.3 Foot-and-mouth disease 
FMD is one of the most important animal diseases known and currently affects 
many parts of the world. The disease affects cloven-hoofed animals such as 
cattle, sheep, pigs, goats and ~70 species of wildlife including African buffalo and 
deer (Grubman & Baxt, 2004; Jamal & Belsham, 2013). In European strains of 
domestic animals, FMDV rapidly replicates and spreads, with signs of disease 
appearing after 2-3 days. In buffalo, however, strains SAT 1, 2 and 3 cause 
inapparent, persistent, infections. Clinical features of the acute form of the 
disease include fever, viremia, excessive salivation and vesicular lesions which 
form on the oral mucosa, nose and feet. The virus is excreted into bodily fluids 
such as semen, urine and in the milk of dairy cattle as well as in faeces.  FMD is 
rarely fatal in adult animals; however it can adversely affect the heart function of 
young animals and may cause high mortality (Grubman & Baxt, 2004). The 
clinical signs of FMD are similar to other diseases, such as SVDV and VSV, and 
therefore it is necessary for diagnosis to be made using laboratory methods. 
Current diagnostics include the “gold standard” virus neutralisation test (VNT), 
ELISA, qRT-PCR and nucleotide sequencing. Determination of the serotype 
involved in outbreaks is crucial for the implementation of proper control strategies 
(Jamal & Belsham, 2013).  
FMD is highly infectious and transmission occurs through many different routes. 
The most common means of transmission are direct contact between infected 
and susceptible animals, through distribution/disposal of contaminated food 
products or by indirect contact through contaminated personnel, vehicles and 
aerosols (wind-borne). Illegal activities have also contributed to spread of the 
disease by the importation of infected meat, illegal movement of animals and the 
feeding of non-heat treated swill to pigs (Sutmoller et al., 2003). 
Following the acute stage of infection FMDV can cause persistent infection in 
ruminants, which has no clinical signs i.e. the carrier state. Carrier animals are 
defined as animals which are virus positive for 28 days or more post infection 
(Grubman & Baxt, 2004; Sutmoller et al., 2003).  These animals show no clinical 
symptoms of the disease and can remain in this state for a long period of time (2- 
3 yrs in domestic cattle; Jamal & Belsham, 2013). The carrier state is 
characterised by isolation of live virus from the pharynx and can also occur in 
vaccinated animals. The site of this persistent viral replication is proposed to be 
the light zone of germinal centres (GC). Tissues (tonsils, lymph nodes and soft 
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palate) isolated from cattle 38 days post-infection were shown to harbour FMDV 
genomes and were restricted to the GCs (Juleff et al., 2008). The role of carrier 
animals in the spread of virus in the field is still largely unknown. It is possible that 
these animals may facilitate in the spread of disease, but this has only been 
shown for African buffalo during an outbreak, and has not been demonstrated in 
experiments with cattle (Grubman & Baxt, 2004; Jamal & Belsham, 2013). The 
mechanisms underlying persistent infection are not well understood, but it has 
been proposed that the immune status of the animal has a direct role (Grubman 
& Baxt, 2004). Due to the occurrence of persistent infection, it is difficult to 
differentiate between infected and vaccinated animals (DIVA). This causes 
problems with trade, as it is important to be able to distinguish between 
previously infected and those that have been vaccinated. Vaccination causes the 
production of antibodies raised against the coat protein only. When animals are 
infected by field isolates of the virus, replication produces both structural and 
non-structural proteins (NSP), therefore it is possible to discriminate between the 
antibodies induced by vaccinated and those induced by infected animals. 
However, repeated vaccination using vaccine that has not been purified, and 
therefore contains contaminating NSPs, can affect serological tests undertaken 
(Jamal & Belsham, 2013; Sutmoller et al., 2003). 
As mentioned previously, FMDV exists as seven different serologically distinct 
serotypes, and various subtypes occur within each serotype. These serotypes 
are distributed geographically with serotypes O, A and C having the widest 
distribution. The SAT 1-3 viruses are usually limited to sub-Saharan Africa and 
Asia-1 viruses are normally restricted to Asia; these viruses have, however, 
caused limited outbreaks in other regions. There is a tendency for the virus to 
recur in the same geographical area, despite the propensity for it to spread to 
surrounding areas and cause small outbreaks. It is thought this is due to 
ecological isolation which may reflect patterns of animal movement and trade, 
and has resulted in the creation of seven regional pools (Figure 1.7). There are 
more than 100 countries affected by FMD worldwide. The distribution of the 
disease reflects economic development, with more developed countries having 
disease-free status. The occurrence of FMD poses a potential threat to countries 
who have eradicated the disease. 
Financial losses caused by an FMD outbreak are high due to loss of meat, milk 
and livestock. Eradication and control costs, as well as indirect costs associated 
with tourism and trade restrictions, contribute to these losses (Grubman & Baxt, 
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2004). The recent 2001 outbreak in the UK was estimated to cause losses of 
12.3-13.8 billion USD. This outbreak also resulted in the culling of 6.5 million 
animals. Large outbreaks in recent years have occurred in Taiwan, Japan and 
South Korea all contributing to huge economic consequences (Jamal & Belsham, 
2013). 
 
1.3.1 Disease control 
Until 1991, continental Europe (except Denmark) systematically vaccinated 
against FMDV. Britain and Ireland, however, did not undertake this strategy and 
as a result these countries had certain trading advantages over other European 
nations. The European Union therefore decided to abolish general vaccination to 
harmonise trading positions (Sutmoller et al., 2003). Benefits to stopping routine 
vaccination include reduction in costs associated with vaccine administration, 
less trade restrictions and problems associated with vaccinating animals such as 
immune surveillance, dispersed herds and persistent infections in vaccinated 
animals. Countries currently control FMD outbreaks by killing and destroying all 
infected animals and inhibition of animal movement, with ring vaccination 
employed during extreme cases. 
 
1.3.1.1 Vaccines 
Of the picornavirus family members, only three agents have commercial vaccines 
available; PV, HAV and FMDV. Initial experiments demonstrating protective 
immunity against these viruses involved the use of immune serum (FMDV) or 
immunoglobulins (PV and HAV). These procedures were, however, impractical 
on a large scale. Current picornavirus vaccines are produced through the growth 
of virus in tissue culture under stringent bio-containment conditions – dramatically 
increasing the cost of vaccine production and storage. The final product must be 
free from cell culture contaminants or infectious agents. These days, inactivation 
(innocuity) and testing (efficacy) is better regulated and such contaminants are 
less likely to occur. The escape of virulent virus from vaccine production facilities, 
however, still remains a large problem with current production strategies (Doel, 
2003).  
Attenuated vaccines consist of viruses which replicate to a minimal level without 
inducing clinical symptoms of the disease. As replication imitates natural 
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infection, a high dose is unnecessary as amplification occurs via the altered 
agent. Desirable advantages include the immune response elicited following 
vaccination as full activation of the relevant immune components occurs. The 
main risk associated with attenuated vaccines is the potential for reversion to 
virulence, with uncontrolled replication or persistence also factors to be 
considered. Inactivated preparations contain viral particles which are unable to 
replicate. The does required is much higher than that of attenuated vaccines due 
to the antigen load needed to produce an adequate immune response (Rowlands 
& Minor, 2010).  
 
1.3.1.1.1 PV vaccines 
The live and inactivated vaccines produced against poliovirus are the most well 
documented of those mentioned thus far. Like FMDV, PV exists as distinct 
serotypes; 1, 2 and 3, and again, like FMDV, protection against one serotype 
does not confer protection against others. Vaccine preparations therefore contain 
a strain from each serotype.  
The inactivated polio vaccine (IPV) developed by Salk was made by inactivating 
PV harvested from infected tissue culture cells with low levels of formalin for 
prolonged periods of time. This was performed to ensure the virus was killed 
without destroying its antigenicity, as PV particles are easily disrupted through 
chemical stress such as heating, UV etc. This vaccine preparation is still used at 
present and has been very effective (Rowlands & Minor, 2010). As mentioned 
previously, there are risks associated with chemically inactivating large amounts 
of pathogenic virus. This was documented for IPV following successful 
vaccination throughout the USA. Cases of poliomyelitis were reported and it was 
soon realised that these cases arose from insufficient chemical inactivation of the 
vaccine. Termed the ‘Cutter Incident’ after the manufacturer involved, it lead to 94 
cases of poliomyelitis and ~160 contact cases (Nathanson & Landmuir, 1995). 
The attenuated oral polio vaccine (OPV) developed by Sabin was produced by 
passaging viruses in tissue culture cells at high or low MOI and suboptimal 
temperatures. This vaccine was used as the basis for the polio eradication 
program and helped to stop this disease from remaining a public health problem. 
Vaccine-derived cases of poliomyelitis have occurred using this vaccine, and it is 
now well documented that this vaccine is able to revert to neurovirulence. For 
example, for all three serotypes, the main neurovirulent attenuating mutation is a 
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single point mutation which lies in domain V of the IRES within the 5’ UTR. It has 
been shown that this mutation leads to a reduction in translation efficiency 
causing an attenuated phenotype  (Ochs et al., 2003; Rowlands & Minor, 2010). 
 
1.3.1.1.2 FMDV vaccines 
There have been several tried, and failed, attempts to generate a live-attenuated 
vaccine for FMD. The genetic stability of the attenuated viruses was not sufficient 
enough to be used within the field without the risk of reversion to virulence. 
The current vaccine for FMD exists as an inactivated vaccine preparation. The 
first functional inactivated vaccines involved chemical inactivation with 
formaldehyde. Virus was isolated from vesicular fluid extracted from lesions on 
the tongues of purposely infected cattle. The first in vitro production method 
involved work by Frenkel who infected suspensions which were produced from 
tongue harvested from healthy cattle (Rowlands & Minor, 2010). This finding 
demonstrated the potential for large scale production of FMD vaccine, however 
the breakthrough for FMD vaccine production was made by Mowat & Chapman, 
(1962) who revolutionised production methods through the growth of virus in 
BHK-21 cells. Initially, cells were grown in monolayers; however this was soon 
replaced by growth in suspension allowing vaccine production involving large-
scale tissue culture fermenters (Telling & Elsworth, 1965). The vaccine 
production process is summarised in Figure 1.8 (Doel, 2003). As the process 
involves chemical inactivation of pathogenic virus, vaccine production takes place 
within a high security biocontainment facility. Formaldehyde has been replaced 
by ethylene imines due to formaldehyde inactivation often proving incomplete (as 
demonstrated by the Cutter Incident). BHK-21 suspension cells grown in large 
stainless steel vessels are infected with virus and non-structural proteins/cell 
debris are removed using centrifugation or filtration. Binary ethylenemine (BEI) is 
mixed with the virus for the inactivation process. The inactivated antigen is then 
purified using ultrafiltration and chromatography, which is stored in the gaseous 
phase of liquid nitrogen units until required (Doel, 2003). 
The multiplicity of FMDV serotypes and subtypes add an element of complexity to 
FMD vaccine production, with vaccine preparations being tailored to specific 
world regions/countries (virus pools, Figure 1.7). Adjuvants are required within 
FMD vaccine preparations as they are essential for sufficient potency. Aluminium 
hydroxide and saponin are widely used for ruminants with oil based adjuvants 
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being preferred for vaccination of pigs. Other drawbacks associated with the 
current vaccine include; poor induction of long-term immunity (especially within 
pigs) with repeated boosters required, short shelf life and a sufficient cold chain is 
required (Rodríguez & Grubman, 2009). 
A rapid humoral response is produced in both infected and vaccinated animals. 
Antibodies specific to FMDV protect animals against re-infection, or infection in 
the case of vaccinated animals. This protection is normally correlated with a high 
level of neutralising antibodies and the literature suggests that both macrophage 
and antibody activity may be required (Mccullough et al., 1992). 
 The role of cellular immunity in protection from FMD is still a matter of some 
debate. T cell responses, CD4+ and CD8+, have been observed in either infected 
or vaccinated animals and a correlation between antibody and T cell responses 
has been reported (Grubman & Baxt, 2004), however, more work is required to 
determine the importance of cellular immunity in protection. 
Due to the disadvantages of the current commercial vaccine available for FMD, 
alternative strategies are required to improve the security-associated risks (e.g. 
the 2007 UK outbreak), as well as broadening the immune response to include 
cell-mediated responses. 
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Figure 1.7. FMDV virus pools and their geographical distribution. The most 
widely distributed serotype is O and is found in 6 out of the 7 pools. Serotypes 
Asia-1 and SAT 1-3 are the most geographically limited. FMDV-free countries are 
shown in off-white (adapted from Jamal & Belsham, 2013). 
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Figure 1.8. FMD vaccine production. Highly pathogenic virus is grown in large 
fermenters, chemically inactivated, and purified to remove adventitious agents 
(figure taken from Doel, 2003). 
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1.4 Reverse genetics systems 
Reverse genetics systems are important as they serve as tools to modify regions 
of the viral genome whereby the effects of such modifications can then be 
studied. Manipulation of the genome can be performed in a strategic manner to 
create pre-determined alterations and investigate the effects of such changes. 
This helps to gain insight into viral functions and the use of derivatives that differ 
from WT for vaccine development and characterisation of the life cycle. They also 
decrease the need for stringent, high-containment facilities, where genome 
alterations make resulting virus that is less (or completely) un-infectious, and 
therefore safer to handle outwith BSL3/4 labs. 
1.4.1 Reverse genetics and synthesis of viral RNA 
The first reverse genetics system was invented in the 1970s by Charles Wiseman 
and colleagues (Taniguchi et al., 1978). Using reverse transcriptase, Wiseman 
and colleagues made a double-stranded cDNA from purified phage Qβ RNA. 
Once this cDNA was inserted into a plasmid it produced Qβ phage when 
transformed into bacteria (Taniguchi et al., 1978). Viral RNA can now be 
prepared readily for a wide range of RNA viruses. Generation of reverse genetics 
systems has been more difficult for negative strand RNA viruses due to reasons 
such as; the need for precise 5’ and 3’-ends for replication and genome 
packaging, the viral polymerase being essential for transcribing both the genomic 
and antigenomic RNA, and due to genomes forming RNP complexes. Reverse 
genetics systems for negative strand RNA viruses can comprise full-length cDNA 
plasmids (unsegmented genomes) or multiple plasmids (segmented genomes) 
which contain promoters such as phage T7 RNA polymerase or endogenous 
promoters, RNA polymerase I or II. Plasmid DNA is transfected into cells 
producing viral particles. For those systems which use T7-based promoters, T7 
RNA polymerase must be supplied in trans through plasmid-based expression, 
cell lines constitutively expressing T7 RNA polymerase, or through superinfection 
with a vaccinia virus vector encoding the T7 polymerase. Some systems also 
require the cDNA plasmids to be transfected along with expression plasmids for 
the viral proteins involved in forming the ribonucleoprotein (RNP) complex 
(reviewed in Hoenen et al., 2011; Pekosz et al., 1999).  
Rescue of positive sense RNA viruses from cDNA plasmids has proven more 
straight forward than those from the negative sense. Viral transcripts are made 
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using the corresponding bacterial polymerase and these transcripts are 
transfected into cells. This cDNA can be genetically manipulated and the 
phenotype observed from rescuing the corresponding infectious virus.  
The first publication demonstrating a eukaryotic RNA virus reverse genetics 
system was from Racaniello and Baltimore (Racaniello & Baltimore, 1981), who 
obtained authentic PV from a cDNA plasmid encoding the PV genome. When this 
plasmid was transfected into HeLa cells PV was produced at very low yields. This 
system was improved a few years later via the insertion of simian virus 40 (SV40) 
transcription and replication signals which increased virus yield by 18-250-fold 
depending on the cell type used (Semler et al., 1984). The use of bacterial 
polymerases such as Salmonella enterica serovar Typhimurium phage SP6 or 
phage T7 RNA polymerase to transcribe viral cDNA from plasmids was a further 
advance in this field for a range of picornaviruses such as Coxsackie B3, 
Cardioviruses, Human Rhinovirus 14, Hepatitis A virus and FMDV (Cohen et al., 
1987; Duke & Palmenberg, 1989; Kandolf & Hofschneider, 1985; Mizutani & 
Colonno, 1985; Zibert et al., 1990). A study by Kaplan et al., involved 
transcription of PV RNA in either direction using the SP6 RNA polymerase. 
These transcripts were not initially infectious (Kaplan et al., 1985). Infectious 
transcripts could only be achieved by employing a strategy that involved PV 
replicase (now known as 3Dpol), which used negative strands transcribed by SP6 
RNA polymerase as template for positive strand synthesis. When these 
transcripts were transfected into HeLa cells the yield was very poor in 
comparison to isolated PV RNA. In the same year, another study was published 
which used T7 RNA polymerase to generate PV transcripts in both orientations 
(van der Werf et al., 1986). Positive-sense transcripts were much more infectious 
than the plasmid alone; however they were only ~0.1% as infectious as purified 
viral RNA (van der Werf et al., 1986). Transcripts produced this way contained 
non-viral nucleotides at both termini of the PV transcript RNA introduced by the 
bacterial polymerase (Clark, 1988; Milligan et al., 1987) and through cloning. 
Removal of these extra sequences; leaving 2 guanine residues after the T7 
promoter and no more than seven nucleotides (nts) past the poly(A), resulted in 
transcripts with increased infectivity: 5 % that of viral RNA (van der Werf et al., 
1986). Removal of large 5’ sequences therefore helped to increase infectivity: 
SP6 negative strand PV transcripts made by Kaplan and colleagues contained 
190 and 82 nts at the 5’ and 3’-ends respectively. This explains the low infectivity 
observed upon transfection of these transcript RNAs. 
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1.4.1.1 Improvement of reverse genetics systems using autocatalytic 
ribozymes 
As mentioned in the previous section, the effect of nonviral nucleotides at the 
ends of transcript RNA can decrease infectivity of viral transcripts. These 
nucleotide extensions arise from additions by bacterial polymerases (Clark, 1988; 
Milligan et al., 1987) and through cloning techniques used to insert the viral cDNA 
into the vector backbone. The importance of removing extensions from the 5’-end 
of positive strand RNA genomes has been demonstrated for Sindbis and Semliki 
Forest virus (Liljeström et al., 1991; Rice et al., 1987) and the picornaviruses 
CVB3, Echovirus 5 and PV (Herold & Andino, 2000; Israelsson et al., 2014; 
Klump et al., 1990). When a self-cleaving hammerhead (HH) ribozyme 
(Uhlenbeck, 1987) was inserted between the T7 promoter and the PV 5’ UTR, 
transcripts produced had authentic ends and replicated more efficiently in 293 
cells with no lag in replication (Herold & Andino, 2000). This was a vast 
improvement on the infectivity and fitness (compared to isolated viral RNA) 
achieved by van der Werf et al., (1986) when PV transcripts contained two 
guanine residues at the 5’ terminus. These transcripts were also able to replicate 
efficiently within Xenopus laevis oocytes which had not been achieved previously.  
Extensions to the 3’-end of positive strand RNA viruses such as Kunjin and 
Sindbis virus can have a profound affect on replication/infectivity (Dubensky et 
al., 1996; Khromykh et al., 2003). Picornaviruses, however, can tolerate 3’ 
additions, unlike extensions to the 5’-end of the genome.  Sarnow (1989) studied 
the effect of 3’ extensions on the infectivity of PV transcript RNA. The addition of 
17 cytosine residues (after the poly(A) tail) decreased infectivity, while a 
reduction to 4 residues increased the infectivity to 10% of virion RNA.  A precise 
3’-end is critical for rescue systems coding for negative sense RNA viruses as 
this contains important replication signals, as well as the importance of the "rule 
of six” where the N protein must cover exactly 6 nt: if this is not followed, the RNA 
is poorly replicated or not at all.  An exact 3’-end is also thought to be important 
for accessibility by the polymerase for RNA synthesis via “open ends” (Ghanem 
et al., 2012; Pattnaik et al., 1992). Introduction of the hepatitis delta virus (HDV) 
ribozyme (Perrotta & Been, 1991) into a rabies virus (RV) reverse genetics 
system improved virus rescue 10-fold, with a 100-fold increase achieved by 
combination of both HH and HDV ribozymes, demonstrating the considerable 
effect ribozymes can make to reverse genetics systems. 
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1.4.1.2 The use of reporter proteins in mini-genome/replicon systems 
Mini-genome or mini-replicon systems can also be used to study characteristics 
of the viral life cycle. These include a reporter protein such as GFP, luciferase or 
chloramphenicol acetyltransferase (CAT) in place  of, or in frame with, viral 
coding sequences (Albariño et al., 2013; McInerney et al., 2000; Mueller & 
Wimmer, 1998). Mutational analysis of viral genome regions can be monitored by 
reporter protein analysis to determine their effects. Attenuation for vaccine 
development and the effect of antivirals on viral replication can also be monitored 
through the use of such systems. 
Using fluorescently-tagged viruses as tools to further characterise the viral life 
cycle has been investigated for various RNA viruses. Viral proteins can be tagged 
and monitored over time, or the virus particles themselves can be fluorescent. 
Attempts to do this using FMDV (Seago et al., 2013), PV (Mueller & Wimmer, 
1998) and CVB3 (Tong et al., 2011) have proven to be quite unsuccessful. In 
both studies the GFP (and Renilla luciferase in the case of FMDV) sequence was 
rapidly deleted after serial passage (~P4), and replication was impaired by the 
insertion of GFP into the viral genome sequence. Packaging limits of the viral 
capsid and stability of the RNA genome following GFP insertion were thought to 
be the attributing factors to the results seen by both groups. Tagging negative 
sense RNA viruses has been more successful with Marburg (Albariño et al., 
2013) and Influenza viruses (Manicassamy et al., 2010) both producing 
recombinant tagged virus. Thus, as tagging of positive sense RNA viruses such 
as PV and FMDV has proven to be a challenge, mini-replicon systems are a 
suitable alternative. 
Experiments investigating defective interfering (DI) particles of PV demonstrated 
that packaged virus genomes lacking the capsid coding region could infect and 
replicate within cells, but could not synthesise capsid proteins (Kajigaya et al., 
1985; Lundquist et al., 1979; Nomoto et al., 1979). Sequence analysis of these DI 
genomes showed that the correct reading frame for protein synthesis was 
retained (Kuge et al., 1986). DI genomes were packaged by capsid proteins from 
co-infecting wild-type viruses which supplied these proteins in trans. Following 
these findings, PV sub-genomic replicons were constructed which contained in-
frame deletions within the capsid coding region. Transcript RNA synthesised from 
these replicons were shown to replicate once transfected into HeLa cells (Kaplan 
& Racaniello, 1988). This evidence allowed researchers to insert reporter 
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proteins in place of the capsid region to study aspects of replication using various 
assays. Such mini-replicon systems have helped to determine important 
elements of the picornavirus life cycle. Luciferase,  CAT and GFP replicons have 
been used in experiments which lead to the discovery of the cre within HRV  and 
PV, and elements of PV and FMDV replication (Andino et al., 1993; Forrest et al., 
2014; Goodfellow et al., 2000; Herold & Andino, 2000; McInerney et al., 2000; 
McKnight & Lemon, 1996; Percy et al., 1992).  
The generation of full-length cDNA copies of a viral genome does not always 
mean successful viral replication or rescue. A prime example of this is the 
difficulties encountered with Hepatitis C Virus (HCV). Tissue-culture propagation 
of isolates and cloned viral RNA proved unsuccessful. Full-length clones were 
generated, but the replication efficiency was extremely low; detection of viral 
replication was only possible using RT-PCR (Blight & Norgard, 1996) – no 
viruses could be rescued. The use of animal models to propagate virus was also 
limited: chimpanzees are the only animal where reproducible results have been 
obtained (Bartenschlager & Lohmann, 2000). The creation and development of a 
HCV subgenomic replicon which could replicate within Huh-7 cells was a 
breakthrough in this field (Lohmann et al., 1999). This replicon encoded the 
selectable marker neomycin phospho-transferase (Neo), and following infection 
of cells with transcript RNA, cells resistant to G418 were found to contain 
replicons which had replicated to high levels. A novel isolate of HCV (JFH-1) 
which supports efficient replication and virus production is now used to study 
HCV; however, until this discovery, replicons played a very important part in HCV 
research (Bartenschlager, 2006). 
Thus, using replicon systems permits viral replication to be studied using various 
assays and have proven critical in certain cases - such as HCV. The use of 
fluorescent proteins as a reporter for replication has certain advantages in that 
replication can be studied in live cells using sensitive microscopy techniques: a 
substantial improvement over methods which rely upon assays of cell extracts. 
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1.5 Aims of the Project 
The overall aim of this study was to generate a FMDV replicon system which 
utilised Aequorea victoria GFP as a reporter of replication, such that replication 
could be monitored indirectly via measurement of GFP fluorescence in live cells. 
The capsid coding region of the genome is to be replaced by a bi-functional 
puromycin-acetyl transferase-GFP fusion protein ([GFP-PAC]), to allow for the 
selection of transfected cells as well as a marker for replication. This GFP-PAC 
replicon could be used to study various aspects of the FMDV life cycle without 
the need for high-containment facilities. Differences in replicating and non-
replicating forms will be investigated during this project to confirm the use of the 
system for measuring attenuated genomes as potential vaccine candidates. 
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Chapter 2: Materials and Methods. 
 
2.1 Materials 
2.1.1 Oligonucleotides 
All primers used during this study were purchased from Integrated DNA 
Technologies (IDT) and are listed in Table A.1.  
 
2.1.2 Gene blocks 
A gene block containing genes for Bovine Enterovirus 2A and Ptilosarcus gurneyi 
GFP was obtained from Dundee Cell Products (DCP). Echovirus 7 region 1 and 2 
gene blocks were purchased from Eurofins. 
 
2.1.3 Plasmids 
All replicons generated were made by altering the pGFP-PAC replicon (described 
in Chapter 3), which was created by modifying the original FMDV CAT Replicon 
(pT7rep, McInerney et al., 2000). The pSP70 and pSP72 plasmids were obtained 
from Promega and used in the construction of the pPt.GFP and pBEV2A 
replicons, respectively. The pcDNA 3.1(+) plasmid was purchased from 
Invitrogen and used to generate all replicons described in Chapters 3-6.  
 
2.1.4 Mammalian cells  
All cell lines were obtained from either the European Collection of Cell Cultures 
(ECACC) or the American Type Culture Collection (ATCC).  
 
2.1.4.1 Cell lines used in this study 
BHK-21 (clone 13):    Baby hamster (Syrian) kidney cell line. 
RD:  Human rhabdomyosarcoma cells (provided by Professor 
Peter Simmonds, University of Edinburgh). 
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BHK-21_RFPNuc: Baby hamster kidney cells stably expressing Red FP (RFP) 
in the nucleus (generated by Mr John Nicholson, University 
of St Andrews). 
 
2.1.5 Antibodies 
Primary antibodies: The polyclonal anti-2A antibody was purchased from Dundee 
Cell Products. The anti-eIF4G antibody was kindly provided by Professor Lisa 
Roberts, University of Surrey, and the anti-FMDV 3Dpol was provided by 
Professor Nicola Stonehouse, University of Leeds. Monoclonal antibodies 
specific to β-tubulin and GFP were purchased from Invitrogen and Roche, 
respectively. 
Secondary antibodies: Anti-mouse IgG and anti-rabbit IgG HRP-conjugated 
antibodies were purchased from Invitrogen. 
 
2.1.6 Viruses used in this study 
E7: Echovirus 7 (isolate Wallace (accession number AF465516) was provided 
by Prof. Peter Simmonds, Roslin Institute, University of Edinburgh. 
Mutant E7 viruses were generated which contained two modified regions of the 
E7 WT genome to study dinucleotide frequencies and CPB on viral replication. 
Region one was located in the capsid coding region at 1878-3119 and region two 
at 5403-6462, which is situated within P3 in the genome. 
 
cuǀcu: A CpG/UpA low mutant, with all CpG dinucleotides and as many 
UpA  dinucleotides removed. 
PǀP: Codon order was permuted while retaining protein coding and 
native dinucleotides. 
Max-U:  Maximised CPB score, with dinucleotide frequency similar to WT 
E7. 
Min-E:   Minimum CPB score, with dinucleotide frequency identical to WT 
E7. 
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Min-U: CPB score identical to Min-E, with a slightly elevated dinucleotide      
frequency. 
Min-H: CPB score identical to Min-E, with a maximised dinucleotide 
frequency. 
 
2.2 Methods 
2.2.1 Computer analysis 
2.2.1.1 DNA sequencing and sequence alignments 
Plasmid DNA generated via cloning was analysed by sequence analysis using 
the SeqMan Pro software (Blattner, 2014). Sanger sequencing data was aligned 
with a reference sequence (compiled using sequences listed in A.2-3) to ensure 
the correct order and composition of the DNA sequence. 
All other sequence alignments were generated using DNAMAN bioinformatics 
software (Lynnon Biosoft, 2001). 
 
2.2.1.2 RNA secondary structure prediction 
Models of the RNA structure from reference sequences were generated using 
mfold v.3.6 (Zuker, 2003) and RNADRAW (Matzura & Wennborg, 1996). 
 
2.2.1.3 Protein structure prediction 
Amino acid sequences were compiled using DNAMAN and the protein structure 
predicted using the Phyre2 software (Kelley & Sternberg, 2009). PDB files 
generated were manipulated using PyMOL (Schrodinger, 2010). 
 
2.2.2 Polymerase chain reaction 
The polymerase chain reaction (PCR) was used to amplify specific DNA 
fragments for cloning purposes. A typical PCR reaction was carried out in a 50 µl 
volume containing; 1 X Go Taq PCR Master Mix (1.5 mM MgCl2), 0.2 mM each 
dNTP (Promega), 0.2 µM of each primer (Table A.1), template DNA (10-50 ng 
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plasmid DNA), 1.25 units (U) of Taq DNA Polymerase (Promega) and nuclease-
free water up to 50 μl. 
Typical reactions were performed using a Veriti 96-well thermal cycler (Applied 
Biosystems) with the following cycling parameters: initial denaturation at 95 °C for 
2 minutes (min) and 35 cycles of; denaturing at 95 °C for 30 seconds (sec), 
annealing at 60 °C for 30 sec, extension at 72 °C for 1 min/kb of DNA template, 
and a final extension at 72 °C for 5 min. The annealing step was typically carried 
out at 60 °C, but was dependent on the melting temperature (Tm) of each primer. 
Samples were then held at 4 °C indefinitely. PCR reactions were checked on an 
agarose gel and the product purified for further use (see 2.2.4). 
 
2.2.2.1 Mutagenesis PCR 
Mutagenesis PCR was performed in a total volume of 100 μl using Pfu DNA 
polymerase (Promega). Reactions contained the following; 1 X Pfu DNA 
polymerase buffer (2 mM MgSO4), 0.2 mM each dNTP (Promega), 0.1 μM of 
each primer (Table A.1), template DNA (10-50 ng) and 1.25 U of Pfu DNA 
polymerase. Cycling parameters consisted of; initial denaturation at 95 °C for 2 
min and 20 cycles of; denaturing at 95 °C for 30 sec, annealing at 60 °C for 45 
sec, extension at 72 °C for 2 min/kb of DNA, and a final extension at 72 °C for 7 
min. Samples were then held at 4 °C indefinitely. PCR reactions were treated 
with 1 U of DpnI (Promega) to remove the plasmid DNA template and a 5 μl 
aliquot run on an agarose gel to check correct amplification. Five μl of each PCR 
reaction was combined and transformed as described (see 2.2.6). 
 
2.2.2.2 Combined reverse transcription PCR 
Reverse transcription PCR (RT-PCR) was used to amplify cDNA from viral RNA, 
followed by PCR amplification in a one-step reaction. This was performed using a 
Superscript III One-Step RT-PCR System with Platinum Taq DNA Polymerase kit 
(Invitrogen). Reactions contained; 10 μl 2 X reaction mix, 6 μl RNA, 0.5 μM each 
gene-specific primer (Region 1, Table A.1), 0.8 μl Superscript III RT/Platinum Taq 
Mix and made up to 20 μl with nuclease-free water. Cycle parameters include a 
cDNA synthesis step followed by PCR amplification. These consisted of: 1 cycle 
at 43 °C for 1 hr and 20 cycles of; 53 °C for 1 min, 55 °C 1 min and 1 cycle at 70 
°C for 15 min. PCR amplification was as follows: initial denaturation at 94 °C for 2 
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min and 40 cycles of; denaturing at 94 °C for 30 sec, annealing at 50 °C for 30 
sec, extension at 68 °C for 1 min/kb of template DNA, and a final extension at 68 
°C for 5 min. Samples were held at 4 °C indefinitely. Products were checked on 
an agarose gel to verify successful amplification, before further use in 
determining competition assay virus pairs (see 2.2.20). 
 
2.2.3 Restriction enzyme digests 
Restriction enzyme (RE) digests of DNA plasmids were performed under 
conditions specified by the supplier (Promega; New England Biolabs).  Generally, 
2-5 µg of DNA was digested in the appropriate enzyme buffer, with 1 U of 
enzyme per µg of DNA, in a volume of 50-100 µl for 1 hr at 37 °C. 
 
2.2.4 Agarose gel purification of DNA fragments 
RE digest products were run on a 0.8-1 % (w/v) agarose (Bioline) gel in 1 X TAE 
buffer (40 mM Tris, 1 mM EDTA). Ethidium bromide was added to a final 
concentration of 0.4 µg/µl. Samples were mixed with the appropriate volume of 6 
X loading buffer (Promega) and ran at 100-120 V in 1 X TAE for ~1 hr. A known-
size 1 kb DNA marker (Thermo Scientific) was run along with the samples to 
determine the band of interest. DNA bands were visualised with UV light, excised 
with a clean scalpel, placed into a sterile microfuge tube and weighed. The DNA 
was extracted with a Gel/PCR Purification kit (Biomiga) according to 
manufacturer’s instructions.   
 
2.2.5 Ligation of DNA fragments 
Vector and insert DNA was prepared as described above in sections 2.2.3 and 
2.2.4. Blunt-end DNA fragments were dephosphorylated with calf intestinal 
alkaline phosphatase (Promega) prior to ligation to prevent self-ligation of the 
vector DNA. Varying molar concentrations of vector:insert DNA; 1:1, 1:3 and 1:5, 
were typically used in a final volume of 10 µl. One unit of T4 DNA ligase was 
used in each ligation reaction with the 10 X buffer supplied (Promega) and 
nuclease-free water. The reaction was incubated overnight at 4 °C and 
transformed into competent E.coli cells as described (see 2.2.6). 
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2.2.6 Transformation of plasmid DNA 
Competent JM109 E.coli cells (Promega) were used to transform plasmid DNA, 
ligation reactions and mutagenesis PCR products. Typically, 1-2 µl of plasmid 
DNA, the entire ligation reaction, or 10 μl of a mutagenesis PCR reaction, was 
added to 50 µl of thawed competent cells and incubated on ice for 30 min. 
Samples were heat shocked in a 42 °C water bath for 50-60 sec before being 
immediately replaced on ice for 1 min. LB (lysogeny-broth) medium (10 g/l 
tryptone, 5 g/l yeast extract, 10 mM NaCl, pH 7) was added to a total volume of 1 
ml and incubated at 37 °C for 1 hr in a shaking incubator. Following incubation, 
the sample was centrifuged at 6,000 rpm for 30 sec and the bacterial pellet 
resuspended in 100 µl of LB. This cell suspension was plated on solid LB-agar 
supplemented with ampicillin (100 μg/ml). The plates were inverted and 
incubated at 37 °C for 12-16 hrs. Colonies were isolated and mini-cultures 
prepared. 
 
2.2.7 Plasmid DNA preparation 
Plasmid DNA extraction was performed according to the E.Z.N.A. Plasmid Mini 
Kit II protocol, as per manufacturer’s instructions (Omega bio-tek).  Briefly, 10 ml 
of LB broth containing 100 µg/ml ampicillin was inoculated with a single colony 
and incubated in a shaking incubator overnight at 37 °C. The overnight culture of 
E.coli was pelleted by centrifugation at 3,000 rpm for 10 min and the supernatant 
discarded. The pellet was resuspended in 500 µl of Solution I (containing Tris-
HCl/RNase A, pH 7.5), lysed with 500 µl Solution II (containing NaOH/SDS, pH 
13.2) and neutralised with 700 µl Solution III (containing GdmCl/CH3CO2H, pH 
13.2). After centrifugation at 13,000 rpm for 10 min, the supernatant was 
removed and passed through the silicon HiBind Mini Column. The plasmid DNA 
was precipitated with 500 µl of Buffer HB (containing GdmCl/C3H8O, pH 7) and 
washed twice with 700 µl DNA wash buffer (containing Tris-HCl/NaCl/70 % 
ETOH, pH 7.5). The DNA was eluted in 50 µl nuclease-free water, and the 
concentration recorded using a NanoDrop 1000 Spectrophotometer (see 2.2.9, 
Thermo Fisher). Potential clones were verified by sequencing (Dundee 
Sequencing Service) with the appropriate primer followed by computational 
alignment (see 2.2.1.1), and stored at – 20 °C until required. 
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2.2.8 Colony screening 
Following isolation and purification of plasmid DNA, samples were screened to 
identify potential positive clones. RE digests were carried out using appropriate 
enzymes to distinguish newly synthesised clones. Reactions were set-up in a 
total volume of 10 μl and contained 1 μl of plasmid DNA, 0.5 U of restriction 
enzyme(s), enzyme buffer and nuclease-free water. Samples were incubated at 
37 °C for 30 min and resolved on an agarose gel (see 2.2.4). 
 
2.2.9 UV spectrophotometry 
The purity and yield of plasmid DNA was checked using a NanoDrop 1000 
Spectrophotometer (Thermo Fisher). DNA concentration was quantified by 
measuring Abs260 (since nucleotides absorb at this wavelength), and DNA purity 
checked using the Abs260/Abs280 ratio, with ratios greater than 1.8 accepted as 
pure. 
 
2.2.10 RNA transcription 
Generally, constructs were linearised with HpaI or AscI (New England Biolabs) 
for 1 hr at 37 °C. Linearised DNA was purified using a Gel/PCR Purification kit 
(Biomiga). Each transcription reaction was carried out in a volume of 100 µl 
containing: 20 µl 5 X transcription buffer (Promega), 10.5 µl 100 mM DTT 
(Promega), 10 µl linearised DNA (~500 ng), 2.5 μl RNasin Ribonuclease Inhibitor 
(40 U/µl, Promega), 2.5 µl T7 RNA polymerase (20 U/µl, Promega), 40 µl 4 x 10 
mM rNTP’s (Promega) and 15 µl nuclease-free water. Reactions were incubated 
at 37 °C for 2 hr. Following this incubation, 5 µl of RQ DNaseI (1U/µl Promega) 
was added to remove template DNA, and reactions incubated for a further 20 min 
at 37 °C. Quality and yield was analysed using 0.8 % agarose gel and by 
spectrometry (NanoDrop 1000 Spectrophotometer, Thermo Fisher).  
 
2.2.11 Mammalian cell culture 
2.2.11.1 Cell maintenance 
BHK-21 cells were grown in Dulbecco’s modified Eagle medium (DMEM) 
containing 10 % (v/v) foetal bovine serum (FBS). Human rhabdomyosarcoma 
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(RD) cells were grown in DMEM with 10 % FBS and supplemented with penicillin 
(100 U/ml) and streptomycin (100 μg/ml).  Cell monolayers were maintained in 75 
cm2 or 175 cm2 tissue culture flasks (Greiner; Nunc), and routinely passaged with 
trypsin/EDTA at ~90 % confluency - determined by the growth rate of the cells.  
All cells were incubated at 37 °C in 5 % CO2. 
 
2.2.11.2 Cell stock freezing and resuscitation 
Adherent cells (~90 % confluent) were incubated in 1 X trypsin/EDTA to detach 
cells from the plastic support and then resuspended in DMEM/10 % FBS, 
followed  by centrifugation at 2,000 rpm for 5 min. Cell pellets were resuspended 
in DMEM supplemented with 20 % FBS and 10 % DMSO and aliquoted into 
labelled cryovials. Aliquots were firstly stored in an isopropanol chamber at -80 
°C overnight before transferring to liquid nitrogen. Frozen cells were resuscitated 
by thawing at 37 °C before centrifuging at 2,000 rpm for 5 min. Pellets were 
resuspended in 1 ml DMEM/10 % FBS and left overnight at 37 °C/5 % CO2. 
Media was replaced the following day to remove residual DMSO. 
 
2.2.11.3 Cell transfection   
The day before transfection, adherent cells were washed with PBS, incubated in 
1X trypsin/EDTA, and detached cells diluted in DMEM/10 % FBS before seeding 
into 12-well, 6-well, or 60 mm plates at the appropriate cell seeding density. 
Replicon transcript RNA (1-4 µg) was transfected into cell monolayers the 
following day (80-90 % confluent) using Lipofectamine 2000 transfection reagent 
(Invitrogen). Briefly, RNA was diluted in 50-200 µl Opti-MEM (Gibco) and added 
to a Lipofectamine-Opti-MEM mixture consisting of; Lipofectamine (3-10 μl) and 
Opti-MEM (to a final volume of 50-200 μl). This RNA-Lipofectamin-Opti-MEM 
mixture was left for 5 min at room temperature, and then added drop-wise to 
cells. The plate was rocked gently back and forward to mix and incubated at 37 
°C/5 % CO2 for the time period required. 
 
2.2.11.4 Cell treatment with Cycloheximide 
To inhibit cell protein synthesis, cells were treated 24 hr post-transfection (unless 
otherwise stated) with cycloheximide (to a final concentration of 100 μg/ml). The 
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required volume of cycloheximide was added to 100 μl Opti-MEM and added 
drop-wise to cells to ensure uniform distribution. Plates were incubated at 37 °C/5 
% CO2 for the duration of the experiment. 
 
2.2.12 IncuCyte microscopy 
Images of transfected cells were captured at intervals between 0-24 hr post-
transfection (unless otherwise stated) using an IncuCyte ZOOM kinetic imaging 
system (Essen BioScience) housed within an incubator maintained at 37 °C/5 % 
CO2. Images were captured from 9 regions/well in a 12-well plate using the 10x 
objective. GFP positive cell counts and GFP intensities were measured using the 
IncuCyte image processing software. Values from all 9 regions of each well were 
pooled and averaged across 4 replicates. 
 
2.2.13 SDS polyacrylamide (SDS-PAGE) analysis of proteins 
Samples were prepared by placing the plates on ice, removing the media, 
washing with 1 ml ice-cold PBS and scraping cells from the plate using a bent 
pipette tip. This cell suspension was transferred to a microfuge tube and 
centrifuged at 2,000 rpm, at 4 °C, for 5 min.  The supernatant was removed and 
the pellet resuspended in RIPA lysis buffer (100 μl of 50 mM Tris-HCl, 150 mM 
NaCl, 1 % (v/v) Nonidet P-40, 0.5 % Deoxycholic acid, 0.1 % (w/v) SDS, pH 7.4). 
Samples were left on ice for 25-30 min with occasional vortexing. This was 
followed by centrifugation at 13,000 rpm for 15 min, at 4 °C and removal of the 
supernatant to a new microfuge tube. To check sample yield, small aliquots (10 
μl) were run on 12 % gels and stained with Coomassie blue (2.5 g/l Coomassie 
Brilliant Blue R250, 50 % (v/v) methanol, 10 % (v/v) acetic acid) for 1 hr. Gels 
were de-stained (40 % (v/v) methanol, 10 % (v/v) acetic acid) overnight and 
suitable protein yield in each sample determined visually. Samples were mixed 
with 5 X SDS- sample buffer (25 % (v/v) β-mercaptoethanol, 10 % (w/v) SDS, 50 
% (v/v) glycerol, 0.5 % (w/v) bromophenol blue) and boiled at 95 °C for 5 min, 
prior to gel-loading. Sodium dodecyl sulphate-polyacrylamide gels, with 5 % 
stacking gels, were cast using ingredients and methods described by Sambrook 
et al., (1989). Precast 4-20 % polyacrylamide gradient gels (Expedeon) were 
used during certain experiments to separate samples containing many proteins of 
interest, of varying size. Gels were run using a KuroGel Verti Electrophoresis unit 
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(VWR) in 1 X SDS-PAGE Tris-Glycine (1.92 M Glycine, 0.25 M Tris, 0.1 % (w/v) 
SDS), or 1 X Tris-Tricine (Expedeon) running buffer, at 100-140 V for 1.5-2.5 hr.  
 
2.2.14 Western blotting 
Proteins were resolved by SDS-PAGE (see 2.2.13) and transferred to a 
nitrocellulose membrane (Invitrogen) at 20 V for 10 min in an iBlot transfer 
system (Invitrogen); as described by the manufacturer. Membranes were blocked 
for 1 hr at room temperature in 5 % PBS-T (PBS, 0.1 % Tween 20, 5 % non-fat 
milk). The membrane was probed with the appropriate primary antibody (1:1000-
2000 dilution in 5 % PBS-T) overnight at 4°C. The following day the membrane 
was washed three times for 5 min in PBS-T (PBS, 0.1 % Tween 20), then probed 
with HRP- conjugated anti-rabbit or anti-mouse (Invitrogen, 1:2000) secondary 
antibodies in 5 % PBS-T for 1 hr at room temperature. Finally, the membrane 
was washed a further three times for 5 min in PBS-T, and antibody binding 
detected using the EZ-ECL HRP chemiluminescence detection kit (Biological 
Industries).  
 
2.2.15 In vitro transcription and translation 
Protein synthesis was measured from replicon plasmids or viral transcript RNA by 
using a coupled or uncoupled system, respectively. [35S] methionine-labelled 
proteins were synthesised from plasmid DNA (100 ng) using a TNT® Quick 
Coupled Transcription/Translation System (Promega) following manufacturer’s 
instructions. Reactions were incubated at 30 °C for 90 min and analysed by SDS-
PAGE (see 2.2.13).   
Transcript RNA was used to programme nuclease-treated Rabbit Reticulocyte 
Lysates (Promega) supplemented with HeLa cell S10 cytoplasmic extracts 
(DCP). Reactions were set-up as follows; rabbit reticulocyte lysate (7 μl), viral 
RNA (0.25 μg-2 μg), amino acid mix (minus methionine; 0.5 μl 1 mM), [35S] 
methionine (1,200 180 Ci/mmol; 0.5 μl ), 10 U RNasin and 2.25 μl HeLa cell 
extract in a total volume of 12.5 μl. Samples were incubated at 30 °C for 3 hr and 
analysed by SDS-PAGE (4-20 % Tris-Glycine, Expedeon, see 2.2.13). Gels were 
stained with coomassie blue for 1 hr and de-stained overnight before fixing (10 % 
(v/v) acetic acid, 25 % (v/v) isopropanol) for 1 hr. Gels were then dried onto filter 
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paper for 15-20 min and exposed to film (Thermo Scientific) for 1-4 days at -70 
°C. 
 
2.2.16 Preparation of virus stocks 
Stocks of the CDLR and cu|cu viruses were provided by Prof. P. Simmonds 
(Roslin Institute, University of Edinburgh). All other virus stocks were prepared by 
transfection of transcript RNA into confluent monolayers of RD cells (1 x 25 cm2 
flask). Plasmids were linearised with NotI and transcript RNA synthesised using 
T7 RNA polymerase (see 2.2.10). RNA (100 ng) was transfected into cells using 
Lipofectamine 2000 (Invitrogen, see 2.2.8.3). Cells were incubated at 37 °C/5 % 
CO2 and monitored for the presence of CPE. This cell lysate was used to 
generate passage 1 stocks by re-infecting RD cells (1 x 75 cm2 flask). Once CPE 
had reached ~70 % (~24 hr), the supernatant was harvested and centrifuged at 
2,000 rpm for 5 min to remove cell debris. Aliquots were made and frozen at -80 
°C. Titres were determined by TCID50 titration (see 2.2.17). 
 
2.2.17 Virus titrations 
RD cells were seeded to ~60 % density in 96-well plates. Virus preparations were 
serially diluted 10-fold in the cell medium (200 μl final volume, DMEM/10 % FBS) 
of the 96-well plate. Plates were incubated at 37 °C/5 % CO2 for ~4 days until 
CPE had formed. The media was removed and monolayers fixed for 1 hr in 10 % 
(v/v) formal saline. Cells were then stained with crystal violet (0.1 % (w/v) crystal 
violet, 10 % (v/v) ethanol) for 1 hr to visualise CPE. This was followed by washing 
with H2O and scoring of plates for the presence or absence of CPE. The 50 % 
end-point dilution (TCID50) was calculated using the method described by Reed 
and Muench (1938). The assay was performed in quadruplicate for each virus. 
 
2.2.18 Virus infections 
Cell monolayers were washed with PBS prior to inoculation to remove traces of 
serum. Monolayers were infected with virus diluted in serum-free DMEM (or 
DMEM only for mock transfections) at the required multiplicity of infection (MOI) 
for 1 hr at 37 °C. The inoculum was removed and the cells washed before 
applying fresh media. Cells were incubated at 37 °C/5 % CO2 until harvested. 
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2.2.19 Replication phenotype 
To determine the viral titre over multiple-step growth cycles, RD cell monolayers 
in triplicate in 24-well plates were infected at an MOI of 0.01 for 1 hr as described 
above (see 2.2.18). Samples were withdrawn at given time points (6, 24 and 42 
hr post-infection) and the viral titre determined by TCID50 assay (see 2.2.17). 
 
2.2.20 Competition assays 
Equal titres of virus pairs (combined MOI of 0.01) were applied to RD cells in 25 
cm2 flasks. Following the development of CPE, supernatants were removed and 
300 μl applied to fresh cell monolayers. This procedure was continued for up to 
10 passages. Viral RNA was extracted from the supernatant (described below) 
and region 1 amplified by combined reverse transcription- PCR (see 2.2.2.2). The 
results were determined by RE digestion of the region amplified. 
 
2.2.21 Extraction of viral RNA from cell supernatant 
RNA was isolated from viral supernatant collected during competition and 
multiple-step growth assays using an RNeasy Mini Kit (Qiagen). Briefly, 100 μl of 
supernatant was mixed thoroughly with RLT buffer (350 μl). This solution was 
mixed with ethanol (250 μl; 100 %) and transferred to an RNeasy mini spin 
column before centrifuging at 12,000 rpm for 15 sec. The column was washed 
with RPE buffer (500 μl) and centrifuged at 12,000 rpm for 15 sec. This step was 
repeated, but with a longer centrifugation step of 2 min. The column was dried by 
centrifugation at full speed for 1 min. The RNA was eluted by the addition of 
nuclease-free H2O (50 μl) to the column membrane, followed by a final 
centrifugation at 12,000 rpm for 1 min. Samples were stored at -80 °C until 
required. 
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Chapter 3: FMDV Replicons Encoding Green 
Fluorescent Protein are Replication Competent. 
 
3.1 Introduction 
The original foot-and-mouth disease virus (FMDV) replicon was based on the 
genome of FMDV type-O O1/Kaufbeuren/FRG/66 (Forss et al., 1984), and was 
created by deletion of sequences encoding the L proteinase (Lpro) and the 
majority of the capsid coding region. The reporter gene CAT was inserted such 
that FMDV RNA replication could be monitored via CAT assays of cell extracts 
(pT7rep, McInerney et al., 2000, Figure 3.1). The use of such replicons allows 
replication of highly pathogenic viruses without the need for high-containment 
facilities, allows the characterisation of viral functions and to screen for 
attenuated forms for vaccine development.  
The aim of this section was to create a new FMDV replicon by replacing CAT 
from pT7rep with a GFP-PAC fusion protein: the pGFP-PAC replicon (Figure 3.1). 
This replicon allows FMDV replication to be monitored via GFP fluorescence in a 
non-invasive manner, in real time, outwith high-containment facilities. The 
presence of Puromycin-N acetyl-transferase (PAC) also permits persistent 
infection to be investigated through selection of FMDV-replicon transfected cells 
with puromycin.  
 
3.2 Construct design 
The existing FMDV replicon system (pT7rep, Figure 3.1) was modified by the 
replacement of sequences encoding chloramphenicol acetyl-transferase (CAT) 
with those encoding a functional L proteinase (Lpro) linked to a bi-functional 
fluorescent/antibiotic resistance fusion protein (enhanced green fluorescent 
protein/puromycin resistance; pGFP-PAC; Figure 3.1). Sequences encoding the 
N-terminal 18 aa of the capsid protein 1A were introduced between Lpro and GFP-
PAC to ensure correct proteolytic processing by Lpro at its C-terminus. Similarly, 
40 aa C-terminal residues of the capsid protein 1D were introduced upstream of 
2A to ensure accurate processing (‘ribosome skipping’) at the 2A/2B site. 
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A function of the proposed system was to distinguish between replicating and 
replication-incompetent forms; therefore an attenuated form of pGFP-PAC was 
generated. As discussed in the Introduction (1.1.2.6), viruses lacking Lpro were 
attenuated in cell culture and in swine (Chinsangaram et al., 1998; Piccone et al., 
1995). Therefore a ‘leaderless’ replicon completely lacking the L gene, pLL-GFP-
PAC, was constructed. The GFP-PAC region was amplified via PCR (primers 
listed in Table A.1) and ligated into the pGFP-PAC replicon which was digested 
with PsiI and XmaI to remove L (Figure 3.1, A.2). Transcript RNA transfected into 
cells can act as mRNA, therefore it was important to create a replicon to 
differentiate fluorescence generated by the input RNA from those genomic forms 
which are replication competent. A replication-incompetent form was created 
through a large deletion in the viral polymerase, 3Dpol, by restriction digestion with 
MluI: pGFP-PAC-Δ3D (Figure 3.1, A.2). 
 
3.3 Restoration of L proteinase activity 
The major host cell target of Lpro is the translation initiation factor eIF4G (Devaney 
et al., 1988). To confirm Lpro activity had been restored in the pGFP-PAC 
replicon, western blots were carried out to detect eIF4G-cleavage by L.BHK-21 
cell monolayers were transfected with 3 μg of replicon RNA and harvested at the 
time points indicated. Proteins were separated by SDS-PAGE and probed using 
anti-eIF4G and anti-β-tubulin antibodies. Figure 3.2A shows eIF4G was cleaved 
as early as 1 hr post-transfection (p.t.) in pGFP-PAC-transfected BHK-21 cells. 
From 6 hr p.t. eIF4G began to re-accumulate and the cleavage product 
disappeared thereafter. It should be noted that transfection of cell monolayers 
leads to ~40-50 % cell-transfection efficiency; therefore these data are due to 
adherent, non-transfected cells.  Cells transfected with leaderless, pLL-GFP-
PAC, transcript RNA did not show the same kinetics of eIF4G degradation 
(Figure 3.2B), however some degradation occurred which is consistent with 
evidence that 3Cpro can also cleave this initiation factor (Belsham et al., 2000). 
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Figure 3.1. Replicon Constructs. The structure of the FMDV genome is shown 
together with replicon plasmid constructs. Polyprotein domains are shown as 
boxed areas, together with the ‘primary’ processing products Lpro (Labpro and Lbpro 
forms), [P1-2A], [2BC] and P3 ([3AB1-3CD]). The original CAT replicon 
(pT7Rep;Ellard et al., 1999; McInerney et al., 2000)  was modified to re-insert the 
L proteinase sequences and the CAT reporter replaced with a GFP-PAC fusion 
protein (pGFP-PAC, assembled by Dr G.Luke). This plasmid was modified to 
create a replication incompetent form by deletion of the 3D polymerase (pGFP-
PAC-Δ3D). A replication attenuated form was created by deletion of the L 
proteinase (pLL-GFP-PAC; similar to that described by Piccone et al., 1995). 
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Figure 3.2. Cleavage of eIF4G in cells transfected with replicon RNA.  BHK 
cell extracts from pGFP-PAC (A) or pLL-GFP-PAC (B) replicon-transfected cells 
(1-24 hr as indicated) were separated by SDS-PAGE, transferred to nitrocellulose 
membranes, and analysed by western blotting with anti-eIF4G or β-tubulin as a 
control. Uncleaved eIF4G and its cleavage products are shown on the right with 
molecular weight markers on the left. 
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3.4 Quantitation of FMDV replicon-derived GFP fluorescence 
RNA replication was quantified indirectly by quantifying GFP fluorescence. 
Plasmids were linearised with HpaI and transcribed in vitro using T7 RNA 
polymerase (Promega). BHK-21 cells were seeded into 12-well plates 24 hr prior 
to transfection. Monolayers were transfected with 1 μg of replicon RNA and 
fluorescence monitored using an IncuCyte ZOOM fluorescent microscope. 
Images were taken every 2 hrs for a total of 24 hrs, with nine images captured 
per well of a 12-well plate. GFP fluorescence could be detected in replicon-
transfected cells ~2 hr p.t. (Figure 3.3, 3.4), with the peak signal achieved ~6 hr 
p.t. (Figure 3.4). This is directly comparable to vRNA replication detected via RT-
qPCR (Chang et al., 2009; Gu et al., 2007). The GFP signal started to decline ~8-
10 hr p.t. (Figure 3.4), with cells displaying a rounded-up morphology compared 
to the characteristic elongated, fibroblastic form of BHK-21 cells (Figure 3.3); 
typical of the cytopathic effect (CPE) observed during viral infection. The life cycle 
of FMDV is a rapid process with replication lasting around 8-10 hrs. At this point 
in the cycle cells lyse releasing particles, however, this process does not occur 
when using the current replicon system. From 8-10 hr onwards cells are 
effectively dead, hence any measurements recorded after this time are that of 
dead cells and this is demonstrated by the rapid decline in GFP fluorescence 
after this time point (Figure 3.4). 
 Since replicon RNA can act as mRNA, it was expected that pGFP-PAC-Δ3D 
would produce fluorescence. Although it cannot replicate due to deletions in the 
viral polymerase, Lpro is still active and able to shut-off host cell translation, which 
in turn increases IRES-driven translation. As predicted, cells transfected with 
RNA transcripts produced from this construct generated GFP fluorescence, albeit 
at a lower level (~2-fold) in comparison to the replication-competent pGFP-PAC 
(Figure 3.4). 
The pLL-GFP-PAC replicon showed a lag in the detection of fluorescence, with 
the GFP signal arising ~4 hr p.t. (Figure 3.3, 3.4). Unexpectedly, the total 
fluorescent signal for cells transfected with this construct was much higher than 
the pGFP-PAC ‘WT’ replicon (~2-fold, Figure 3.4B). It was hypothesised that 
deletion of Lpro would lead to a reduction in fluorescent signal as the replicon RNA 
would have to compete with cellular mRNA for the host-cell translation 
machinery, and therefore viral protein synthesis would decrease. Due to the 
results obtained with the pLL-GFP-PAC replicon, cell extracts were prepared and 
53 
 
probed with anti-GFP antibodies. Western blotting of these extracts showed that 
in pGFP-PAC replicon transfected cells the [Δ1A-GFP-PAC-Δ1D-2A] processing 
product was cleaved, but not in cells transfected with the leaderless form (Figure 
3.5A). Examination of the Lpro /1A, eIF4G cleavage sites (Kirchweger et al., 1994; 
Strebel & Beck, 1986) and the GFP-PAC sequence (Figure 3.5B) suggested a 
potential Lpro cleavage site within GFP at  Lys126 –Gly127 , which maps to the C-
terminus of β-sheet 6 (Ormö et al., 1996; Yang et al., 1996), and would produce a 
product corresponding to the molecular mass of the major cleavage product (~42 
kDa, Figure 3.6A). The cleavage of [Δ1A-GFP-PAC-Δ1D-2A] was much slower 
than eIF4G, with the cleavage product appearing ~4 hr p.t. (Figure 3.5A), in 
contrast to eIF4G which was mostly cleaved by then (Figure 3.2A). The plasmid 
pJC3-PAC (unpublished; encodes GFP-PAC, FMDV 2A and mCherry FP) and 
was used to show the size of the fusion product [GFP-PAC-2A]. As 3Cpro can also 
cleave eIF4G, potential 3Cpro sites were examined and none were detected within 
GFP or PAC.  
Due to both the western blotting and IncuCyte data obtained from analysis of 
pLL-GFP-PAC replicon-transfected cells, the average GFP intensity was 
calculated at various time points over the course of the experiment using the 
IncuCyte. Analysis of transfected cells at 2, 6 and 12 hr p.t. showed that the WT 
pGFP-PAC replicon increased up to ~1.4-fold from 2-6 hr (Figure 3.6), steadily 
decreasing from 12 hr onwards (data not shown). In conjunction with the data 
described above, the average intensity of pLL-GFP-PAC transfected cells was 
lower at 2 hr p.t., but increased ~7-fold from 2-6 hr. As expected, there was no 
change in pGFP-PAC-Δ3D average GFP fluorescence. This data demonstrates 
two points. Firstly, cell death induced by both replication and through cleavage of 
eIF4G impacts on measurements obtained from 12 hr onwards. Secondly, 
cleavage of GFP by Lpro affects the GFP intensity derived from the ‘WT’ pGFP-
PAC replicon placing constraints on experiments involving analysis of GFP 
fluorescence: the true signal intensity is not being determined. Both of these 
points should be addressed prior to commencing studies into aspects of the viral 
life cycle. 
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3.5 Conclusions 
 FMDV replicons encoding a GFP-PAC fusion protein were replication 
competent and could be used to measure RNA replication indirectly via 
GFP fluorescence.  
 A fully functional Lpro was reinstated into the existing replicon system and 
could cleave its major host cell target, eIF4G.  
 The fluorescent signal generated from replicating/non-replicating forms 
could be distinguished, despite some cleavage of GFP by Lpro. This 
system will facilitate studies to screen for attenuated genomes which can 
be rescued by colleagues at the Pirbright Institute as potential live-
attenuated vaccine candidates. 
 Measurement of replication indirectly via GFP fluorescence can allow for 
characterisation of the viral life cycle through screening studies which can 
incorporate mutagenesis, deletions, insertions etc., with rescue of 
infectious copies verifying experimental observations. 
 This screen provides a rapid, facile method of quantifying FMDV 
replication in comparison to nucleic-acid based methods, and removes 
the need for high-containment facilities to measure FMDV RNA 
replication.  
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Figure 3.3. GFP expression in FMDV replicon-transfected BHK-21 cells. 
Transcript RNA from the pGFP-PAC, pLL-GFP-PAC and pGFP-PAC-Δ3D 
replicons was introduced into cell monolayers, and fluorescent images captured 
at 2 hr intervals over a 24 hr period using the IncuCyte ZOOM imaging system. A 
representative of the nine images captured is shown at 4, 6, 8 and 24 hr post-
transfection. Data was obtained from 3 independent transfections, with 4 
replicates per transfection. Scale bar represents 100 μm. 
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Figure 3.4. Time course of FMDV replicon-derived GFP fluorescence.  Data 
from mock-transfected BHK-21 cells are shown, together with cells transfected 
with transcript RNA derived from the pGFP-PAC replicon, ‘leaderless’ replicon 
pLL-GFP-PAC and the polymerase deletion pGFP-PAC-Δ3D. At the time points 
indicated images were captured and the GFP fluorescence quantified for each 
replicon construct over a 24 hr period: data shown as the green object count/mm2 
(A) or as the total integrated GFP fluorescence intensity (B). Data points/error 
bars shown are derived from 3 independent transfections, with 4 replicates for 
each transfection. 
 
 
(A) 
(B) 
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Figure 3.5. Cleavage of GFP in cells transfected with replicon RNA.  Extracts 
were prepared from pGFP-PAC or pLL-GFP-PAC (A) replicon-transfected BHK-
21 cells at the time points indicated. Extracts were separated by 12 % SDS-
PAGE, transferred to nitrocellulose membranes, and analysed by western blotting 
with anti-GFP and anti-β-tubulin antibodies. The sequence flanking the L/1A, 
eIF4G and predicted GFP-L proteinase cleavage sites are shown (B). 
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Figure 3.5. Average mean intensity of GFP-positive replicon-transfected 
BHK cells. At the time points indicated images (9/well) were captured and the 
average mean intensity quantified for each replicon construct. Data shows the 
average mean intensity at 2, 6 and 12 hr p.t. and is derived from 3 independent 
transfections, with 4 replicates for each transfection. 
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3.6 Discussion 
 
3.6.1 Detection of FMDV replication via GFP fluorescence 
Replicon RNA can act as mRNA and, therefore, will be translated following entry 
into the cell. Fluorescence generated by input RNA must be differentiated from 
fluorescence generated by active replication. The replication-incompetent pGFP-
PAC-Δ3D replicon allows for this to be distinguished: replicon RNA cannot be 
synthesised by the viral polymerase as it contains a large deletion- thus, signal 
intensities are derived from initial input RNA only. Detection of GFP fluorescence 
from replication-competent replicon RNA, however, includes (i) translation of the 
input RNA, (ii) the synthesis of –ve strand and (iii) subsequent +ve strand 
synthesis, followed by further protein translation. The GFP fluorophore also 
requires time for post-translational modifications and maturation of the protein 
structure. Therefore, one might expect some additional lag in the detection of 
replicon RNA replication via GFP fluorescence in comparison to nucleic acid-
based detection methods. GFP fluorescence was, however, detected ~2 hr p.t. 
which is directly comparable to strand-specific RT-qPCR (Gu et al., 2007). The 
pLL-GFP-PAC replicon showed a lag in replication of ~2 hr that continued until 6-
8 hr p.t. The number of GFP positive cells then increased up to ~1.5- fold above 
pGFP-PAC for the remainder of the experiment. This trend could be attributed to 
the stronger signal attained by the pLL-GFP-PAC replicon, resulting in a larger 
proportion of transfected cells being detected by the IncuCyte microscope in 
comparison to pGFP-PAC. The observation that 3Cpro can also cleave eIF4G 
(Belsham et al., 2000) explains the kinetics observed in pLL-GFP-PAC 
transfected cells from 4 hr onwards. Once cells are unable to undergo cap-
dependent translation, the machinery can be used solely by FMDV replicon RNA, 
therefore increasing the rate of translation and detection of GFP. 
 
As both eIF4G and replication induce cell death, measurements taken following a 
single growth cycle i.e. 8- 10 hr are essentially of dead cells. Induction of cell 
death can affect analysis due to cells rounding-up and detaching from the plastic 
support. This does not pose problems when measuring differences between 
replicating and non-replicating forms to screen for attenuated genomes; however, 
it may cause complications when studying aspects of the viral life-cycle. It could 
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be more beneficial to plot data corresponding to the first 6-10 hr only, allowing for 
the kinetics during a single growth curve to be captured. 
 
Interestingly, although the pLL-GFP-PAC replicon demonstrated a lag in 
replication, active replication was detected; an observation not reported by 
Piccone et al., (1995). In this study, when BHK-21 cells were transfected with 
transcript RNA lacking Lpro, virus could not be rescued. Viruses containing the 84 
nt “spacer” region (described in Introduction 1.1.2.6) between the two Lpro 
initiation codons grew, however, to slightly lower titres and produced a reduced 
plaque phenotype when compared to WT (Piccone et al., 1995). This virus was 
also attenuated when tested in cattle and swine (Brown et al., 1996; 
Chinsangaram et al., 1998).  A replicon containing the 84 nt spacer region, pLa-
GFP-PAC, displays kinetics that are comparable to pGFP-PAC at 2 hr p.t. – no 
lag in GFP detection was observed, however, like the pLL-GFP-PAC replicon the 
signal intensities were higher (data not shown). Furthermore, insertion of Lpro or 
Lbpro into plasmid pJC3-PAC (pLpro-PAC or pLbpro-PAC), further implies that GFP 
is cleaved by this protease, with GFP fluorescence substantially reduced when 
compared to plasmids containing either the spacer region of Lpro or Δ1A (data not 
shown). mCherry expression generated by the pLpro-PAC plasmid was 10-fold 
higher than Aq.GFP expression, implying that Aq.GFP was being cleaved by the 
proteinase. 
 
Insertion of the spacer region into pJC3-PAC, such that the GFP now bears the 
N-terminal 28 amino acids of Lpro, showed ΔL-GFP localised to the perinuclear 
region of transfected BHK-21 cells (data not shown). A different localisation 
pattern was observed with both the pLpro-PAC or pLbpro-PAC plasmids, with GFP 
remaining in the cytoplasm (data not shown). The presence and utilisation of the 
two conserved AUG’s in Lpro is still largely unexplained, as is the conserved RNA 
secondary structure found in this region (Witwer et al., 2001). These findings 
suggest the spacer region may serve as a localisation signal, ensuring the Lab 
form is delivered to specific areas of the cell to carry out activities essential to the 
viral life cycle. This is supported by sequence analysis performed by Carrillo et 
al., (2005) on isolates of FMDV, and found the methionines within this region to 
be invariant, suggesting  that both isoforms of Lpro are important for aspects of 
FMDV biology. These results pose very interesting and future experiments are 
planned to investigate these findings. 
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3.6.2 Cleavage of GFP by Lpro 
Unexpectedly, following fluorescence and western blot analyses it was apparent 
that the Aequorea GFP reporter protein showed some cleavage by Lpro, leading 
to a ~2-fold reduction in signal derived from pGFP-PAC. Despite this unforeseen 
anomaly, attenuation could still be measured, and the strong signal obtained from 
the leaderless form demonstrated the potential for this system.  Experiments 
undertaken to either mutate the possible Lpro cleavage site within GFP, or to 
replace GFP with another fluorescent protein that is not cleaved by Lpro are 
described in Chapter 5. 
 
The next two chapters describe further development of this system to increase 
replication efficiency to mimic a viral infection as closely as possible, within the 
constraints of the reporter system. Decreasing time and costs through 
modification of the replicon is also investigated, as well as mutagenesis of the 
potential Lpro-GFP cleavage site and the use of other fluorescent reporter proteins 
that are not cleaved by Lpro (Chapters 4-5). 
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Chapter 4: An Improved FMDV Replicon System 
Encoding Self-Cleaving Ribozymes. 
 
4.1 Introduction 
Synthetic transcripts produced from viral cDNA vectors can contain extra non-
viral nucleotides introduced during cloning, from vector sequences, through 
linearization of plasmids creating overhangs and from additions made by 
bacterial polymerases (Clark, 1988; Milligan et al., 1987). During PV RNA 
replication, the viral polypeptide 3BVPg is uridylated onto the 5’-end of both 
negative and positive sense transcripts and is thought to be an important step 
during initiation of RNA synthesis (Paul et al., 1998). It has previously been 
reported that PV RNA transcripts with authentic 5’-ends replicated more 
effectively in cell culture when compared to transcripts containing non-viral 
sequences (Herold & Andino, 2000). Using a hammerhead ribozyme to produce 
exact 5’-ends, Herold and Andino (2000) demonstrated that transcripts replicated 
with better kinetics and there was no lag before replication.  
A precise 3’-end doesn’t seem to be as imperative for picornavirus replication; 
however the presence of extra nucleotides has been shown to reduce infectivity 
of viral RNA transcripts. Sarnow (1989) showed that long extensions of 17 or 
more nucleotides decreased infectivity of PV transcripts, with extensions of 4 
nucleotides showing a 5-fold increase in comparison to virion RNA. Ghanem et 
al., (2012) demonstrated a 10-fold increase in rabies virus rescue when using an 
improved version of the HDV ribozyme to generate an exact 3’-end.  
The synthesis of RNA transcripts by the use of bacterial polymerases is a costly 
and time-consuming process. The use of the major late T7 Φ terminator (T7TΦ) 
sequence (Carter et al., 1981) at the 3’-end of viral sequences can remove the 
need for linearisation of cDNA plasmids in preparation for transcription, or reduce 
the addition of non-viral sequences onto the ends of transcripts that have been 
linearised. 
Transfection of cDNA plasmids encoding infectious PV RNA can produce viral 
particles, albeit to a low yield (Racaniello & Baltimore, 1981; Semler et al., 1984), 
and also eliminates the requirement for synthesising transcript RNA. 
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Thus, this section describes improvement of the existing pGFP-PAC FMDV 
replicon (Tulloch et al., 2014a), by introducing self-cleaving ribozymes into the 5’- 
and 3’ UTRs. The 5’-end of pGFP-PAC contains three extra guanine residues 
which are introduced by T7 RNA polymerase following transcription initiation at 
the T7 promoter (Ikeda & Richardson, 1986; Imburgio et al., 2000; Martin et al., 
1988, A.2). The 3’-end contains consecutive cytosine residues (C16) following the 
poly(A) tail (A.2) that were introduced via cloning (Zibert et al., 1990). 
Linearization with HpaI prior to RNA transcription also results in the addition of 
non-viral sequences (GTT, A.2), leading to transcripts containing nineteen non-
template nucleotides added onto the poly(A) sequence. 
Further modifications include incorporation of the human cytomegalovirus (CMV) 
promoter (Boshart et al., 1985), with the intention to transfect replicon DNA into 
cells; driving transcription of replicon RNA via the promoter, diminishing the need 
for RNA transcription kits (A.3). A T7TΦ sequence was also inserted at the 3’-end 
of the viral cDNA to either eliminate the necessity for linearisation prior to 
transcription, or to aid in the termination of T7 RNA polymerase following 
linearization (A.3). In combination, these modifications could reduce the time 
taken to prepare transcript RNA, lower costs by limiting the need for expensive 
reagents, and increase the efficiency of the existing system by improving replicon 
kinetics to closely represent a viral infection.   
 
4.2 Construct design 
Insertion of the CMV promoter was achieved by cloning replicon cDNA from 
pGFP-PAC into the commercially available pcDNA 3.1 (+) (Invitrogen). This clone 
was modified further to include cDNA copies of each ribozyme which were 
provided as gene blocks (Dundee Cell Products). The cis-active Hammerhead 
(HH) ribozyme (Herold & Andino, 2000; Uhlenbeck, 1987) was cloned between 
the T7 promoter and 5’ terminal sequences of the UTR, with the cis-active 
Hepatitis delta ribozyme (HDV), followed by a T7TΦ sequence, inserted between 
the poly(A) tail and the vector backbone, creating the pRbz replicon (Figure 4.1). 
To examine the activity of each ribozyme independently from one another and to 
ensure both were fully functional, constructs were generated that contained either 
the HH ribozyme (pHH_Rbz) or the HDV ribozyme (pHDV_Rbz) (Figure 4.1). 
This was achieved through RE digestion of the pGFP-PAC and pRbz replicons 
with SpeI and EcoRI, followed by ligation of the corresponding insert into the 
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appropriate vector (A.2-A.3 for sequence maps and RE sites). Finally, replicons 
containing a modification to the HDV ribozyme were made in order to increase 
the processing activity, as a previous report demonstrated that the cleavage 
activity of the HDV “core” sequence was poor in comparison and viral rescue and 
mini-genome expression was increased when constructs contained this altered 
HDV sequence (Ghanem et al., 2012). A sequence consisting of 5 nucleotides 
(AGCCA; Ghanem et al., 2012; Perrotta & Been, 1998) was added to the 3’-end 
of the HDV ribozyme in both the pRbz and pHDV_Rbz replicons, generating 
pRbz_5nts and pHDV_Rbz_5nts, respectively (Figure 4.1).  
 
4.3 The effect of ribozymes at the 5’ and 3’-ends on replicon-derived 
replication 
To examine the effect of exact ends on replication, BHK-21 cells were transfected 
with 1 μg of transcript RNA and replication measured indirectly via GFP 
fluorescence using an IncuCyte ZOOM fluorescent microscope, as previously 
described (Tulloch et al., 2014a). GFP fluorescence increased almost 
immediately for the pRbz_5nts and pHH_Rbz replicons, whereas in comparison 
the pGFP-PAC replicon showed a delay of ~2 hr (Figure 4.2, 4.3B). At 2 hr p.t. 
there was a 20-fold increase in GFP fluorescence from constructs containing the 
5’ HH ribozyme compared to all others tested (Figure 4.3B). This increase in 
fluorescence continued throughout the course of the experiment resulting in an 
increase in overall expression of up to 1.5-fold (Figure 4.3B). Constructs 
containing the HDV ribozyme alone exhibited replication kinetics that were similar 
to pGFP-PAC, with the pHDV_Rbz_5nts replicon exhibiting ~1.5-fold less 
fluorescence than the pHDV_Rbz replicon (Figure 4.3B) This was unexpected 
since previous reports demonstrated that the 5 nt extension improved processing 
of the ribozyme (Ghanem et al., 2012; Perrotta & Been, 1998). Nevertheless, the 
combination of both ribozymes increased the initial GFP signal at 2 hr p.t. to 20-
fold above that of the existing pGFP-PAC replicon. GFP counts showed identical 
trends to total GFP fluorescence, with a 16-fold increase in the number of GFP 
positive cells at 2 hr p.t. in comparison to constructs lacking the 5’ HH ribozyme 
(data not shown). An increase in the number of GFP cells of up to 1.5-fold 
continued throughout the experiment (data not shown). 
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Figure 4.1 Improved FMDV Replicon System. An improved version of the 
FMDV replicon (pGFP-PAC, Tulloch et al., 2014a) was created, the pRbz 
replicon, containing both T7 and CMV promoters, self-cleaving ribozymes and a 
T7TΦ sequence. To test the activity of each ribozyme independently from each 
other, replicons containing either the 5’ Hammerhead (HH) or the 3’ Hepatitis 
Delta Virus (HDV) ribozyme were constructed; pHH_Rbz and pHDV_Rbz 
replicons. A 5nt sequence, AGCCA, was inserted into the 3’-end of the HDV 
ribozyme to optimise the cleavage activity. This generated the pRbz_5nts and 
pHDV_5nts replicons. 
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Figure 4.2 GFP expression generated by FMDV replicons containing self-
cleaving ribozymes. GFP expression from replicons containing both (pRbz 
replicon) or each ribozyme alone (pHH or pHDV_Rbz replicons), were compared 
to the unmodified pGFP-PAC replicon. Following transfection of BHK-21 cells 
with 1 μg transcript RNA from each construct, fluorescent images were captured 
at 2 hr intervals over a 24 hr period using the IncuCyte ZOOM imaging system. 
Data is representative of one image captured (from nine) at 2, 6 and 24 hr post-
transfection, and was obtained from 3 independent transfections, with 4 
replicates per transfection. Scale bar represents 100 μm. 
 
67 
 
 
 
Figure 4.3. The effect of ribozymes on FMDV replicon-derived GFP 
expression. (A) Predicted structure of the HH ribozyme connected to the 5’-end 
of the FMDV genome (generated using mfold; Zuker, 2003). Numbering begins at 
the first nucleotide of the HH ribozyme C-1. Orange box and arrow indicate 
cleavage site. (B) GFP expression from BHK-21 cells transfected with transcript 
RNA derived from mock, pRbz, pRbz_5nts, pHDV_Rbz, pHDV_Rbz_5nts, 
pHH_Rbz, pGFP-PAC and pGFP-PAC-Δ3D replicons. Images were captured at 2 
hr intervals over a 24 hr period and the GFP fluorescence quantified for each 
replicon construct: data shown as the total integrated GFP intensity. Data 
points/error bars are derived from 3 independent transfections, with 4 replicates 
for each transfection. 
(A) 
(B) 
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4.4 CMV promoter-driven transcription of replicon RNA 
To test the efficiency of promoter-driven transcription of replicon RNA, plasmid 
DNA from both the pRbz and pRbz_5nt replicons (the only replicons containing a 
fully-functional CMV promoter) was transfected into BHK-21 cells and GFP 
fluorescence measured. Fluorescence was not detected until 6 hr p.t. with the 
peak being reached ~12 hr later at 18 hr p.t. (Figure 4.4): in contrast to replication 
kinetics displayed by linear transcript RNA (Figure 4.3B). The total GFP 
fluorescence differed by a ~20-fold decrease at the peak of replication for the 
pRbz replicon (18 hr p.t., Figure 4.4), when compared to cells transfected with 
transcript RNA from this construct (6 hr p.t., Figure 4.3B). Analysis of GFP 
fluorescence generated by transcript RNA showed the signal arising at 2 hr p.t., 
whereas upon transfection of replicon plasmid DNA there was a lag in detection 
of 4 hr, with the signal being ~2.5-fold lower on average at this early time point 
(Figure 4.3B, Figure 4.4). There was ~1.5-fold difference in the total fluorescence 
derived from the pRbz and pRbz_5nt replicons, with the pRbz replicon producing 
a higher signal. The number of GFP positive cells displayed a similar trend to the 
fluorescence data obtained, with pRbz giving rise to a higher GFP cell count 
(data not shown). This correlates with the previous fluorescence data shown in 
Figure 4.3B, with replicon RNA containing the HDV_5nt modification replicating 
less efficiently. In contrast, transfection of replicon RNA containing both 
ribozymes (pRbz and pRbz_5nt) did not show such a difference (Figure 4.3B). 
 
4.5 Replication kinetics of replicon RNA synthesised using the T7 Φ 
terminator 
A T7TΦ sequence was inserted directly after the HDV ribozyme in order to 
increase the efficiency of T7 RNA polymerase transcription. To test the 
effectiveness of the T7TΦ, plasmids were linearised using SspI (located ~3.2 kb 
upstream of the T7TΦ sequence, A.3) and transcript RNA synthesised using T7 
RNA polymerase. The pGFP-PAC and pHH_Rbz replicons, which do not contain 
a T7TΦ, were linearised with both HpaI and SspI to function as controls. 
Reaction products were run on a non-denaturing 0.8 % (w/v) agarose gel to 
check integrity and yield. Transcript RNA from the HpaI-linearised pGFP-PAC 
and pHH_Rbz replicons displayed a single, sharp band, whereas RNA 
synthesised from templates containing the T7TΦ and linearised with SspI 
exhibited three bands, one of which co-migrated with RNA from both the pGFP-
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PAC and pHH_Rbz replicons (Figure 4.5A). RNA synthesised from SspI-
linearised pGFP-PAC and pHH_Rbz also contained multiple transcripts, with two 
bands present (Figure 4.5A). These results suggested that both the SspI enzyme 
and the T7TΦ were responsible for the generation of multiple transcripts. These 
bands could have arisen from i) inefficient termination at the T7TΦ and read 
through to the end of the template DNA, ii) successful termination and iii) 
cleavage by the HDV ribozyme leading to transcripts of the correct size (compare 
HpaI transcripts which are the correct length, Figure 4.5A). Irrespective of these 
results, transcript RNAs generated displayed replication kinetics comparable to 
those shown in Figure 4.3B and did not seem to affect replication efficiency (data 
not shown).  
 
Although replication did not seem to be affected by the presence of multiple 
transcripts, other RE sites were used to generate transcripts to establish whether 
distinct bands could be generated for future use. The pRbz_5nts replicon was 
linearised with AscI, BstBI and SspI (A.3) for comparison. Transcripts produced 
by both the AscI and BstBI-linearised template were sharp, distinct bands, in 
contrast to the multiple transcripts seen when SspI-linearised template was used 
(data not shown). The AscI site is situated directly after the 3’ terminus of the 
HDV ribozyme, leading to the removal of the T7TΦ following linearisation; 
however data obtained suggests the T7TΦ does not improve termination 
efficiency and therefore is not required. Thus, it was decided that all replicons 
would be linearised using AscI during future experiments. 
 
To compare the use of a linear template when synthesising  transcript RNA with 
that of circular plasmid DNA containing a T7TΦ, RNA was made using AscI 
linearised pRbz_5nts as a template, together with plasmids from the pRbz, 
pRbz_5nts, pHDV_Rbz and pHDV_Rbz_5nts replicons. RNA synthesised from 
circular plasmid DNA appeared as a smear when resolved on a 0.8 % (w/v) 
agarose gel, with RNA made from a linear template displaying a bright, distinct 
band (data not shown). GFP expression from BHK-21 cells transfected with RNA 
made from the linear template displayed kinetics as expected, whereas RNA 
produced from circular plasmids gave GFP intensities ~70-fold lower at 2 hr p.t. 
and ~10-fold lower thereafter on average (Figure 4.5B). 
 
70 
 
4.6 Conclusions 
 Insertion of a HH ribozyme to the 5’-end of a FMDV cDNA increased GFP 
detection by 20-fold initially, with an overall increase of ~1.5-fold 
throughout the 24 hr time-course. Constructs containing the 3’ HDV 
ribozyme exhibited kinetics similar to the existing pGFP-PAC replicon, 
however when combined with the HH ribozyme exhibited kinetics almost 
identical to the pHH_Rbz replicon which contained the HH ribozyme 
alone. 
 DNA transfection of replicon plasmids displayed poor GFP fluorescence 
when compared to transcript RNA. There was a lag in GFP detection of 
~4 hr and the peak of replication was not reached until 18 hr p.t.: a 12 hr 
delay in comparison to transcript RNA (6 hr p.t.).  
 Use of the T7TΦ to generate transcript RNA from plasmids resulted in 
RNA smearing and a large reduction of fluorescent signal initially of ~70-
fold, with a ~10-fold decrease throughout. 
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Figure 4.4. GFP expression derived from transfection of FMDV replicon 
plasmid DNA containing ribozymes.  BHK-21 cells were mock transfected, 
together with cells transfected with plasmid DNA from the pRbz, and pRbz_5nts 
replicon. At the time points indicated images were captured over a 24 hr period 
and the GFP fluorescence quantified for each replicon construct: data shown as 
the total GFP integrated intensity. Data points/error bars are derived from 2 
independent transfections, with 3 replicates for each transfection. 
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Figure 4.5. Replicon RNA synthesised using the T7TΦ. (A) RNA transcripts 
prepared from template DNA linearised with SspI or HpaI (as indicated). (B) GFP 
expression from mock-transfected BHK-21 cells, together with cells transfected 
with transcript RNA derived from the pRbz, pRbz_5nts, pHDV_Rbz and 
pHDV_Rbz_5nts replicons- created using the T7TΦ. The pRbz_5nts replicon was 
linearised prior to T7 transcription (as indicated), acting as a control. At the time 
points shown images were captured and the GFP fluorescence quantified for 
each replicon construct over a 24 hr period: data represents the total integrated 
GFP intensity. Data points/error bars are derived from 2 independent 
transfections, with 4 replicates for each transfection. 
(A) 
(B) 
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4.7 Discussion 
 
4.7.1 Addition of self-cleaving ribozymes to the 5’ and 3’-ends 
Replicons containing cis-active ribozymes at the 5’ and 3’-ends of a FMDV cDNA 
were made via cloning in order to improve replication kinetics. Enhanced GFP 
fluorescence was observed for constructs containing the HH ribozyme alone, or 
in combination with the 3’ HDV ribozyme, when compared to the pGFP-PAC 
replicon, which does not contain self-cleaving ribozymes. In contrast, pGFP-PAC 
showed delayed kinetics, suggesting the extra sequences at the 5’-end were 
contributing to the observed lag in replication. This is in agreement with the work 
of others who have shown that removal of non-viral guanosines at the 5’-end of 
picornavirus genomes improves replication kinetics (Herold & Andino, 2000; 
Israelsson et al., 2014). The overall trend in replication was similar for all 
constructs tested; the peak of fluorescence occurred at 6 hr p.t. and declined 
thereafter. The trend only differed dramatically within the first 2 hr p.t., which is in 
accordance with results from other groups who demonstrated that RNA 
transcripts accumulated to similar levels, following an initial lag, when the 5’-end 
contained extra guanosine residues (Herold & Andino, 2000; Sarnow, 1989). It is 
known that the viral peptide 3BVPg is uridylated during initiation of replication, and 
this (3BVPg-pUpU) acts as a primer for RNA synthesis (Paul et al., 1998). 
Therefore, it was expected that removal of non-viral guanosines would increase 
the synthesis of positive-strand RNA, as the negative-strand template would have 
authentic ends ready for attachment of uridylated 3BVPg to the 5’ terminus. The 
lag in replication observed with pGFP-PAC could indicate the time taken to 
remove these extra sequences, as the GFP fluorescence increases exponentially 
from 2 hr p.t. - the time fluorescence is initially detected for this construct. It is 
also important to note that the delay is comparable to the replication-incompetent 
pGFP-PACΔ-3D replicon, which also contains extra guanosines. Therefore, these 
sequences must delay replication. This is also in agreement with findings from 
Herold and Andino (2000). PV luciferase replicons containing an active or 
inactive HH ribozyme and a form without the HH ribozyme, displayed luciferase 
activity comparable to GFP fluorescence derived from constructs listed in the 
present study. Initial luciferase activity from the PV replicon containing the active 
HH ribozyme increased exponentially immediately, whereas PV replicons without 
authentic ends displayed a sigmoid curve, with a lag of ~1.5 hr, before increasing 
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exponentially at 2 hr. Activity detected during the first 2 hr from these replicons 
was directly comparable to both untreated cells, and cells treated with 
guanidinium hydrochloride (GuHCl): a potent inhibitor of poliovirus replication. 
The authors suggested this activity was due to translation of the input RNA, 
which is in contrast to the GFP fluorescence obtained from the pGFP-PAC and 
replication-incompetent form during a similar time-frame in this study. Little-to-no 
fluorescence was detected from 0-2 hr, with fluorescence increasing thereafter. 
The replication curve observed for pGFP-PAC-Δ3D displayed a similar trend as 
pGFP-PAC, albeit at much lower levels, whereas the luciferase activity from 
inhibited PV replicons remained at a constant level from 2 hr onwards. This could 
reflect the difference in assays used, as GFP fluorescence is detected in live cells 
in real-time, whereas extracts are harvested, prepared, and then analysed during 
a luciferase assay. Regardless of this slight discrepancy, the data reported by 
Herold and Andino (2000) and observations made during this study suggest the 
extra guanosines are removed by an unknown mechanism, or, initiation of 
positive-strand synthesis can occur internally within the 3’-end of the negative-
strand, but at a lower efficiency. 
A HDV cis-active ribozyme was introduced at the 3’-end of the FMDV replicon 
genome directly after the poly(A) tail, replacing a string of non-viral cytosine 
residues (C16) to generate a precise 3’-end. Sarnow (1989) found non-viral 
extensions to the 3’-end of PV transcripts reduced infectivity, and when these 
extensions were reduced to around 4 nucleotides in length infectivity of transcript 
RNA increased. GFP fluorescence derived from the pHDV_Rbz replicon 
displayed similar kinetics as the pGFP-PAC replicon and had no effect on GFP 
fluoresence. This highlights the importance of a precise 5’-end for efficient 
replication and suggests an exact 3’-end is not essential. Enterovirus 71 cDNA 
plasmids encoding differing lengths of poly(A) and 3’ terminal sequences did not 
have any effect on the infectivity of transcripts in cell culture when the poly(A) 
tract was of sufficient length (Lazouskaya et al., 2014). Thus, it seems there is 
more plasticity at the 3’-end of picornavirus genomes, but authenticity of the 5’-
end is more important. 
The insertion of a 5 nt sequence to increase the cleavage efficiency of the HDV 
ribozyme did not increase GFP fluorescence in either the pRbz_5nts or the 
pHDV_Rbz_5nts replicons, despite previous studies reporting enhanced 
cleavage activity with this modification (Ghanem et al., 2012; Perrotta & Been, 
1998). These 5 nt are well conserved amongst clinical HDV isolates and were 
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shown to increase the cleavage efficiency under denaturing and physiological 
salt conditions (Perrotta & Been, 1998). Ghanem et al., (2012) reported a 10-fold 
increase in rescue events and reporter gene expression from mini-genome 
cDNAs containing this 5 nt addition to the HDV sequence. A correct 3’-end is 
more critical during replication of negative sense RNA viruses as RNAs with 3’ 
overhanging ends are  not replicated (Ghanem et al., 2012; Hoenen et al., 2011)  
and could therefore explain the differences observed with our replicon system. It 
has also been demonstrated that flanking sequences can inhibit cleavage activity 
of the HDV ribozyme with the authors suggesting this could be due to these 
sequences interfering with structure formation (Perrotta & Been, 1990). There is 
also the possibility that the stem-loop structures within the 3’ UTR could be 
affecting the correct formation of the HDV ribozyme. The HH ribozyme is also 
located at the terminus of a structured region and cleavage activity seemed 
unaffected, however the HDV ribozyme is highly structured in comparison to the 
HH ribozyme and this could explain the differences observed. Despite no 
measurable difference detected in replication by the presence of the HDV 
ribozyme within the FMDV replicon during fluorescent reporter studies, perhaps 
this ribozyme will play a better role during rescue events following insertion of the 
capsid sequences by collaborators at Pirbright by increasing infectivity, as seen 
by Sarnow (1989) with PV transcripts.  
 
4.7.2 Replication derived from plasmid DNA transfection 
Transfection of cDNA plasmids encoding viral sequences into susceptible cells 
resulted in the recovery of virus (Racaniello & Baltimore, 1981; Semler et al., 
1984). It was considered that GFP expression could be monitored following 
transfection of FMDV replicon DNA, removing the need for costly and time-
consuming RNA transcription. Transfection of replicon DNA resulted in an initial 
decrease in GFP expression of ~2.5-fold and a ~20-fold decrease at the peak of 
replication when compared to cells transfected with transcript RNA. The peak of 
replication occurred at 18 hr p.t., 12 hrs later than observed with transcript RNA 
and the GFP counts obtained were also considerably lower suggesting a 
decrease in transfection efficiency.  Semler et al., (1984) observed an 18 to 250-
fold increase in PV rescue when SV40 transcription and replication signals 
(promoter, enhancer and origin of replication sequences) were inserted into 
cDNA plasmids encoding PV. This increase was cell dependent and the largest 
increase was found when COS-I cells were used. These cells express the SV40 
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T antigen which is known to increase expression of plasmids containing the SV40 
origin of replication. The vector backbone used during transfection experiments 
contains both the CMV promoter and SV40 signals, therefore it was expected 
that transcription would proceed as normal. It is possible that expression is cell-
line dependent, as reported by Semler et al., (1984). A study by Liu et al., (1997), 
compared the transcription efficiencies of several enhancer/promoter elements in 
different cell lines via CAT assays of cell extracts, and found a large variation in 
plasmid expression depending on the cell line used. In agreement with Semler et 
al., (1984), HEK 293 and COS cells provided the largest expression from 
plasmids containing the SV40 or CMV elements, with BHK-21 cells 
demonstrating lower expression on average (Liu et al., 1997). Perhaps GFP 
expression could be increased using these cell lines, however initial testing of 
transfection efficiencies in differing cell lines resulted in low GFP expression 
when replicon RNA was introduced into HEK 293 cells, with BHK-21 cells 
providing the best expression and transfection efficiency (data not shown). It 
seems the best option is the synthesis of RNA transcripts, as this provided the 
best expression and transfection efficiency with replication kinetics similar to viral 
growth curves, which is the desired outcome of using this system.  
 
4.7.3 The use of a T7 Φ terminator sequence for RNA synthesis 
It was hoped that use of a T7TΦ would aid in termination of T7 RNA polymerase 
during synthesis of RNA transcripts and eliminate the need for linearisation, 
which in turn would reduce costs and save time. Following linearisation of 
constructs with HpaI (no T7TΦ sequence) or SspI (located ~3.2 kb downstream 
of the T7TΦ sequence), RNA was synthesised and transcripts analysed by non-
denaturing agarose gels. RNA synthesised from SspI-linearised template DNA 
contained multiple transcripts, whereas lanes corresponding to transcripts made 
from HpaI-linearised contained single bands. This seemed to be due to both the 
T7TΦ and the use of SspI, as transcripts made from SspI-linearised templates 
which did not contain T7TΦ also contained multiple bands. Synthesis of 
extraneous RNA transcripts following linearization with enzymes which generate 
3’ overhanging ends has been reported, so called “snap-back”  transcription 
where T7 RNA polymerase can turn to use the 3’ protruding end as a  second 
template (Schenborn & Mierendorf, 1985); however all enzymes used during this 
study to linearise templates contained blunt or 5’ protruding ends and therefore 
this cannot explain the observed results. RNA synthesised using circular DNA as 
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template appeared smeared following examination on an agarose gel, and 
replicated poorly with a ~10-fold decrease observed during the course of the 
experiment. This could be due to the circular template affecting the transcription 
reaction, however the use of supercoiled plasmid DNA as a template by T7 RNA 
polymerase has been described (Du et al., 2012; Jeng et al., 1990), and no major 
effect on transcription termination was found. T7TΦ sequences fall into two 
classes. Class I terminators, like T7TΦ, are similar to the intrinsic terminators of 
E.coli RNA polymerase and form stem-loop structures in the nascent RNA, 
causing the polymerase to disengage from the template strand, halting 
transcription. Class II terminators do not involve secondary structures but share a 
common sequence 7 bp long within the template DNA which causes transcription 
termination (He et al., 1998). It is known that sequences up- and downstream of 
the T7TΦ sequence are  important for efficiency of termination , as well as stable 
hairpin formation (Jeng et al., 1990, 1992). It is possible that the large amount of 
secondary structure upstream of the terminator within the 3’ UTR of FMDV and 
the HDV ribozyme is inhibiting secondary structure formation and affecting 
termination when either linear or circular templates are used. It has also been 
demonstrated that RNA lacking secondary structure at the 3’-end can be 
accepted as a second template by T7 RNA polymerase and extended (Triana-
Alonso et al., 1995). SspI-linearised templates contain ~3.2 kb of vector 
sequence between the T7TΦ and SspI site and therefore may encourage 
formation of these aberrant transcripts. Due to these results, it was decided that 
future experiments would involve linearisation of the template DNA with AscI to 
ensure transcription terminated at the 3’-end of the HDV ribozyme. 
 
The next chapter describes further modification to the replicon system through 
site-directed mutagenesis of the potential Lpro-GFP cleavage site (described in 
Chapter 3) or replacement of GFP with an alternative reporter protein.  
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Chapter 5: Fluorescent Reporter Proteins. 
 
5.1 Introduction 
Aequorea victoria GFP (Aq.GFP) and its many derivatives have been used widely 
as a visual marker in a large variety of organisms for protein localisation and 
gene expression studies (Chalfie, 1995; Chudakov et al., 2010; Tsien, 1998). 
Aq.GFP was firstly discovered by  Shimomura et al., (1962), however, when the 
gene was cloned by Prasher et al., (1992) and expressed in other organisms 
such as E.coli (Inouye & Tsuji, 1994) this led to a huge advance in the field of 
molecular biology.  
Since the discovery of GFP, many more GFP-like proteins have been discovered 
in bioluminescent species with a large spectral diversity and improved 
characteristics (Chudakov et al., 2010; Rizzo et al., 2009). GFPs with enhanced 
fluorescent properties have been isolated from Anthozoan species such as the 
sea pansy Renilla mulleri and the sea pen Ptilosarcus gurneyi (Peelle et al., 
2001). These GFPs share ~25 % aa sequence identity with Aq.GFP and were 
found to be more fluorescent when expressed in mammalian cells (Peelle et al., 
2001). 
Attempts to shift the fluorescent properties of Aq.GFP beyond yellow to red 
proved to be very unsuccessful. Therefore, researchers sought red FPs from 
animals such as corals and sea anemones (Rizzo et al., 2009). All red FPs 
discovered thus far have required a large amount of optimisation in comparison 
to other FPs. The tendency to oligomerise and form tetramers, as well as poor 
maturation and fluorescent properties, has hindered their use as reporter proteins 
(Chudakov et al., 2010; Rizzo et al., 2009; Shaner et al., 2004). The monomeric 
cherry FP (mCherry) arose from mRFP1, a derivative of DsRed FP from 
Discosoma striata. Mutations to mRFP1, including the addition of C-and N-
terminal aa sequences from GFP, improved the maturation speed, photostability 
and tolerance of C- and N-terminal tags (Shaner et al., 2004). As with Renilla and 
Ptilosarcus FPs, mCherry originates from Anthozoan species and should 
therefore have low sequence similarity with the Hydrozoan Aq.GFP.  
During initial studies in Chapter 3 it was evident that Aq.GFP was undergoing 
cleavage and evidence suggested this involved FMDV Lpro. This affected 
quantitative studies to distinguish between replicating and non-replicating forms 
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through the measurement of GFP fluorescence. Due to this unforeseen cleavage 
of Aq.GFP, it was necessary to mutate the putative cleavage site, or, to replace 
Aq.GFP with a suitable alternative. Therefore, the aim of this chapter was to 
firstly carry out mutagenesis to prevent GFP cleavage by Lpro and, since this 
proved to be unsuccessful, to replace GFP with mCherry FP (Shaner et al., 
2004), or, the reportedly brighter Ptilosarcus gurneyi GFP (Pt.GFP; Peelle et al., 
2001), both of which might well be suitable substitutes due to a lower level of 
sequence identity with Aq.GFP.  
 
5.2 Mutagenesis of the potential Lpro cleavage site within Aequorea GFP 
Analysis of GFP fluorescence derived from the pGFP-PAC WT replicon in 
comparison to the pLL-GFP-PAC replicon lacking Lpro led to the observation of a 
2-fold decrease in GFP signal. Further investigation via western blotting of cell 
extracts with anti-GFP antibodies and subsequent examination of the GFP-PAC 
sequence, strongly suggested a potential Lpro cleavage site within GFP (Tulloch 
et al., 2014a, Figure 5.1). An alignment of the Lpro/1A cleavage site and the 
predicted Lpro cleavage site within Aq.GFP are shown in Figure 5.1B, with the 
potential residues involved highlighted on the Aq.GFP crystal structure (Ormö et 
al. 1996, Figure 5.1A). Bioinformatics analysis suggested that cleavage at this 
site within the GFP-PAC fusion protein would produce a cleavage product of ~42 
kDa (data not shown). Western blot analysis demonstrated the major cleavage 
product was indeed ~42 kDa, and corresponded well to Lys127-Gly128 within β-
sheet 6 of Aq.GFP (Ormö et al., 1996; Yang et al., 1996). Therefore, Lys 127 was 
mutated  to either Leu, Pro, His or Arg using site-directed mutagenesis of the 
pRbz replicon with primers spanning the cleavage site  containing the motif CNC 
(Table A.1), where ‘N’ is any nucleotide (Figure 5.1B). Following sequence 
analysis of potential positive clones, two mutants were generated comprising 
both a proline and histidine in place of Lys127. They were designated as the 
pGFPmut_K127P and pGFPmut_K127H replicons, respectively. A polymerase 
deletion form of the pRbz replicon containing self-cleaving ribozymes was also 
generated by RE digestion with MluI, to ensure that subsequent analysis of 
replicons was comparable. 
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Figure 5.1. Mutagenesis of possible Lpro cleavage site within Aequorea GFP. 
(A) Predicted Lpro cleavage site on β-sheet 6 of Aq.GFP at residue Lys127 (blue), 
between Leu 126 and Gly 128 (grey). Residues are represented as ball-and-stick. 
Image generated using PyMOL (Schrodinger, 2010). (B) The predicted cleavage 
site is shown with the proposed strategy to mutate K127 to L, P, H or R amino 
acids in order to abolish cleavage activity. 
 
 
 
 
 
 
(A) 
(B) 
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5.3 GFP expression derived from replicons bearing a mutation within 
Aequorea GFP to prevent cleavage by FMDV Lpro 
To investigate whether Aq.GFP fluorescence was affected by mutagenesis of Lys 
127, Aq.GFP fluorescence of the pRbz, pGFPmut_K127P, pGFPmut_K127H and 
pRbzΔ3D replicons was monitored over a 24 hr period using the IncuCyte ZOOM 
fluorescent microscope. Replicon plasmid DNAs were linearised with AscI, RNA 
synthesised using T7 RNA polymerase and 1 μg of transcript RNA transfected 
into BHK-21 cells. Virtually no fluorescence could be observed in cells 
transfected with both the pGFPmut_K127P and pGFPmut_K127H constructs 
(Figure 5.2, 5.3). The pRbz replicon displayed kinetics as expected. Rather 
unexpectedly, the pRbzΔ3D replicon also exhibited no fluorescence, in contrast 
to the existing replication-incompetent form, pGFP-PAC-Δ3D, which exhibits 
Aq.GFP fluorescence 2-fold lower than the replication-competent pGFP-PAC. 
Transcript RNA derived from these replication-incompetent forms differ only in 
the presence or absence of ribozymes at the 5’ and 3’-ends. Data described in 
Chapter 4 shows that replicons containing the 5’ HH ribozyme replicate 
considerably better than those lacking this ribozyme, and hence contain non-viral 
guanosines at their 5’-end. Therefore, this data implied removal of these residues 
resulted in either no or very little translation. The cell morphology in both Aq.GFP-
mutants and the polymerase deletion was characteristic of the rounded-up 
morphology associated with CPE during viral infection (Figure 5.2) and 
suggested active replication had occurred; however all contained an intact Lpro, 
hence this observation could have been solely due to Lpro – which induced cell 
death through inhibition of host cell translation (Devaney et al., 1988). Aq.GFP 
cell counts displayed trends identical to that observed for the total Aq.GFP 
fluorescence (data not shown). 
 
5.4 Cleavage of Aequorea GFP and synthesis of viral proteins during 
replication  
Due to the findings presented above, western blotting of cell extracts prepared 
from replicon-transfected cells were analysed with anti-GFP antibodies to check 
whether Aq.GFP cleavage occurred following mutagenesis of the possible 
cleavage site, and to assess the production of viral proteins during replication to 
ensure replicons were actively replicating. While mutagenesis of Lys 127 seemed 
to decrease the amount of Aq.GFP cleaved, it did not abolish cleavage activity 
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completely (Figure 5.4). FMDV 3D and 2A (data not shown) expression 
confirmed that the pGFPmut_K127P mutant was actively replicating and 
suggests the lack of fluorescence was due to the mutation within Aq.GFP.  
 
5.5 Replacement of Aequorea GFP with Ptilosarcus GFP and mCherry 
fluorescent proteins 
 
Due to mutagenesis of the putative Lpro-GFP cleavage site proving unsuccessful, 
a suitable alternative was investigated. The replicon system was designed to 
study FMDV replication to screen for attenuated forms as potential vaccine 
candidates, and for a better understanding of aspects of the viral life cycle, such 
as persistent infection. In order to facilitate such studies into persistence, a 
strategy had been devised to replace Aq.GFP with a brighter FP before this 
became a necessity due to unexpected cleavage by Lpro. A brighter FP should aid 
in the detection of low-level replication and increase the detection limits of 
experiments undertaken. As the IncuCyte ZOOM imaging system can detect both 
green and red fluorescence, mCherry FP was also investigated as a suitable 
replacement. 
Almost all FPs derived from  Aq.GFP will contain the potential Lpro cleavage site 
due to identical sequence composition, except for mutations to the chromophore 
which yield different spectral properties (Chudakov et al., 2010; Rizzo et al., 
2009). As expected, amino acid sequence alignment of cyan and yellow FPs with 
the parental GFP confirmed the presence of this site and any FPs originating 
from Aq.GFP were ruled out (Figure 5.5). Pt.GFP and mCherry FPs (Peelle et al., 
2001; Shaner et al., 2004) displayed  lower sequence  similarity with the potential 
Lpro cleavage site than Aq.GFP, and were therefore explored as substitutes. 
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Figure 5.2. GFP expression in FMDV replicons containing the Lys127Pro 
mutation within Aequorea GFP. Expression of Aq.GFP from the 
pGFPmut_K127P and pGFPmut_K127H (data not shown) replicons was 
compared to WT and pRbzΔ3D replicons. Following transfection of BHK-21 ells 
with transcript RNA from each construct, fluorescent images (nine/well) were 
captured at 2 hr intervals over a 24 hr period using the IncuCyte ZOOM imaging 
system. Data represents a captured image at both 8 and 24 hr post-transfection, 
and was obtained from 2 independent transfections, with 4 replicates per 
transfection. Scale bar represents 100 μm. 
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Figure 5.3. GFP fluorescence derived from replicons containing a mutation 
within Aequorea GFP to prevent cleavage by Lpro.  Data from mock-
transfected BHK-21 cells is shown, together with cells transfected with transcript 
RNA derived from the pGFPmut_K127P, pGFPmut_K127H, pRbz replicons and 
the polymerase deletion pRbz3D. At the time points indicated, images were 
captured over a 24 hr period and the GFP fluorescence quantified for each 
replicon construct: data shown as the total integrated Aq.GFP intensity. Data 
points/error bars shown are derived from 2 independent transfections, with 4 
replicates for each transfection. 
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Figure 5.4. Cleavage of Aequorea GFP in cells transfected with pRbz and 
GFP mutant replicons. Extracts were prepared from pRbz or pGFP mut_K127P 
replicon-transfected BHK-21 cells at the time points indicated. Extracts were 
separated by 4-20 % SDS-PAGE, transferred to nitrocellulose membranes, and 
analysed by western blotting with anti-GFP, anti-β-tubulin and anti-3D antibodies. 
FMDV 3D was used as a measure of viral protein production. 
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Figure 5.5. Alignment of mCherry and Ptilosarcus GFP with Aequorea GFP 
and its derivatives.  Residues comprising the chromophore are highlighted with 
the colour corresponding to each FP. The Lpro/1A and eIF4G cleavage sites are 
shown. The potential Lpro cleavage site is annotated with similarity to this site 
shown in grey or yellow. Lysine-glycine pairs are highlighted throughout all 
sequences in yellow. Amino acid sequences and alignment generated using 
DNAMAN. 
 
 
 
CFP             MVSKGEELFTG----VVPILVELDGDVNGHKFSVSGEGEGDATYGKLTLKFICTTG-KLP 
GFP             MVSKGEELFTG----VVPILVELDGDVNGHKFSVSGEGEGDATYGKLTLKFICTTG-KLP 
YFP             MVSKGEELFTG----VVPILVELDGDVNGHKFSVSGEGEGDATYGKLTLKFICTTG-KLP 
mCherry         MVSKGEEDNMAIIKEFMRFKVHMEGSVNGHEFEIEGEGEGRPYEGTQTAKLKVTKGGPLP 
PtGFP           -MNRNVLKNTG-LKEIMSAKASVEGIVNNHVFSMEGFGKGNVLFGNQLMQIRVTKGGPLP 
                 :.:.     .    .:   . ::* **.* *.:.* *:*    *.   ::  *.*  ** 
 
CFP             VPWPTLVTTLTWGVQCFSRYPDHMKQHDFFKSAMPEGYVQERTIFFKDDGNYKTRAEVKF 
GFP             VPWPTLVTTLTYGVQCFSRYPDHMKQHDFFKSAMPEGYVQERTIFFKDDGNYKTRAEVKF 
YFP             VPWPTLVTTFGYGLQCFARYPDHMKQHDFFKSAMPEGYVQERTIFFKDDGNYKTRAEVKF 
mCherry         FAWDILSPQFMYGSKAYVKHPADIP--DYLKLSFPEGFKWERVMNFEDGGVVTVTQDSSL 
PtGFP           FAFDIVSIAFQYGNRTFTKYPDDIA--DYFVQSFPAGFFYERNLRFEDGAIVDIRSDISL 
                ..:  :   : :* : : ::* .:   *::  ::* *:  ** : *:*..      : .: 
 
eIF4G                  -ANLGRTTL- 
L/1A                   -RKLKGAGS- 
 
CFP             EGDTLVNRIELKGIDFKEDGNILG-HKLEYNYISHNVYITADKQKNGIKANFKIRHNIED 
GFP             EGDTLVNRIELKGIDFKEDGNILG-HKLEYNYNSHNVYIMADKQKNGIKVNFKIRHNIED 
YFP             EGDTLVNRIELKGIDFKEDGNILG-HKLEYNYNSHNVYIMADKQKNGIKVNFKIRHNIED 
mCherry         QDGEFIYKVKLRGTNFPSDGPVMQKKTMGWEASSERMYPEDGALKGEIKQRLKLKDGG-H 
PtGFP           EDDKFHYKVEYRGNGFPSNGPVMQKAILGMEPSFEVVYMNSGVLVGEVDLVYKLESGN-Y 
                :.. :  ::: :* .* .:* ::    :  :   . :*   .   . :.   *:. .    
 
CFP             GSVQLADHYQQNTPIGDGPVLLPDNHYLSTQSALSKDPNEKRDHMVLLEFVTAAGITLG- 
GFP             GSVQLADHYQQNTPIGDGPVLLPDNHYLSTQSALSKDPNEKRDHMVLLEFVTAAGITLG- 
YFP             GSVQLADHYQQNTPIGDGPVLLPDNHYLSYQSALSKDPNEKRDHMVLLEFVTAAGITLG- 
mCherry         YDAEVKTTYKAKKPV-----QLPGAYNVNIKLDITS-HNEDYTIVEQYERAEGRHSTGG- 
PtGFP           YSCHMKTFYRSKGGVK----EFPEYHFIHHRLEKT--YVEEGSFVEQHETAIAQLTTIGK 
                 . .:   *: :  :      :*  : :  :   :    *.   :   * . .   * *  
 
CFP             -MDELYK-- 
GFP             -MDELYK-- 
YFP             -MDELYK-- 
mCherry         -MDELYK-- 
PtGFP           PLGSLHEWV 
                 :..*::   
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5.6 Ptilosarcus GFP construct design 
Pt.GFP was synthesised as a gene block and inserted into the pRbz replicon via 
RE digestion with NsiI and XmaI, creating the pPt.GFP replicon (Figure 5.6, A.3). 
The pPt.GFP-PAC replicon was generated via PCR of the Pt.GFP coding region 
(primers listed in Table A.1) which was inserted into the pJC3-PAC vector 
(unpublished, not shown) through RE digestion with BamHI and PstI. The 
resulting plasmid was digested with NsiI and StuI and the fragment of interest 
ligated into the pRbz replicon, similarly restricted (A.3). The pGFP replicon was 
generated previously through PCR of the Aq.GFP sequence, followed by RE 
digest with EcoRV and XmaI and subsequent ligation into the similarly digested 
pGFP-PAC replicon (A.2). Replicons lacking PAC were made as a precaution in 
the event of a C-terminal fusion affecting Pt.GFP fluorescence as previous 
studies have not used Pt.GFP fusion proteins (Peelle et al., 2001; Schulte et al., 
2006). 
 
5.7 Ptilosarcus GFP replicon-derived expression 
To investigate GFP expression generated by Pt.GFP replicons in comparison to 
replicons encoding Aq.GFP, plasmids were linearised with AscI or HpaI, 
respectively, and RNA synthesised as described in previous chapters. BHK-21 
cells expressing RFP localised to the nucleus were used during transfections in 
order to obtain cell numbers for estimation of the transfection efficiency and as an 
indication of cell death, with the expectation that RFP cell counts from replicon 
transfected cells would decline over the time period studied. Monolayers were 
transfected with 1 μg of transcript RNA and fluorescence measured every 2 hr 
over a 24 hr period using the IncuCyte ZOOM. Examples of microscopy images 
taken for the duration of the experiment are shown in Figure 5.7. The fluorescent 
nuclei could be clearly distinguished and changes in cell morphology were more 
prominent due to all cells containing a fluorescent marker. RFP counts indicated  
a ~2-3-fold decrease in cell numbers in comparison to mock-transfected cells 
during the course of the experiment (data not shown), which can be attributed to 
both cellular death and  host cell translational shut-off via eIF4G cleavage by Lpro 
(Devaney et al., 1988) leading to the inhibition of cap-dependent RFP synthesis. 
Cell transfection efficiency was estimated (at 6 hr post-transfection) from GFP 
and RFP cell counts and was shown to be ~45% for pPt.GFP replicon-
transfected cells and ~20% for replicons containing Aq.GFP (data not shown). 
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GFP counts derived from pPt.GFP replicon-transfected cells were ~10-fold higher 
on average (Figure 5.8A) and the signal obtained was considerably greater than 
replicons containing Aq.GFP, with GFP fluorescence ~45-fold higher at 2 hr p.t. 
and ~30-fold on average thereafter (Figure 5.8B). This increase can in part be 
attributed to the presence of ribozymes within the pPt.GFP replicons, which were 
shown to improve replication kinetics in Chapter 4. Comparison of data obtained 
from Figure 4.3B with data from Figure 5.8B indicates the pPt.GFP replicon is 
~20-fold brighter on average. The fluorescent signal arising from Pt.GFP during 
these experiments is higher than previously reported (Peelle et al., 2001), 
however this could be largely due to differences in measurement techniques.  
The pPt.GFP-PAC and pGFP-PAC replicons displayed a decrease in signal 
intensity when compared to replicons lacking the PAC coding region, and this 
suggests the C-terminal fusion affects fluorescence of both GFPs (Figure 5.8). As 
observed previously within this chapter, the polymerase deletion pRbzΔ3D 
generated no fluorescence (Figure 5.8). 
Due to the high level of GFP fluorescence generated from the pPt.GFP replicon, 
a number of experiments were undertaken to ensure this increase in brightness 
was an intrinsic property of this FP and not due to overexpression or increased 
stability of the protein. 
 
5.8 Ptilosarcus GFP structure prediction 
Peelle et al., (2001) performed Circular Dichroism (CD) to determine the 
secondary structure of both Renilla mulleri GFP (Rn.GFP) and Pt.GFP. The CD 
spectra obtained were virtually identical to Aq.GFP and indicated a β-strand 
conformation with small unstructured chains. The GFPs also exhibited similar 
stabilities when thermal melting curves were measured (Peelle et al., 2001). The 
crystal structure of GFP from Renilla reniformis, closely related to Renilla mulleri, 
has  been solved (Loening et al., 2007) and adopts a β-can conformation highly 
similar to Aq.GFP. As Rn.GFP and Pt.GFP have comparable fluorescent 
properties, share a similar amino acid identity to Aq.GFP, and near identical CD 
spectra, it can be assumed that Pt.GFP also shares a β-can structure. Therefore, 
the structure of Pt.GFP was predicted using Phyre2 (Kelley & Sternberg, 2009) to 
add to this body of evidence, and to eliminate this as a potential reason for the 
difference in fluorescence generated during replicon studies. Residues 9-231 of 
the 237 aa sequence were successfully predicted. The PDB generated was 
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aligned to the Aq.GFP structure (PDB ID: 1EMA) using PyMOL software 
(Schrodinger, 2010). Superposition of the two GFP structures showed a high 
degree of structural similarity, with Pt.GFP forming the characteristic β-barrel that 
is typical of Aq.GFP (Figure 5.9). The C-terminal regions differed in their length, 
with Pt.GFP having a large unstructured terminus. Several β-strands within 
Pt.GFP seem to be longer than Aq.GFP; however, apart from the differences 
mentioned, the proteins appear almost identical. 
 
5.9 Ptilosarcus GFP protein expression in replicon-transfected cells  
Western blots were carried out on pPt.GFP and pGFP replicon-transfected cells 
to ensure that protein production was similar between both constructs. BHK-21 
monolayers were transfected with 3 μg of transcript RNA and extracts prepared 
at 2, 4 and 6 hr p.t. (Figure 5.10). Anti-2A and 3D antibodies were used to 
measure GFP expression and non-structural protein production, respectively. 
Expression profiles obtained for each construct gave rise to a band correspond to 
the [Δ1A-GFP-Δ1D-2A] fusion protein, showing no major differences in 
expression levels between the two replicons and suggested Pt.GFP was not 
cleaved by Lpro. This was also supported by the fluorescent data generated thus 
far which showed no obvious signs of Pt.GFP cleavage. Plasmid pJC3 (Figure 
5.11) was used as a control to indicate a [GFP-2A] fusion protein. A band present 
within both sets of replicon cell extracts migrated slightly above this GFP-2A 
product. It is known from our own work on FMDV 2A that the polyclonal antibody 
raised against the 2A peptide cross-reacts with unknown cellular proteins 
(unpublished observations; not shown), and it is likely this band has arisen from 
such non-specific interactions. A Pt.GFP antibody is in production (DCP) and will 
provide better analysis of Pt.GFP synthesis during the course of replicon 
experiments. 
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Figure 5.6. Ptilosarcus GFP Replicons. Aq.GFP was replaced with the brighter 
Pt.GFP in the pRbz replicon. A replicon lacking PAC was also created in the 
event of a C-terminal fusion affecting Pt.GFP fluorescence. A version of the 
pGFP-PAC replicon without PAC had been created previously, the pGFP 
replicon, and was used as a comparison to the Pt.GFP replicon. 
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Figure 5.7. Ptilosarcus GFP expression in FMDV-transfected nuclear red 
BHK-21 cells. BHK-21_RFPNuc cell monolayers were transfected with pPt.GFP 
or pGFP replicon RNA, and fluorescent images captured at 2 hr intervals over a 
24 hr period using the IncuCyte ZOOM imaging system. Data represents one 
image from nine captured at 2, 6 and 24 hr post-transfection, and was obtained 
from 3 independent transfections, with 4 replicates per transfection. Scale bar 
represents 100 μm. 
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Figure 5.8. Time course of Ptilosarcus GFP expression in FMDV-transfected 
BHK-21-RFPNuc cells. Data from mock-transfected BHK-21 cells is shown, 
together with cells transfected with transcript RNA derived from the pPt.GFP, 
pPt.GFP-PAC, pRbzΔ3D, pGFP and pGFP-PAC replicons. At the time points 
indicated images were captured over a 24 hr period and the GFP fluorescence 
quantified for each replicon construct: data shown as the green object count/mm2 
(A) or as the total integrated GFP fluorescence intensity (B). Data points/error 
bars shown are derived from 3 independent transfections, with 4 replicates for 
each transfection. 
(A) 
(B) 
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Figure 5.9. Structure of Aequorea GFP and predicted structure of 
Ptilosarcus GFP. Aligned cartoon diagram of Aequorea (green, PDB ID: 1EMA) 
and Ptilosarcus (blue) GFP. The Ptilosarcus GFP structure was predicted using 
Phyre2 (Kelley & Sternberg, 2009). N- and C-termini are labelled. Image 
generated using PyMOL (Schrodinger, 2010). 
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Figure 5.10. Ptilosarcus GFP expression in replicon-transfected BHK-21 
cells.  Extracts from BHK-21 cells transfected with pPt.GFP or pGFP replicon 
RNA (2-6 hr as indicated) were separated by 12 % SDS-PAGE, transferred to 
nitrocellulose membranes, and analysed by Western blotting with anti-2A (top 
panel), anti-3D or β-tubulin antibodies. FMDV 3D expression was used as a 
measure of non-structural protein production and pJC3 (diluted 1:50) to 
demonstrate a GFP-2A fusion protein. 
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5.10 Comparison of GFP half-lives 
5.10.1 Construct design 
Plasmids containing Pt.GFP and/or flanking sequences from FMDV Δ1A, 1D and 
2A were created to test the half-life of Pt.GFP. Primers listed in Table A.1 were 
used to amplify the desired region from the pPt.GFP replicon and inserted into 
pJC3 via BamHI and ApaI RE sites. This generated a panel of plasmids to study 
the half-life of Pt.GFP (Figure 5.11). Plasmids containing PAC between the GFP 
and 2A sequences were also created, pPt.GFP-PAC-JC3 and pJC3-PAC, which 
encode Pt.GFP and Aq.GFP respectively (not shown). 
 
5.10.2 GFP expression of plasmids created to test GFP half-life 
Addition of the FMDV capsid sequences to the Pt.GFP sequence dramatically 
affected the fluorescent properties of Pt.GFP; pPt.GFPΔ1A/D-JC3 exhibited ~1.5-
fold lower fluorescence on average than pPt.GFP-JC3 and ~7-fold lower than 
pPt.GFPΔ1D-JC3 (Figure 5.12). It was clear that addition of FMDV Δ1D 
increased Pt.GFP fluorescence, as a ~10-fold increase was observed when 
comparing the pPt.GFP-JC3 and pPt.GFPΔ1D-JC3 plasmids (Figure 5.12). This 
is also evident by the ~15-fold difference between pJC3 and pPt.GFP-JC3, which 
is reduced to a ~3-fold difference when the FMDV Δ1D sequence was added to 
the C-terminus of Pt.GFP (Figure 5.12). Unexpectedly, pJC3 exhibited a higher 
signal than all pPt.GFP-JC3-based plasmids, with a ~3-fold increase over the 
highest expressing Pt.GFP plasmid, pPt.GFPΔ1D-JC3. Plasmids containing PAC 
produced GFP signals of similar intensity, however while this extension 
decreased Aq.GFP fluorescence by ~8-fold on average (compare pJC3-PAC with 
pJC3; Figure 5.12), Pt.GFP expression increased by ~4-fold (compare pPt.GFP-
PAC-JC3 with pPt.GFP-JC3; Figure 5.12). This, in combination with data 
observed for the pPt.GFPΔ1D-JC3, suggests Pt.GFP fluorescence is increased 
by C-terminal extensions in contrast to hypotheses described in section 5.7 
following examination of replicon-derived fluorescence. The fluorescent signal 
decreased for constructs containing Aq.GFP fused to PAC, supporting data 
observed with the pGFP-PAC replicon which also produced a decrease in signal 
intensity in comparison to the pGFP replicon (Figure 5.8). As expected, red 
fluorescence data showed no major differences between constructs tested (data 
not shown). 
96 
 
Due to the results obtained pPt. GFPΔ1D-JC3 was used in further experiments to 
study the half-life of Pt.GFP, as this plasmid generated the best expression level. 
  
5.10.3 GFP expression following cycloheximide treatment 
To quantify GFP degradation, BHK-21 cells were transfected with 1 μg of plasmid 
DNA and fluorescence monitored for 24 hr. Cells were then treated with CHX 24 
hr p.t. and fluorescence monitored further: allowing GFP intensity to be measured 
in the absence of newly synthesised GFP. Figure 5.13 demonstrates the half-life 
of each GFP is ~36 hr, and, as observed in Figure 5.12 pJC3, expression was 
higher than pPt.GFPΔ1D-JC3. Green and red counts exhibited trends similar to 
total intensity data (data not shown). Therefore, the data observed for sections 
5.8-5.10 suggests the increased fluorescent properties of Pt.GFP are due to 
intrinsic factors and the preference for a C-terminal extension, not due to over-
expression or increased stability.  
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Figure 5.11. Plasmids created to study the half-life of Ptilosarcus GFP. The 
pJC3 plasmid (unpublished) encoding GFP, Thosea asigna 2A (TaV 2A; Donnelly 
et al., 2001), and mCherry, was modified to include Pt.GFP, replacing Aq.GFP. 
This construct was modified further to include coding regions from the FMDV 
capsid proteins 1A and 1D and FMDV 2A.  
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Figure 5.12. GFP expression from plasmids created to compare the 
fluorescent properties of Ptilosarcus or Aequorea GFP’s. BHK-21 cells were 
mock-transfected, together with cells transfected with plasmid DNA encoding 
Pt.GFP, or Aq.GFP; pPt.GFP-JC3, pPt.GFP-PAC-JC3, pPt.GFPΔ1D-JC3, 
pPt.GFPΔ1A/1D-JC3, pJC3 and pJC3-PAC). At the time points shown images 
were captured over a 36 hr period and the GFP fluorescence quantified for each 
construct: data represents the total integrated GFP intensity. Data points/error 
bars are derived from 2 independent transfections, with 4 replicates for each 
transfection. 
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Figure 5.13. Comparison of the half-life of Ptilosarcus or Aequorea GFP’s 
by measurement of GFP fluorescence following cycloheximide treatment. 
BHK-21 cells were transfected with plasmid DNA from pPt.GFPΔ1D-JC3, pJC3 
or mock-transfected (not shown). Cells were treated with cycloheximide 24 hr 
post-transfection to determine the protein half-life. At the time points shown 
images were captured over a 48 hr period and the GFP fluorescence quantified 
for each construct: data represents the total integrated GFP intensity. Data 
points/error bars are derived from 2 independent transfections, with 3 replicates 
for each transfection. 
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5.11 Construction of the pmCherry replicon 
A panel of mCherry replicons were made via PCR and cloning. ‘Leaderless’ 
versions lacking L or containing the ‘spacer’ region, as well as a WT and 
polymerase deletion (not shown) were constructed (Figure 5.14, constructs and 
all further experiments performed by a senior honours project student under 
supervision of F.Tulloch). PCR was carried out using primers listed in Table A.1 
using the pJC3 plasmid (Figure 5.11) as a template. The pRbz_5nts_mod 
replicon was generated previously (Dr G. Luke) by deletion of sequences 
encoding the CMV promoter and neomycin resistance from the pRbz_5nts 
replicon, and all PCR fragments amplified were inserted into this vector following 
RE digestion with PsiI or NsiI and XmaI. The pmCherryΔ3D replicon was made 
by RE digestion of the pmCherry replicon with MluI (not shown). 
 
5.12 pmCherry replicon expression 
Plasmids were linearised using AscI and transcript RNA synthesised as 
described in previous chapters. BHK-21 monolayers were transfected with 1 μg 
of transcript RNA and fluorescence monitored every hour over a 14 hr period 
using the IncuCyte imaging system. Fluorescence was detected ~1-2 hr p.t. 
(Figure 5.15), with the level of mCherry expression ~65-fold lower at this time 
point when compared to Pt.GFP replicons (Figure 5.8B) and ~15-fold lower than 
replicons containing Aq.GFP (Chapter 4, Figure 4.3B); however this can be 
attributed to differences in fluorescent properties between these FPs. The 
leaderless mCherry replicon displayed fluorescence which was ~20-40-fold lower 
at 2-3 hr p.t. in comparison to the WT pmCherry replicon. This is in contrast to the 
signal obtained from the pLL-GFP-PAC replicon which produced fluorescence 
~2-fold higher than pGFP-PAC (Figure 3.4B) and suggests mCherry FP is not 
cleaved by Lpro. Western blots on cell extracts with anti-RFP antibodies will 
confirm if mCherry is indeed intact. Data generated with the pLa-mCherry 
replicon, which contains the ‘spacer’ region of Lpro (described in Introduction 
1.1.2.6), was in agreement with the pLL-mCherry data and suggested this FP 
was not cleaved. Results obtained from both the ‘leaderless’ replicons 
demonstrates that replicons lacking L are attenuated, which is in some 
agreement with previous observations (Piccone et al., 1995), and exhibits the 
true potential of this system to measure differences between replicating and 
attenuated forms. This is particularly important for future work which may involve 
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investigation of Lpro and would require a suitable screen for measuring differences 
in fluorescence. No fluorescence was detected from cells transfected with 
pmCherryΔ3D transcript RNA, which is in agreement with data obtained above 
with the pRbzΔ3D replicon (Figure 5.3, 5.8B). RFP counts exhibited similar 
trends as RFP fluorescence data (not shown). 
 
5.13 Conclusions 
 Mutagenesis of the potential Lpro cleavage site within Aq.GFP resulted in a 
loss of fluorescence. However, it does seem that the amount of GFP 
cleaved was reduced when cell extracts were probed with anti-GFP 
antibodies.  
 Due to the unsuccessful attempt to mutate the putative cleavage site, 
other FP replacements were investigated. Alignment of Aq.GFP with both 
Pt.GFP and mCherry FPs showed low sequence homology and were 
explored as potential substitutes. Pt.GFP replicons showed a 
considerable increase in expression, with a ~20-fold increase in overall 
expression when compared to Aq.GFP. Experiments undertaken to 
elucidate whether this increase was due to overexpression or increased 
stability, demonstrated that Pt.GFP was expressed to similar levels as 
Aq.GFP, with the half-lives of these GFPs being almost identical. 
 Replicons encoding mCherry did not seem to undergo cleavage by Lpro, 
and attenuated forms could be more easily distinguished, unlike identical 
forms investigated previously (Chapter 3) encoding Aq.GFP. 
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Figure 5.14. mCherry Replicons. The pRbz_5nts_mod replicon was adapted by 
replacing Aequorea GFP with mCherry FP. ‘Leaderless’ versions lacking either L 
or the Lb coding region; pLL-mCherry and pLa-mCherry, respectively, and a 
polymerase deletion pmCherryΔ3D (not shown) were also created. 
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Figure 5.15. Time course of mCherry expression in FMDV replicon-
transfected BHK-21 cells. Cells were mock transfected (not shown) or 
transfected with transcript RNA derived from the pmCherry, pLLmCherry, pLa-
mCherry and pmCherryΔ3D replicons. At the time points indicated images were 
captured over a 14 hr period and the RFP fluorescence quantified for each 
replicon construct: data shown as the total RFP integrated intensity. The 
data/error bars shown are derived from 2 independent transfections, with 3 
replicates for each transfection. 
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Figure 5.16. mCherry expression in FMDV replicon-transfected BHK-21 
cells. Transcript RNA from the pmCherry, pLa-mCherry and pLa-mCherry 
replicons was introduced into cell monolayers, and fluorescent images (nine/well) 
captured at 1 hr intervals over a 24 hr period using the IncuCyte ZOOM imaging 
system. Data is representative of a captured image at 4 and 8 hr post-
transfection, and was obtained from 2 independent transfections, with 3 
replicates per transfection. Scale bar represents 100 μm. 
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5.14 Discussion 
 
5.14.1 Mutagenesis of Aequorea GFP 
Mutagenesis of Lys127 within β-sheet 6 of Aq.GFP abolished fluorescence. No 
GFP fluorescence was detected from replicons containing mutated Lys127Pro or 
Lys127His. Western blots performed on replicon-transfected cell extracts with 
antibodies raised against FMDV non-structural proteins 2A and 3Dpol confirmed 
active replication and reduction in the amount of GFP cleaved, however cleavage 
activity was not completely eliminated. FMDV 3Cpro cleaves predominantly at Glu-
Gly (-EG-) residue pairs (Ryan et al., 1989), and this could account for the 
remaining cleavage products observed following mutagenesis of the putative Lpro 
cleavage site within Aq.GFP, due to the presence of -EG- pairs within this protein 
(see Figure 5.5). Deletion analysis of Aq.GFP defined the minimal domain 
required for fluorescence to be residues 7-229, with only 15 residues able to be 
deleted without affecting fluorescence (Li et al., 1997). The 7-229 region spans 
from the α-helix within the N-terminus to the end of the last β-strand of GFP. 
Deletions or substitutions to the N-terminus, or internally, eliminate fluorescence, 
whereas C-terminal changes are more tolerable (Li et al., 1997). GFP comprises 
11 anti-parallel β-sheets surrounding a central α-helix that is attached to the 
chromophore consisting of Ser65, Tyr66, and Gly67 (Ormö et al., 1996; Yang et 
al., 1996). This structure forms a compact ‘barrel’ or ‘can’ that ensures protection 
of the fluorophore from quenching and creates a unique environment for the 
production of fluorescence (Figure 5.9). Any modifications made to GFP which 
affect proper folding and structure formation will reduce the fluorescent signal, as 
will mutations which allow contact with the surrounding environment.  
It was hoped that mutagenesis of Lys127 to another positively charged amino 
acid would lead to retention of activity; however the Lys127His mutant also 
eliminated fluorescence. The larger, bulky side-chain of Histidine could be 
affecting important contacts with other residues of GFP, leading to loss of 
fluorescence. An arginine mutant was not obtained during mutagenesis 
experiments- perhaps this may have retained some fluorescent activity due to the 
higher degree of similarity with lysine; however due to the critical residues of GFP 
being located within region 7-229 of GFP (Li et al., 1997), this may not be 
achievable regardless of the amino acid substituted. 
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5.14.2 Alternative reporter proteins 
Unsuccessful attempts to mutate Aq.GFP led to the investigation of appropriate 
substitutions. FPs which arose from different species than the jellyfish GFP would 
be expected to be more suitable due to their low sequence homology. Therefore 
Ptilosarcus GFP and mCherry from the sea pen and mushroom coral (Peelle et 
al., 2001; Shaner et al., 2004), respectively, were chosen for subsequent replicon 
studies. 
 
5.14.2.1 Ptilosarcus GFP replicon expression 
Replicons encoding Pt.GFP exhibited enhanced fluorescence in comparison to 
those encoding Aq.GFP. Both GFP count and fluorescence intensity data was 
substantially higher than data obtained with replicons expressing Aq.GFP. This 
increase in fluorescence can be attributed to the presence of ribozymes within 
the Pt.GFP replicons which accounts for ~10-fold of the ~30-fold increase 
observed. Since further experiments investigating the protein expression profile 
and stability of Pt.GFP showed these attributes to be comparable to Aq.GFP 
(discussed below), this suggests the enhanced signal is due to intrinsic 
characteristics of Pt.GFP.  
The best figures of merit to express the ‘brightness’ of a FP are the molar 
extinction coefficient (EC) and the quantum yield (QY). The EC is a measurement 
that determines the efficiency of light absorption by the FP and the QY 
determines the efficiency of the fluorescence process (number of photons emitted 
in relation to the number absorbed; Chudakov et al., 2010).  It is possible that the 
enhanced fluorescence could be due to Pt.GFP possessing a higher QY and EC 
in comparison to Aq.GFP; however these measurements have not been 
calculated for Pt.GFP and are as yet unknown. Nevertheless, these 
measurements aren’t the only factors that should be taken into account as 
transcription and translation efficiency, mRNA and protein stability, and 
chromophore formation can all affect the resulting signal produced by a FP 
(Chudakov et al., 2010). It should also be noted that Schulte et al., (2006) 
reported the formation of tetramers for Pt.GFP and it is possible this could lead to 
increased fluorescence. It is known that oligomeric FPs often exhibit enhanced 
spectral and biochemical properties in comparison to monomeric FPs (Chudakov 
et al., 2010).  
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The pH stability of a FP can also affect the fluorescent signal obtained. Schulte et 
al., (2006) reported that Pt.GFP was much more robust at low pH when 
compared to pH-sensitive variants of Aq.GFP (pHluorins). Cells transfected with 
replicon RNA will undergo cell death due to the process of viral replication and 
cell protein synthesis shut-off. The pH of the cells will therefore decrease and 
become acidic (Lagadic-Gossmann et al., 2004), which can quench the 
chromophore leading to a loss in fluorescence. Aq.GFP is quenched by 50% at  
pH 5.5 (Tsien, 1998). Apoptotic cells reach pH levels near to (and  lower) than 
this (Lagadic-Gossmann et al., 2004).  Schulte and colleagues reported a pH 
range of 3.8-8.2 for Pt.GFP which was broader than the range of pH 4.8-7.6 for 
Aq.GFP, thus the robust pH stability of Pt.GFP could attribute to the higher signal 
produced by this FP. 
 
5.14.2.1.1 Ptilosarcus GFP structure prediction 
Experiments performed by Peelle et al., (2001) to determine the structure of 
Pt.GFP using CD indicated a β-can formation almost identical to Aq.GFP. Phyre2 
structure prediction (Kelley & Sternberg, 2009) carried out during this study is in 
agreement with this finding and eliminates the possibility that structural 
differences account for the variation in fluorescent signal generated by Pt.GFP 
and Aq.GFP. 
 
5.14.2.1.2 Ptilosarcus GFP half-life 
GFP expression was monitored in cells treated with CHX to measure the rate of 
GFP degradation. Fluorescence data generated indicates that both GFPs have 
similar half-lives of ~36 hr. Aq.GFP has been reported to have a half-life of 26-30 
hr based on previous studies (Corish & Tyler-Smith, 1999; Li et al., 1998). The 
differences between studies could be due to the measurement techniques (image 
analyses of radiolabelled protein, western blotting and flow cytometry versus live 
cell imaging) , cell lines used (human cell lines versus rodent cells) the number of 
time points taken and the duration of the experiments throughout (3 and 12 hr 
versus 24 hr). The half-life measured during fluorescence experiments correlates 
well with the N-end rule, where the terminal amino acid determines the half-life of 
a protein; proteins with a Met N-terminal residue have half-lives of ~30 hr  
(Gonda et al., 1989), which is the resulting terminal amino acid of these FPs. 
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The pPt.GFPΔ1D-JC3 plasmid exhibited a higher fluorescent signal than 
pPt.GFP-JC3. Peelle et al., (2001) investigated the effect of the addition of a 14 
amino acid flag-tag to the C-terminus of Pt.GFP upon fluorescence. They 
observed a 1.4-fold increase in Pt.GFP expression, which explains observations 
reported in this study where insertion of the FMDV Δ1D capsid sequence (~ 40 
aa) enhanced fluorescence ~ 10-fold.  
 
The addition of ~40 aa of Δ1D increased fluorescence 10-fold whereas a 
combination of both Δ1A and Δ1D caused a 1.5-fold reduction. It is interesting to 
note that the N-terminal residue of both Aq.GFP and Pt.GFP will be the terminal 
glycine from Δ1A (produced by Lpro cleavage). The N-terminal region of 
picornavirus 1A proteins comprises a myristolation signal: it may well be the case 
that this [Δ1A-Pt.GFP-Δ1D] fusion protein also becomes myristolated and this 
could affect the half-life or fluorescent properties of Pt.GFP.  
PAC C-terminal fusions also increased Pt.GFP fluorescence but, interestingly, 
not to the same extent as the much shorter Δ1D C-terminal extension.  It 
appears, therefore, that different C-terminal extensions have different affects 
upon the fluorescent properties of Pt.GFP. 
 
As a general observation, cells expressing plasmid constructs encoding PAC 
displayed a rounded-up morphology in comparison to cells transfected with 
constructs lacking the PAC gene (data not shown). Acetyl-coenzyme A (acetyl-
CoA) is very important for cellular metabolism (Vara et al., 1985). Since acetyl-
CoA is used during the biosynthesis of PAC, it’s depletion may produce 
cytopathic effects. 
Plasmid pJC3 displayed fluorescence ~3-fold higher than pPt.GFP Δ1D-JC3. 
This was unexpected due to the large differences observed between replicons 
expressing Aq.GFP or Pt.GFP. The main differences between experiments 
carried out with replicon RNA versus plasmid DNA is cytoplasmic replication 
versus nuclear transcription. It is known that Aq.GFP expression was limited 
when used within plants due to the presence of a cryptic splice site. Expression 
was restored following alterations to the codon usage within Aq.GFP (Haseloff et 
al., 1997). Hence, it is possible such a site exists within Pt.GFP and this could 
explain the observations during these experiments. 
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5.14.2.2 mCherry replicon systems 
Initial fluorescence from mCherry replicons was reduced in comparison to 
Aq.GFP and Pt.GFP replicons. The QY of mCherry is 0.22 in contrast to 0.60 of 
Aq.GFP with the relative brightness of mCherry  47% that of Aq.GFP (Chudakov 
et al., 2010; Shaner et al., 2004); therefore it is unsurprising mCherry 
fluorescence was ~15-fold lower than Aq.GFP at 2 hr p.t. and ~2-fold overall.  
Differences between attenuated forms can clearly be detected by the use of 
mCherry FP. ‘Leaderless’ replicons displayed reduced fluorescence with the pLL-
mCherry replicon also having a 2-3 hr lag in replication. Replicons lacking L and  
encoding Aq.GFP failed to show such a decrease, which was due to cleavage of 
this FP by Lpro (Chapter 3; Tulloch et al., 2014a). Replacement with a FP that is 
not cleaved by the viral protease demonstrates the true potential of this replicon 
system. Indeed, Pt.GFP replicons of a similar nature have been constructed 
(undertaken by a senior honours project student) and display identical trends, 
with ‘leaderless’ replicons showing attenuation (data not shown). This is further 
evidence that this system can be used to measure attenuated phenotypes and 
allows us to use ‘leaderless’ replicons within our panel of ‘control’ attenuated 
genomes as a benchmark for attenuation. The use of FPs with different spectral 
properties will also be very useful for competition and trans-complementation 
studies using replicons. 
 
5.14.3 GFP expression derived from replicon forms encoding polymerase 
deletions, but encoding ribozymes 
Interestingly, and rather unexpectedly, replicons encoding polymerase deletions 
containing all FPs tested throughout Chapter 5 (Aq.GFP, pRbzΔ3D; mCherry, 
pmCherryΔ3D; Pt.GFP, pPt.GFPΔ3D) generated no fluorescence when 
transfected into BHK-21 cells. This is in stark contrast to the pGFP-PAC-Δ3D 
replicon which produces a signal ~3-fold less than the WT pGFP-PAC (Tulloch et 
al., 2014a). Chapter 4 described the importance of a precise 5’-end to replicon-
derived fluorescence, with an increase in fluorescent signal when replicons 
encoded a self-cleaving ribozyme. This has also been observed with PV 
replicons encoding luciferase (Herold & Andino, 2000). These observations 
suggest that transcript RNA which cannot replicate (due to a large deletion within 
the polymerase) and does not contain non-viral guanosine residues at the 5’ 
terminus, is sequestered into abortive replication complexes and is not translated. 
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When non-viral guanosines are present, transcript RNA is predominantly 
translated - as observed for the pGFP-PAC-Δ3D replicon which exhibits a 
replication curve identical to WT pGFP-PAC, but at a reduced level of 
fluorescence (Tulloch et al., 2014a). These data pose interesting questions with 
regards to the initiation of FMDV replication where the mechanisms are still 
poorly understood. 
 
One of the main advantages of the system described is the ability to study areas 
of the viral life cycle. Regulation of the primary cleavage between 2A and 2B of 
the FMDV polyprotein has not been investigated in detail. The next chapter 
describes the generation of replicons to examine this process. 
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Chapter 6: Replicative Fitness: The Nature of the 
‘Primary’ Separation between Capsid and 
Replication Proteins. 
 
6.1 Introduction 
The 2A region of picornaviruses is highly variable. Within many genera, such as 
the aphthoviruses, 2A is an oligopeptide which mediates a novel translational 
effect- “ribosome skipping”. However, within the entero- and sapeloviruses, a 2A 
proteinase (2Apro) is found (Martı́nez-Salas & Ryan, 2010). The 2Apro from these 
genera mediates a primary cleavage at a tyrosine-glycine pair of the junction 
between the P1 capsid and the N-terminus of 2Apro. In aphthoviruses, a 
secondary cleavage by 3Cpro at the C-terminus results in full release of 2Apro from 
the [P1-2A] polyprotein processing product (Ryan & Flint, 1997). In common with 
Lpro from FMDV, enterovirus 2Apro also cleaves eIF4G inactivating host cell cap-
dependent protein synthesis (Glaser & Skern, 2000). 
The 18 aa 2A peptide from FMDV is responsible for the primary cleavage event 
which separates the downstream region encoding proteins involved with 
replication, from the upstream region which comprises the capsid proteins. This is 
mediated by “ribosome skipping”, where the synthesis of a specific peptide bond 
is “skipped” when the ribosome encounters the motif DxExNPG
↓
P within 2A 
(Donnelly et al., 2001b). The cleavage occurs between the C-terminal glycine of 
2A and the proline of the downstream protein 2B. The 2A peptide remains 
attached to the C-terminus of the upstream protein, with the downstream protein 
containing an N-terminal proline residue (Ryan & Drew, 1994; Ryan et al., 1991). 
In this model, translation either terminates at the C-terminus of 2A, or translation 
reinitiates and the downstream region is synthesised. A molar excess of the 
proteins coded upstream of 2A is also observed (Donnelly et al., 2001b). 
It is thought that FMDV 2A mediates translational control of the FMDV polyprotein 
under increasing cell stress. Here, the model states that increasing cell stress 
(through infection) leads to increased levels of phosphorylation of eEF2 
(eukaryotic elongation factor 2) – decreasing its activity. Ribosome processivity 
rates would decline throughout infection. A key step in the model of FMDV 2A 
activity is re-association of prolyl-tRNA into the A site of the ribosome following 
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egress of eRF1  (Doronina et al., 2008) However, to continue polypeptide chain 
elongation, prolyl-tRNA must be transclocated from the A-to P-site – mediated by 
eEF2. It is proposed that termination is in competition with this process of 
translocation: if the rate of translocation falls too low then termination at the C-
terminus of 2A becomes predominant. This model predicts that as infection 
progresses, an ever-increasing proportion of aminoacyl-tRNAs are used to make 
capsid proteins – increasing the yield of particles. Alteration of the ‘balance’ of 
protein synthesis (capsid versus replication proteins) could result in a decrease in 
FMDV replication - sensu particle yield. Thus, insertion of a 2Apro could change 
the molar excess of upstream protein synthesis to an equal stoichiometry of all 
virus proteins – a more uniform translation profile. Bovine enterovirus 2Apro was 
chosen to compliment the replacement of FMDV 2A with a species-specific 
(bovine) protein.  
This section describes the design and construction of novel FMDV replicons 
where BEV 2Apro has replaced FMDV 2A within the P2 coding region. These 
replicons will be used to investigate the regulation of FMDV 2A during replication, 
particularly during cell stress, with protein ratios and cellular factors such as eEF2 
and phosphorylated eEF2 monitored throughout to study their role within this 
mechanism.  
 
The insertion of BEV 2Apro has been investigated in replicons containing the 
‘spacer’ region of Lpro (lacking the Lb coding region). If full replicative fitness can 
be restored to that of WT, then it can be postulated that the main function of Lpro 
activity is cleavage of eIF4G; a function common to enterovirus 2Apro. Otherwise, 
this could suggest other roles for Lpro during FMDV replication which will be 
studied further.  
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6.2 Construct design 
All replicons generated were made by firstly inserting a StuI-EcoRI RE fragment 
from the pGFP-PAC replicon into the commercially available pSP72 vector 
(Promega). The resulting Stu-Eco subclone was restricted with XmaI and ApaI 
and the BEV 2A region (synthesised as a gene block; Dundee Cell Products) 
inserted following similar RE digestion. This second subclone was then restricted 
with XmaI and EcoRI and the resulting fragment ligated into the pRbz_5nts_mod 
replicon (described in Chapter 5.11), similarly restricted. Finally, Lpro was 
removed from the resulting replicon by RE digestion with KpnI and XmaI and 
replacement of this region with that of the pLa-GFP-PAC replicon, similarly 
restricted. This generated the pBEV 2A replicon which contained the ‘spacer’ 
region of Lpro, self-cleaving ribozymes and BEV 2Apro in place of FMDV 2A 
(Figure 6.1).  
Initial experiments demonstrated that the pBEV 2A replicon did not replicate, with 
no fluorescence detected upon transfection of transcript RNA into BHK-21 cells. 
However, these results were not completely unexpected, as the pBEV 2A 
replicon contained a novel 3Cpro cleavage site at the BEV 2Apro/ FMDV 2B 
junction. FMDV 3Cpro does not normally cleave at this site as FMDV 2A cleaves 
at its own C-terminus (Ryan et al., 1991), therefore it was assumed that BEV 
2Apro remained fused to FMDV 2B, hindering replication. In vitro 
transcription/translation (TnT; Promega) experiments implied this was the case 
due to the presence of a ~40 kDa band in the lane corresponding to the pBEV 2A 
replicon (Figure 6.2). This band was not present in lanes containing pGFP-PAC 
and pLa-GFP-PAC, with the size of this band correlating to a [BEV 2Apro-FMDV 
2B] fusion protein (Figure 6.2). It was also evident that the translation profile of 
the pBEV 2A replicon varied in comparison to the other replicons tested. The 
ratio of upstream to downstream proteins obtained from the pGFP-PAC and pLa-
GFP-PAC replicons contained more upstream (“capsid” i.e. Δ1A-GFP-PAC-Δ1D) 
proteins/protein precursors; consistent with the translational model for replicons 
encoding a 2A peptide (Donnelly et al., 2001b). In contrast, a strong band 
corresponding to [Δ1A-GFP-PAC-Δ1D] was not observed for the pBEV 2A 
replicon (Figure 6.2), which correlates with the initial GFP fluorescence data (not 
shown). 
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The presence of important FMDV proteins such as 2C, the P3 precursor and 
3Dpol within translation reactions programmed with the pBEV 2A replicon 
suggests that translation is able to occur as usual, but incomplete processing is 
rendering important proteins such as 2B from performing their critical role during 
replication: hence the lack of GFP fluorescence observed following introduction of 
this replicon into BHK cells. This lack of replication could have been due to; i) 
incomplete processing by BEV 2Apro at its N-terminus, ii) incomplete processing 
by 3Cpro at the novel BEV 2Apro/ FMDV 2B junction, or iii) a combination of both 
these possibilities. Therefore, further constructs were produced in order to 
address these issues. Firstly, 10 aa of BEV 1D was introduced upstream of BEV 
2Apro to improve cleavage activity. To examine whether incomplete processing at 
the C-terminus of BEV 2Apro was the root cause of  reduced replication  Thosea 
asigna virus 2A (TaV 2A), which also encodes a ribosomal ‘skipping’ peptide 
(Donnelly et al., 2001b), was inserted immediately after BEV 2Apro to induce 
‘cleavage’ at the BEV 2Apro/ FMDV 2B junction, thus removing the necessity for 
3Cpro-mediated processing at the BEV 2Apro/ FMDV 2B site. This modification was 
carried out with the aim of replacing TaV with differing 3Cpro dipeptides if it was 
shown that improved processing at this region increased replication.  Finally, a 
replicon encoding both the 10 aa of BEV 1D and TaV 2A was generated. All 
replicons were produced through amplification of the desired region using primers 
listed in Table A.1 and inserted into the pRbz_5nts_mod replicon as described 
above. This created the pBEV Δ1D-2A, pBEV-TaV 2A and pBEV Δ1D-TaV 2A 
replicons, respectively (assembled by Dr E. Minskaia; Figure 6.1). 
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Figure 6.1. BEV 2A Replicons. The pGFP-PAC replicon was modified to create 
the pLa-GFP-PAC, which contains the coding area between each of the AUG 
initiation codons in Lpro: the ‘spacer’ region. This was used to create replicons 
containing BEV 2Apro in the improved replicon backbone (pRbz_5nts_mod 
replicon), which comprises self-cleaving ribozymes. Replicons containing either a 
small region of the BEV 1D capsid protein, and/or TaV 2A were made to help 
achieve complete cleavage between BEV 2Apro and the [Δ1A-GFP-PAC-Δ1D] 
fusion protein, and/or FMDV 2B, in order to increase processivity and replication 
of the pBEV 2A replicon. 
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Figure 6.2. In vitro translation of pBEV 2A, pGFP-PAC and pLa-GFP-PAC 
replicons. Rabbit reticulocyte lysates (Promega) were programmed with the 
plasmids indicated and radiolabelled products examined by  12 % SDS-PAGE. 
35S-Met labelled viral proteins were visualised via autoradiography and predicted 
positions are shown.  
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6.3 BEV 2A replicon-derived GFP expression 
Replicons were linearised with AscI and RNA synthesised as described during 
previous chapters. Transcript RNA (1 μg) was transfected into BHK-21 cells and 
fluorescence monitored for the duration of the experiment. The ‘WT’ 
pRbz_5nts_mod, pBEV-TaV 2A and pBEV Δ1D-TaV 2A replicons displayed 
fluorescence, with all other replicons tested showing kinetics similar to the 
replication-incompetent pRbzΔ3D replicon (Figure 6.3, 6.4). The lack of 
fluorescence in both the pBEV 2A and pBEV Δ1D-2A replicons was most likely 
due to inefficient cleavage at the BEV 2Apro/ FMDV 2B junction by 3Cpro. This 
would result in a [BEV 2Apro-FMDV 2B] fusion protein, impeding the activity of this 
protein, and therefore preventing replication to proceed as normal. 
There was a lag in the detection of GFP fluorescence of ~2 hr for both pBEV-TaV 
2A and pBEV Δ1D-TaV 2A replicons (Figure 6.4), despite encoding self-cleaving 
ribozymes which were shown to increase replication kinetics (Chapter 4). The 
total fluorescence intensity was ~10-fold lower for the pBEV Δ1D-TaV 2A replicon 
and ~40-fold lower for pBEV-TaV 2A in comparison to the pRbz_5nts_mod 
replicon (Figure 6.4B). On average throughout the experiment, the fluorescent 
signal generated by pBEV Δ1D-TaV 2A and pBEV-TaV 2A was ~2- and ~6-fold 
lower, respectively (Figure 6.4B). GFP cell counts were also reduced, with an 
overall decrease of ~3-fold for pBEV Δ1D-TaV 2A and ~10-fold for the pBEV-TaV 
2A replicon (Figure 6.3, 6.4A). This suggests that insertion of 10 aa of BEV 1D 
and/or TaV 2A improved processing which had an effect on replication. These 
results also imply that full replicative fitness could not be restored when replicons 
lacking Lpro, but encoding 2Apro with a similar function, were transfected into BHK-
21 cells. More experiments are needed to fully investigate these findings. 
In the case of the pBEV-TaV 2A, it cannot be ruled out that a decrease in GFP 
signal, and therefore GFP positive cell counts, was due to a loss in fluorescence 
as a consequence of BEV 2Apro remaining fused to FMDV Δ1D, creating a [Δ1A-
GFP-PAC-Δ1D-BEV 2Apro] fusion protein. Examination of protein extracts from 
transfected cells with anti-GFP and FMDV-specific antibodies would clarify the 
presence of such a fusion protein, and would also allow for viral protein 
production to be assessed.  
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Figure 6.3. GFP expression derived from pBEV 2A replicon-transfected 
BHK-21 cells. Transcript RNA from the pRbz_5nts_mod, pBEV-TaV 2A and 
pBEV Δ1D-TaV 2A replicons was introduced into cell monolayers, and 
fluorescent images captured at 2 hr intervals over a 20 hr period using the 
IncuCyte ZOOM imaging system. Data from mock, pBEV 2A, pBEV Δ1D-2A and 
pRbzΔ3D replicon-transfected cells is not shown. A representative of the nine 
images captured is shown at 4, 6 and 8 hr post-transfection, and was obtained 
from 1 independent transfection, with 4 replicates per transfection. Scale bar 
represents 100 μm. 
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Figure 6.4. pBEV 2A replicon-derived GFP fluorescence.  Data from mock-
transfected BHK-21 cells is shown, together with cells transfected with transcript 
RNA derived from the pRbz_5nts_mod, pBEV 2A, pBEV Δ1D-2A, pBEV Δ1D-
TaV 2A, pBEV-TaV and pRbzΔ3D replicons. At the time points indicated images 
were captured over a 20 hr period and the GFP fluorescence quantified for each 
replicon construct: data shown as the green object count/mm2 (A) or as the total 
integrated GFP fluorescence intensity (B). Data points/error bars shown are 
derived from 1 independent transfection, with 4 replicates. 
(A) 
(B) 
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6.4 Conclusions 
 Attenuation of FMDV replicons could be achieved by replacing the FMDV 
2A peptide, encoding a ribosomal ‘skipping’ mechanism, with a 2A 
proteinase. 
 Initial experiments demonstrated a lack of fluorescent signal from the 
pBEV 2A replicon following transfection of transcript RNA into BHK-21 
cells. TnT reactions, programmed with pBEV 2A, pGFP-PAC and pLa-
GFP-PAC showed that the ratio of up-and downstream proteins produced 
by replicons encoding BEV 2Apro were quite different from replicons 
encoding FMDV 2A. 
 Insertion of BEV Δ1D and/or TaV 2A increased fluorescence of the pBEV 
2A replicon, with a combination of both modifications having the greatest 
effect. This suggests that cleavage at both junctions flanking BEV 2Apro 
was impaired within the original pBEV 2A replicon.  
 GFP expression from both the pBEV Δ1D-TaV 2A and pBEV-TaV 2A 
replicons was reduced when compared to the pRbz_5nts_mod replicon, 
indicating that replicons encoding BEV 2A were attenuated, and 
suggested that full replicative fitness could not be restored to a ‘WT’ 
replicon encoding both Lpro and FMDV 2A. 
 Coupled transcription/translation experiments in vitro with each of the 
newly created replicons will gain insight into the ratio of proteins produced 
by these constructs, with further experiments investigating regulation of 
this process during cellular stress. 
 Western blots with anti-eIF4G antibodies on replicon-transfected cell 
extracts will determine if BEV 2Apro is active and able to carry out 
cleavage of this host translation factor. Incomplete processing at the 
FMDV Δ1D-BEV 2A junction within the pBEV-TaV 2A replicon will be 
examined using anti-GFP antibodies to determine whether this is the main 
factor contributing to reduced fluorescence. 
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6.5 Discussion 
 
6.5.1 FMDV replicons encoding Bovine Enterovirus 2A are replication 
competent and attenuated 
Interestingly, insertion of BEV 2Apro into the pRbz_5nts_mod replicon produced 
replication competent – but attenuated - genomes. Initial experiments showed no 
detectable replication for the pBEV 2A replicon, most likely due to incomplete 
polyprotein processing at either the BEV 2Apro/ 2B junction (by 3Cpro) and the 
FMDV Δ1D/ BEV 2Apro junction (by BEV 2Apro) – or both. A unique 3Cpro cleavage 
site was introduced between the 2A/2B junction, likely producing a [BEV2Apro-
FMDV 2B] fusion protein as a result of incomplete processing which, in turn, 
could have affected correct processing of the Δ1D/ BEV 2Apro junction. Although 
the  Δ1D/ BEV 2Apro region was designed to contain the appropriate residues to 
facilitate BEV 2Apro cleavage (-YG- pair; Stanway, 1990), incomplete processing 
at this region is probable. Initial IncuCyte experiments revealed no detectable 
fluorescence; therefore further replicons were constructed to overcome the 
possible polyprotein processing issues. Ten amino acids of BEV 1D were 
inserted immediately upstream of BEV 2Apro (replacing sequences encoding 
FMDV Δ1D) to aid in BEV 2Apro N-terminal processing. To address the 
processing issue at the C-terminus of BEV 2Apro, TaV 2A was inserted 
immediately after BEV 2Apro to induce ribosome skipping-mediated cleavage. 
3Cpro- mediated cleavage at this region  may have been achieved by the insertion 
of other 3Cpro cleavage residues (-EG-, -QG-, -EL- and -QS- dipeptides; Ryan & 
Flint, 1997), however, introduction of TaV 2A was considered the easiest and 
quickest modification to perform  initially. Finally, a replicon containing both BEV 
Δ1D and TaV 2A was constructed. If insertion of TaV 2A proves successful, with 
replication increasing due to induced cleavage at the BEV 2Apro C-terminus, the 
addition of potential 3Cpro dipeptides will then be investigated in conjunction with 
removal of TaV 2A.  
Fluorescence data generated from these new BEV replicons displayed 
decreased signal intensities and the number of GFP positive cells was also lower 
than WT. The pBEV Δ1D-2A replicon exhibited no fluorescence upon cell 
transfection, suggesting impaired cleavage of BEV 2Apro from the polyprotein (2B) 
at its C-terminus by FMDV 3Cpro. The reduced fluorescent signal of both the 
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pBEV-TaV 2A and pBEV Δ1D-TaV2A replicons implies attenuation of these 
replicons. The WT replicon, pRbz_5nts_mod, encodes a fully functional Lpro and 
therefore Aq.GFP will undergo cleavage induced by Lpro  (Chapter 3; Tulloch et 
al., 2014a). Leaderless replicons generate higher signal intensities in 
comparison, due to Aq.GFP remaining un-cleaved. Picornaviral 2Apro cleavage 
within eIF4G occurs between an -RG- pair (Lamphear et al., 1993), with N-
terminal cleavage occurring at a -YG- pair within the polyprotein. There are no -
RG- dipeptides present within the Aq.GFP coding sequence; however two -YG- 
pairs exist (Chapter 5, Figure 5.5). It cannot be ruled out that BEV 2Apro can 
cleave at these sites; however like 3Cpro, the context of these dipeptide pairs 
within the polyprotein determines cleavage and not just their presence (Ryan & 
Flint, 1997). Nonetheless, western blots using anti-GFP antibodies must be 
performed to eliminate this possibility. Incomplete cleavage at the FMDV Δ1D/ 
BEV2Apro junction within the pBEV-TaV2A replicon could also result in the 
formation of an Aq.GFP fusion protein which could affect fluorescence. Thus, 
replicon-transfected cells generated from this replicon must also be probed with 
anti-GFP antibodies for confirmation.  Investigation of eIF4G levels over the 
course of replication will determine if BEV 2Apro is active. HRV 2Apro cleavage 
activity of eIF4G was shown to be three times slower than FMDV Lpro (Glaser & 
Skern, 2000), therefore this must be taken into account when comparing the 
relative levels of fitness between replicons. 
 
6.5.2 Fitness of BEV 2A replicons could not be restored to that of WT 
replicons encoding Lpro 
Replicons encoding BEV 2Apro could not be restored to a similar level of 
replicative fitness as a replicon encoding Lpro (pRbz_5nts_mod). Both L and  2A 
proteinases cleave eIF4G, with the cleavage sites being only 6 amino acids apart 
(Glaser & Skern, 2000). This is the main substrate for each of these enzymes, 
even though these proteinases are quite different in sequence composition and 
proteolytic activity (2A – a serine protease vs L – a cysteine protease; Ryan & 
Flint, 1997). FMDV Lpro, however,  has also been implicated to  antagonise the 
innate immune response via degradation of NF-κB (de los Santos et al., 2007, 
2009). The observation that replicative fitness could not be restored in replicons 
lacking the Lb coding sequence, but encoding BEV 2Apro which performs the 
same main function as Lpro, may strengthen the findings of de Los Santos et al., 
(2007, 2009). 
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6.5.3 Regulation of virus protein biogenesis by the FMDV 2A ribosome 
skipping mechanism can be studied using BEV 2A replicons 
Regulation of the 2A-mediated cleavage mechanism (“ribosome skipping”) is 
unknown. 2A ‘cleavage’ involves host cell translation termination factors, eRF1 
and eRF3. These RFs were shown to relieve the pause in translation induced by 
2A by hydrolysing the peptidyl-tRNA ester linkage, causing release of the nascent 
protein (Doronina et al., 2008). Synthesis of sequences downstream of 2A can 
then commence through re-initiation, or the ribosome subunits dissociate and 
translation ceases (Brown & Ryan, 2010). Involvement of these RFs raises the 
possibility that this mechanism could be influenced by cellular pathways that 
regulate their activity. Translation elongation involves delivery of an 
aminoacylated tRNA into the ribosomal A site by eukaryotic elongation factor 1A 
(eEF 1A). Anticodon pairing of the aminoacyl-tRNA in the A-site with the mRNA 
codon leads to formation of a peptide bond with the peptidyl-tRNA within the P 
site. eEF2 is responsible for catalysing the movement of both peptidyl- (A-site) 
and deacylated tRNAs (P-site) within the ribosome (reveiwed in Kaul et al., 
2011). It is known that eEF2 is phosphorylated by eEF2 kinase (eEF2K) under 
cell stress conditions. Phosphorylated eEF2 is inactive and inhibits the activity of 
un-phosphorylated eEF2 leading to a decrease in translation (Ryazanov et al., 
1988). Translation elongation is a process which consumes a large amount of 
cellular energy; therefore during periods where there is an increased demand for 
energy, or a decrease in energy supply, it would be beneficial to decrease the 
rate of protein synthesis. This decrease in translation would lead to a reduction in 
the synthesis of sequences downstream of 2A, as eEF2 would be required for 
translation to resume following 2A-mediated cleavage (Brown & Ryan, 2010). 
Increased synthesis of the capsid coding region (located upstream of 2A) would 
be favourable during such cellular conditions to encapsidate RNA genomes 
present within the cytoplasm, leading to a higher yield of infectious particles. 
Interestingly, eEF2 does indeed become progressively phosphorylated during 
TMEV (Theiler’s murine encephalitis virus) infection (L. Brown, unpublished 
observations). The proposed model of 2A-mediated cleavage is shown below in 
Figure 6.5. 
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Figure 6.5. Outline of 2A-mediated ‘cleavage’.  Peptidyl-tRNA is located in the 
ribosome A-site (a). Peptidyl-tRNA is translocated to the P-site, allowing prolyl-
tRNA to enter the A-site (b). Interactions between 2A and the ribosome, and the 
tight turn, prevents the peptidyl-tRNA ester linkage from undergoing nucleophilic 
attack, as prolyl-tRNA dissociates from the ribosome (c). eRF1 enters the A-site 
(d) and hydrolyses the ester bond (e). eRF1 then leaves the A-site (promoted by 
eRF3), and the nascent peptide is released from the ribosome (f). Prolyl-tRNA 
(re)enters the A-site (g) and is translocated to the P-site by eEF2 (h). The 
subsequent amino acid enters the A-site and sequences downstream of 2A are 
translated (i), or, the ribosome subunits dissociate and translation it terminated. 
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6.5.4 Translation profiles of FMDV replicons altered by insertion of BEV 
2Apro 
The translation profile of the pBEV 2A replicon was initially investigated in 
comparison to pGFP-PAC and pLa-GFP-PAC replicons. Preliminary results 
indicated that up- and down-stream protein production was altered within the 
pBEV 2A replicon. Both the pLa-GFP-PAC and pGFP-PAC replicons generated 
translation profiles indicative of polyproteins encoding a ribosome skipping 
sequence. The decrease in upstream protein synthesis within the pBEV 2A 
replicon (i.e. GFP-PAC) could be attributed to the lack of FMDV 2A which 
mediates the production of a molar excess of proteins encoded upstream. These 
initial findings can be used to investigate the hypothesis outlined above for 2A-
mediated regulation of FMDV translation and prompts further experimentation. 
Further studies using the replicons described within this chapter will be designed 
to examine (i) the ratios of proteins up- and down-stream of 2A synthesised 
throughout replication, (ii) host-cell shut-off by viral proteinases (Lpro & BEV 
2Apro), (iii) particle yield derived from infectious copies, and (iv) interactions of Lpro 
(or 2Apro) with the host-cell immune response. Protein ratios will be difficult to 
quantify due to the multiple precursors synthesised by the FMDV genome. In an 
attempt to measure differences in protein synthesis between replicons containing  
BEV 2Apro and FMDV 2A, pulse-labelling experiments will be performed involving 
immunoprecipitation of both cellular and in vitro translation extracts with anti-GFP 
and anti-3D antibodies. Protein levels will be quantified and differences between 
each replicon calculated. This will allow de novo synthesis of both upstream and 
downstream to be measured, rather than accumulated protein levels. The levels 
of eEF2 and phosphorylated-eEF2 will also be monitored within both WT and 
BEV replicon transfected cells. This will be correlated with protein levels 
synthesised using the differing 2A’s  to examine whether this translation factor 
has a role in regulating FMDV 2A ribosome-skipping.  
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Before such experiments can commence, polyprotein processing within these 
replicons must be improved through modification of the C-terminus of BEV 2Apro 
with varying 3Cpro dipeptides (following removal of TaV 2A) and passaging RNA 
from replicon transfected cells, or, by virus rescue and passage (Pirbright 
Institute): genomes would be sequenced throughout the process of passage and 
the properties of this new form of picornavirus compared with FMDV. 
The final results chapter of this thesis describes the influence of dinucleotide 
frequency on Echovirus 7 growth kinetics and the potential application of this 
strategy to the FMDV replicon system for vaccine development. 
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Chapter 7: RNA Virus Attenuation by Codon-pair 
De-Optimisation is an Artefact of Increases in 
CpG/UpA Dinucleotide Frequencies. 
 
7.1 Introduction 
There are a number of factors which contribute to translation regulation within 
eukaryotes, bacteria and viruses. These comprise codon usage, relative 
aminoacyl-tRNA abundancies, elongation rates (ribosome ‘processivity’) and 
translation regulation (Gingold & Pilpel, 2011). Biases exist toward certain 
synonymous codons (the “codon bias”) and codon-pairs (the “codon-pair bias”). 
Codon-pair bias refers to the preferential pairing of certain codons over others 
(e.g. in human genes the codon-pair GCC-GAA encodes the adjacent amino 
acids alanine-glutamic acid less often than GCA-GAG, even though GCC and 
GAA are the most used codons; (Luke et al., 2013). These biases are thought to 
influence gene expression by altering translation efficiency. 
Both codon and codon-pair de-optimisation have been adopted as strategies for 
attenuating viral replication within RNA viruses (Burns et al., 2006; Coleman et 
al., 2008; Martrus et al., 2013; Mueller et al., 2006, 2010; Ni et al., 2014). This 
approach involves replacement of codons within the viral coding region for 
synonymous non-preferred codons or codon-pairs. It is thought that by altering 
codon usage, translation efficiency is altered resulting in reduced viral replication. 
The design of such viruses has the potential for the production of safer, non-
reverting, live-attenuated vaccines, since attenuation arises from the 
incorporation of literally 100s of mutations – each of which only very slightly 
reduces replicative fitness, but taken together produce significant attenuation. 
Traditional methods of producing live, attenuated, vaccines involve attenuation of 
viral genomes by serial passage in tissue-culture, such as the OPV Sabin 
vaccine which had huge impacts on human health. This method of attenuation is 
time consuming and relies upon chance alone to generate attenuating mutations 
which then must undergo another lengthy process of selection to produce the 
required phenotype. However, using this method often a small number of key 
(attenuating) mutations may back mutate leading to reversion to virulence. The 
introduction of a large number of synonymous changes within the genome 
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reduces, therefore, the risk of back-mutation increasing the genetic stability of the 
vaccine strain. 
Another compositional feature which can affect the replication phenotype is the 
suppression of CpG and UpA dinucleotide frequencies among RNA and small 
DNA viruses (Rima & Mcferran, 1997; Simmonds et al., 2013). Artificially 
increasing the dinucleotide frequencies has been shown to impair replication 
kinetics of Echovirus 7 (E7) and PV (Atkinson et al., 2014; Burns et al., 2009). 
The authors of these studies speculate that the selection of disfavoured codon-
pairs which attenuate PV and other viruses alters the CpG/UpA frequency within 
the genome, and it is this which accounts for, the most part (if not all!), the 
attenuating effects observed. Indeed, Burns et al., (2009) demonstrated that their 
previous strategy using codon de-optimised PV mutants to attenuate viral 
replication was due to greatly enhanced frequencies of CpG and UpA 
dinucleotides, rather than alterations in codon or codon-pair bias.  
The study described in this chapter sought to disentangle the relationship 
between codon-pair bias (CPB) and dinucleotide frequencies in a re-examination 
of their effects on the replication of an RNA virus, E7. To resolve this functionally, 
comparisons were made of the replication kinetics and relative fitness of native 
E7 with a series of novel mutants of E7 in which dinucleotide frequencies and 
CPB were independently manipulated. 
 
7.2 Construction of mutant viruses and insert compositions 
Two regions of the E7 genome were replaced within P1 and P3 (Figure 7.1), 
used previously to examine the effects of dinucleotide frequencies on virus 
replication (Atkinson et al., 2014). These areas were selected for mutagenesis 
due to (i) their lack of predicted RNA secondary structure and (ii) the absence of 
RNA elements required for replication or translation (Atkinson et al., 2014). 
Mutants which contained a pre-determined CPB score whilst retaining the 
composition of CpG and UpA dinucleotide frequencies were generated using 
computational analysis with a specifically developed computer program 
(Sequence Mutate in the SSE package, performed by Professor P.Simmonds; 
Simmonds, 2012). This allowed numerous synonymous changes to be introduced 
within the E7 genome: the amino acid sequence of all virus proteins remained 
identical. Gene blocks comprising either (i) altered dinucleotide frequencies, or, 
(ii) altered CPB scores were synthesised. These sequences were flanked by the 
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unique restriction sites SalI (genome position 1878) and HpaI (3119) for region 1 
and EcoRI (5403) and BglI (6462) for region 2 (Figure 7.1). The E7 cDNA clone 
pT7:E7 was digested with the enzymes described and the appropriate gene block 
inserted.  
The mutant Min-E possessed the minimum possible CPB score (-0.111) while 
retaining dinucleotide frequencies identical to WT (CP score: -0.014; CpG: 0.525; 
UpA: 0.718; Figure 7.2; Table 7.1). Mutants comprising identical CPB scores as 
Min-E but with slightly elevated dinucleotide frequencies (Min-U; CpG: 0.82; UpA: 
0.95), or where dinucleotide frequencies were maximised (Min-H; CpG: 1.3; UpA: 
0.98) were also generated (Figure 7.2; Table 7.1). These mutants allowed the 
effects of dinucleotide frequencies on virus replication to be analysed 
independently of CPB. The mutant Max-U comprised a maximised CPB score 
(0.320), but contained similar CpG/UpA frequencies to WT. This mutant could be 
compared with the previously described CpG/UpA low cu|cu mutant which 
contained a CPB score slightly greater than WT (CpG; 0; UpA; 0.22; CPB; 0.11; 
Figure 7.2; Table 7.1). The permuted mutant (P|P) was designed such that codon 
order was permuted, while retaining protein coding and WT dinucleotide 
frequencies. The CpG/UpA low mutant (cu|cu) was designed such that (i) all CpG 
dinucleotides were eliminated and (ii) the maximum number of UpA dinucleotides 
as possible were removed - as described previously (Atkinson et al., 2014). 
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Figure 7.1. Schematic of Echovirus 7 mutant constructs with insert 
positions aligned to WT. The E7 coding region is shown in boxed areas: the 
capsid (P1) region is shown in green and the replication proteins domain P3 
shown in beige. Differently coloured or striped boxes indicate modified cassettes 
which have altered CPB or dinucleotide frequencies (described in the text). 
Nucleotide positions were calculated relative to the pT7:E7 cDNA sequence. 
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Figure 7.2. Codon-pair scores and numbers of CpG and UpA dinucleotides 
in native (WT) and mutated regions of E7. Mean codon-pair scores for Regions 
1 and 2 shown on x-axis; total of CpG and UpA dinucleotides in each sequences 
are shown on the y-axis. The histogram shows codon-pair scores for the 35170 
human mRNA sequences >200 bases in length (mean 0.072; standard deviation 
± 0.031). CpG/UpAL = cu|cu (image generated by Prof. P. Simmonds). 
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Table 7.1. Composition and codon usage of E7 WT and mutant insert sequences 
 
       G+C              CpG    O/E               UpA   O/E       Codon Usage  
Region  Sequence (Symbol) content          Total1  ratio2,3  Total  ratio2,3  CAI4 ENc CP Bias3 
  
     1  Native (WT)  47.6%    51 (-)  0.730    62 (-)          0.742      0.685 56.5  -0.043 
Permuted (P)  47.6%    51 (0)  0.730     2 (0)          0.742  0.694 55.8  -0.025  
  CpG/UpAL (cu) 47.5%   0 (-51)            0     19 (-43)        0.227  0.686 43.5   0.087  
  Max-U     50.1%   47(-4)   0.610  43 (-19)        0.573  0.708 49.6   0.328  
  Min_E     47.5%   51 (0)       0.736    62 (0)    0.735  0.748 54.3  -0.131  
  Min_U     47.5%   69 (+18)       0.992  76 (+14)    0.939  0.709 58.3  -0.134  
  Min_H     49.8%  106(+55)       1.400  79 (+17)    0.981  0.696 49.2  -0.130  
 
     2  Native (WT)  47.1%   18 (-)       0.320   48 (-)          0.695  0.743 53.2   0.015  
Permuted (P)  47.6%   18 (0)         0.320   48 (0)         0.695  0.739 49.0   0.013  
CpG/UpAL (cu) 48.5%    0 (-18)           0   48 (0)            0.214  0.739 47.2   0.118 
Max-U   46.3%   24 (+6)        0.440   43 (-3)        0.601  0.750 46.1   0.311  
Min-E   45.7%   18 (0)  0.343  48 (0)        0.657  0.785 53.3  -0.091  
Min-U   47.4%  37 (+19) 0.649  50 (+2)          0.738  0.767 57.6  -0.083  
Min-H   47.8%  68 (+50)          1.172  65 (+15)     0.970  0.715 49.7  -0.085 
1Total number of CpG and UpA dinucleotides in sequence. Changes in numbers between mutated and original WT sequence are indicated in 
parentheses 
2Ratio of observed dinucleotide frequency (O) to that expected based on mononucleotide composition (E) ie.  f(CpG) / f(C) * f(G).  
3Values deliberately changed are shown in red (maximised) and blue (minimised).  
4Calculatedfromhttp://genomes.urv.es/CAIcal/(Puigbò et al., 2008). 
(table generated by Prof. P. Simmonds). 
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Table 7.2. Relationship between codon-pair de-optimisation, CpG and UpA Frequencies and Virus Fitness Reduction. 
       WT    CPD   Replication 
Region       Gene  Prop’n             CPB CpG UpA             CPB CpG UpA  Reduction Ref 
Poliovirus 
PV-X  Capsid  14.8%  -0.03 0.52 0.75  -0.46 1.34 1.25      x 25  (Coleman et al., 2008) 
PV-XY  Capsid  25.9%  -0.03 0.54 0.75  -0.46 1.31 1.27      x 400 
 
Influenza A virus* 
HA
Min
        Segs.4  11.4%  0.02  0.43 0.64  -0.42 1.65 1.11      x 3.5  (Mueller et al., 2010) 
HA/NP
Min  
Segs.4,5 21.3%  0.02  0.44 0.55  -0.42 1.56 1.14      x 14          
PR8
3F
        Segs.1,4,5 29.1%   0.01  0.43 0.53  -0.41 1.55 1.07      x 35 
 
HIV-1 
A       gag  4.6%  0.03 0.47 1.04  -0.43 1.43 1.25       x 7  (Martrus et al., 2013) 
B       gag  4.7%  0.08   0 0.91  -0.37 1.22 1.15       x 3 
C       gag  4.8%  0.03 0.31 1.00  -0.38 1.50 1.09       x 8 
D       gag  2.1%  -0.02   0 0.49  -0.42 1.47 0.99       x 1.5 
 
PRRSV 
SAVE5     gp5  2.6%*  -0.06 0.63 0.73  -0.38 1.37 1.14       x 4*  (Ni et al., 2014) 
 
*Codon-pair minimised sequences of IAV were not provided in (Mueller et al., 2010) and for the purposes of comparison these have been reconstructed in 
SSE. Note that the codon-pair scores described in Table 1 of that paper (-0.386, -0.420 and -0.421 for PB1, HA and NP respectively) are not minimum scores; 
these are in fact -0.533, -0.585 and -0.602. Therefore, for the purposes of comparison, codon-pair score minimisation in the current study was targeted to 
those values. Although the sequences generated by SSE are not identical to those obtained previously, they would demonstrate a similar distortion of 
dinucleotide frequencies to those used in the previous study (Coleman et al., 2008).  
*Mutated region only (positions 147-542 in gp5) 
*Data from replication assay in PAM cells. 
(table generated by Prof. P. Simmonds). 
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Table 7.3. Enzymes used in selective digests for competition assays. 
Pairwise fitness comparisons between WT and mutant viruses are listed with the 
restriction enzyme used to determine each virus. The RE target and region 
amplified is also shown.   
 
 
Virus 1 Virus 2 Region Enzyme Target 
W|W P|P 1 SpeI Permuted 
W|W Max-U 1 SacI Max 
W|W Min-E 1 NcoI WT 
W|W Min-U 1 NcoI WT 
W|W Min-H 1 EcoRV WT 
W|W cu|cu 1 EcoRV WT 
P|P cu|cu 1 SpeI Permuted 
Max-U P|P 1 SpeI Permuted 
Max-U cu|cu 1 SacI Max 
Min-E Min-U 1 ClaI Min-U 
Min-E Min-H 1 EcoRV Min-E 
Min-U Min-H 1 ClaI Min-U 
 
 
 
 
 
 
 
 
 
 
 
 
 
135 
 
7.3 The effect of CPB or dinucleotide frequency on viral replication  
Coding regions of poliovirus, influenza A virus, PRRSV and HIV-1 have all been 
subjected to codon-pair de-optimisation (CPD) and effects on virus replication 
quantified  (Coleman et al., 2008; Martrus et al., 2013; Mueller et al., 2010; Ni et 
al., 2014). Despite their diversity of replication and translation mechanisms, each 
showed a similar relationship between the extent of CPD and reduction in virus 
replication ability (Table 7.2). Typically, 10-fold or greater attenuation in cell 
culture required >12-15% replacement of WT genome with CPD sequences. It is 
notable, however, that for each virus, CPD invariably increased frequencies of 
CpG and UpA dinucleotides (Table 7.2), typically from 0.4-0.6 to 1.4-1.6 (CpG) 
and from 0.5-0.8 to 1.1-1.4 (UpA) in the mutated regions.  
RD cell monolayers were infected with transcript RNA transcribed from NotI 
linearised cDNA from both WT and mutant viruses. Infectious virus was 
recovered from transfected cells, and supernatants titrated into 96-well plates by 
measurement of TCID50 values. Multi-step growth curves were performed to 
investigate replication kinetics of the E7 mutants in comparison to WT. RD cells 
were infected at an MOI of 0.01, and viral supernatants harvested at 6, 24 and 42 
hr post infection (p.i.; Figure 7.3). Experiments were performed in triplicate. 
Replication kinetics of the P|P and cu|cu viruses were evaluated previously 
(Atkinson et al., 2014) and have been omitted from the current graph. Over the 
course of the experiment both the Min-U and Min-E viruses showed similar 
replication to WT, with a slight reduction in titre at 24 hr p.i. Max-U also displayed 
kinetics similar to that of WT, with a higher titre produced at 42 hr p.i. 
Contrastingly, the Min-H mutant produced ~30-fold less infectious virus than WT 
over the duration of the experiment, with a ~70-fold reduction at 24 hr p.i. Cell 
monolayers were destroyed for all viruses tested with the exception of Min-U and 
Min-H mutants, which displayed incomplete CPE (data not shown). 
 
7.4 Determination of viral fitness 
The relative fitness of wild-type and the various mutant viruses was investigated 
via competition assays. RD cells were co-inoculated with equal MOIs of each 
virus combination and serially passaged up to ten times. vRNA was extracted 
from harvested supernatants and PCR amplified across the modified region.  The 
relative compositions of vRNA populations were determined by cleavage with 
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restriction enzymes of the PCR amplification products: this differentiated between 
WT and mutant sequences (Table 7.3). Twelve pair-wise combinations were 
examined (Figure 7.4). Examples of three combinations are shown (Figure 7.5);  
(i) Max-U showed similar fitness to WT, but a greater population 
representation at passage 10 (P10).  
(ii) Max-U was completely out-competed by cu|cu by P10, and in the final 
example shown,  
(iii) WT and Min-E displayed equal populations at P5, and P10 (data not 
shown).  
All other combinations tested were at completion by P5 and are summarised 
along with the examples described (Figure 7.4, 7.6). Thus, the fitness ranking 
indicated was as follows; cu|cu > Max-U > (WT = P|P = Min-E) > Min-U > Min-H. 
These results demonstrate that when altered independently from CPB, only 
dinucleotides were associated with replication fitness. 
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Figure 7.3. Replication kinetics of WT and mutant viruses in multiple-step 
growth curves. RD cell monolayers were infected at low MOI (0.01), and 
infectious titre of viral supernatants determined by TCID50 assay at the time points 
indicated. Results are the standard error of the mean of three biological 
replicates. 
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Figure 7.4. Pairwise combinations investigated during competition 
experiments. (A) Twelve combinations of mutant and WT viruses were 
examined. (B) Summary of the outcomes of pairwise fitness comparisons for 
viruses tested. Results indicated by colour shading at passages 5 and 10. For 
example, Min-E and WT showed equal fitness (yellow shading) and cu|cu 
outcompeted WT by passage 5 (red) and Max-U by passage 10. W|W = WT 
(image (B) generated by Prof. P. Simmonds).   
 
 
 
 
 
 
(A) 
(B) 
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Figure 7.5. Fitness determination of WT and mutant viruses by competition 
assays. RD cells were co-infected with an equal MOI of WT or mutant viruses 
and supernatants serially passaged in cells following development of CPE. RNA 
was isolated from viral supernatant and virus composition verified by selective 
restriction enzyme digest. Images shown are examples of three pairwise 
combinations. The virus composition of the starting inoculum (lane 3) and two 
biological replicates (lanes 4 and 5) at passage 10 (panels 1 and 2) or P5 (panel 
3) of WT, Max-U, cu|cu and Min-E starting viruses (lanes 1 and 2) are shown. 
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Figure 7.6. Fitness ranking of remaining competition assays examined. 
Images shown are the results from each pairwise combination, indicated by a 
number (details listed in Figure 7.4A), and starting viruses. All examples were 
completed by P5 unless indicated.  
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7.5 Translation efficiency 
The translation profiles of each mutant virus were compared to examine whether 
altering dinucleotide frequency or CPB score had an effect on the rate of 
translation, and therefore influenced replication. In vitro translation assays were 
used to avoid any effects mediated through cellular stress-response-related RNA 
mechanisms that may restrict E7 replication (Atkinson et al., 2014). Rabbit 
reticulocyte lysates were programmed with transcript RNA (2 μg: transcribed from 
WT and mutant cDNA), in the presence of [35S]-methionine. Reactions were 
incubated for 3 hr and subsequently resolved on SDS-PAGE gradient gels. 
Translation profiles were as expected, with cleaved and partially cleaved proteins 
observed (Figure 7.7). Translation efficiencies of each mutant in comparison to 
WT were comparable. Any differences observed did not, therefore, correlate with 
replicative fitness. This indicated that alteration of CPB or dinucleotide 
frequencies had no significant effect on viral translation, and therefore cannot be 
attributed to the differences observed in the replication phenotype documented. 
 
7.6 Conclusions 
 CpG and UpA dinucleotide frequencies were primarily responsible for 
differences observed in viral replication kinetics. 
 No fitness differences were observed for mutants with different CPB 
scores, where dinucleotide frequencies were kept constant. 
 Translation efficiencies, however, were not affected by either CPB or 
dinucleotide frequencies.  
 Insight of the mechanism underlying attenuation is crucial for the design 
and safety of future live attenuated vaccines. 
 
NOTE: The data presented in this chapter were generated by myself, unless 
specifically stated otherwise. These data made the major contribution towards the 
publication (Tulloch et al., 2014b).   
 
 
 
 
142 
 
 
 
 
 
Figure 7.7. In-vitro translation profiles of WT and mutant viruses. Rabbit 
reticulocytes were programmed with 2 μg of transcript RNA generated from WT 
and mutant cDNA templates. Radiolabelled products were separated by 
SDS_PAGE. Predicted viral protein positions were calculated based on molecular 
weights on SDS-PAGE.  
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7.7 Discussion 
 
7.7.1 Increasing dinucleotide frequency and not CPB generates an 
attenuated replication phenotype 
Studies which have adopted codon-pair de-optimisation as a strategy for the 
production of live-attenuated vaccines have failed to recognise the effects of this 
procedure has on dinucleotide frequencies (Coleman et al., 2008; Mueller et al., 
2006, 2010). Selection of disfavoured codon-pairs elevated UpA or CpG 
dinucleotide frequencies to levels 2.5 to 3-fold higher than native sequences 
(Table 7.2). The frequencies of such dinucleotides are suppressed in most 
mammalian RNA viruses (Rima & Mcferran, 1997) and have been documented in 
other studies to contribute towards the observed attenuation (Burns et al., 2009). 
The mutants constructed within this study provided the influences of CPB and 
dinucleotides on viral phenotype and fitness to be analysed separately. The 
fitness ranking observed following competition assay analysis was as follows; 
  
        (cu|cu > Max > (WT = P|P = Min-E) > Min-U > Min-H) 
 
This demonstrated that it was the increase in dinucleotide frequencies which 
contributed to the fitness phenotype observed - and not CPB.  
 
7.7.2 Translation efficiency of E7 and mutant viruses and mechanism of 
attenuation 
It was proposed that reduced viral replication from CPB de-optimised mutants 
was caused by changes in the translation rate (Coleman et al., 2008; Mueller et 
al., 2006, 2010). If CPB was responsible for such changes then differences 
between the translation profiles of WT and CPB-maximised or CPB-minimised 
mutants would have been observed: no measurable differences were observed 
either between these different mutants, or, the mutants and WT genomes- as 
analysed by in vitro translation assays. This demonstrates that it is not the virus 
itself that is intrinsically defective as a template for translation per se, but that the 
modified nature of these viral genomes is now recognised by the cell and 
inhibiting replication. The mechanism of attenuation remains unknown: it was 
shown, however, that inhibition of replication of elevated CpG/UpA genomic 
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forms was not mediated through conventional pattern recognition receptors or 
PKR (Atkinson et al., 2014). These authors also demonstrated that high and low 
CpG/UpA mutated genomes were not sensitive to the cellular IFN response. 
Viruses were, however, sensitive to the addition of the kinase inhibitor C16 
(supposedly PKR specific; Jammi et al., 2003), with the replication phenotype 
reversed following treatment. This suggests regulation could occur through an 
unknown PKR-related component of the stress response pathway. Thus, 
investigation into the innate cellular responses produced against viruses with 
altered dinucleotide frequencies is essential for the safe production of these new 
high CpG/UpA live-attenuated vaccines. 
 
7.7.3 Application to the FMDV replicon system 
The regions modified within the E7 genome spanned both the P1 and P3 
sequences. The capsid coding region will not be manipulated during studies 
using the FMDV replicon due to (i) HSE guidelines, and (ii) the strategy proposed 
for the generation of live-attenuated vaccines during this project. Here we aim to 
produce an attenuated (replication proteins) ‘backbone’ such that capsid proteins 
from a range of serotypes can be inserted into the attenuated backbone cDNA 
clone – producing either strain or serotype ‘chimeric’ vaccine strains. This would 
allow cross-protection across serotypes utilising a single strategy for attenuation 
which could be applied to all FMDV strains – once the sequence encoding the 
capsid proteins was determined. Replicons which are attenuated using the 
mechanism of increased dinucleotide frequency will be compared to a panel of 
known, published, attenuated FMDV replicons to monitor levels of replication 
between these genomes.  
 
The E7 work determined the (genomic) basis of attenuation (by whatever cellular 
mechanism) and now provides a rational basis for interpretation of CPD forms 
that had already been generated  and, critically, for further design of CPD FMDV 
genomes. 
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Chapter 8: Concluding Remarks. 
 
This thesis has primarily focused on the design and optimisation of an efficient 
replicon system for FMDV, which can be used to study replication outwith high 
disease-secure facilities. The use of the system to screen for attenuated 
genomes followed by the creation of corresponding infectious copies (by 
collaborators) is of high priority. Working within high bio-containment facilities 
such as the Pirbright Institute involves laborious health-and-safety procedures 
which are very important for safety reasons, however, they lengthen the time 
taken to execute experiments, especially those involving virus. A replicon system 
which removes the need for such facilities enables experiments to be performed 
quicker using techniques which differ from classical methods. This allows for 
screening of potential areas of interest before commencing time-consuming, but 
essential, virus work. Screening of attenuated genomes at St Andrews can help 
to ‘rank’ replicons in order of interest/importance, reducing the work load involved 
with viral growth curves and aiding in the quick progression to animal studies.  
 
During experiments to analyse attenuated replicon genomes, it became apparent 
that the spacer region of Lpro could be of some interest for future investigation. 
Replicons encoding the 84 nt spacer sequence did not demonstrate an initial lag 
in replication, in contrast to replicons completely lacking Lpro, but did exhibit a 
decrease in fluorescent signal when compared to WT replicons containing a fully 
functional Lpro. This was observed for replicons coding for both mCherry (Chapter 
5), and for Pt.GFP (data not shown). Interestingly, insertion of this 84 nt spacer 
region into a plasmid encoding Aq.GFP and mCherry FPs (such that the 28 aa of 
the spacer sequence was fused onto the N-terminus of Aq.GFP) produced a 
perinuclear distribution of fluorescence within transfected BHK-21 cells. In 
contrast, plasmids encoding Labpro (able to produce both forms of L) or Lbpro 
displayed a more uniform distribution of Aq.GFP within the cytoplasm. These 
interesting observations suggest the spacer region may play a role in the sub-
cellular localisation of the Lab, but not the Lb, form of the L proteinase. The two 
initiation codons within Lpro are conserved within all sequenced isolates of FMDV 
across all seven serotypes (Carrillo et al., 2005; Sangar et al., 1987). The spacer 
region does not show a high sequence similarity between isolates, unlike the Lb 
region which is more conserved. It has been suggested that the spacer serves as 
146 
 
an extension which modifies the activity of Lbpro (Sangar et al., 1987), but as yet 
there is no known alternative function for either forms.  
Replicons completely lacking Lpro were attenuated (following insertion of a FP 
which was not cleaved by L) and this finding also merits additional investigation, 
as this is in disagreement with the work of others (Belsham, 2013; Piccone et al., 
1995). As mentioned in the discussion, these laboratories have been unable to 
rescue viruses lacking Lpro: only viruses containing the spacer region of Lpro could 
be rescued.  
Thus, the data described within this thesis pose interesting questions regarding 
the function of the differing forms of L proteinase. Further experiments will involve 
Deltavision microscopy of cells transfected with replicons/plasmids encoding 
different forms of Lpro and determination of their localisation with the use of anti-
Lpro antibodies. Hopefully this will help to elucidate the possible function of these 
forms within cells. Experiments to abolish RNA secondary structure using SHAPE 
analysis are also planned to confirm whether this plays a role in the function of 
Lpro, as well as experiments investigating a protein-dependent function. 
 
Introduction of ribozymes into polymerase deleted forms of the replicon lead to 
the rather unexpected observation of no fluorescence detected upon transfection 
into BHK-21 cells. A polymerase deletion which did not contain these ribozymes 
(pGFP-PAC-Δ3D) exhibited fluorescence, albeit lower than WT. It should be 
noted that a lack of fluorescence was observed for all polymerase mutants 
generated (encoding all FPs examined) during this study. These data suggest 
that RNA may be sequestered into abortive replication complexes when a precise 
5’- end is generated – or at least a complex which supresses translation. If this 
were the case, however, these data suggest that 3Dpol is not involved in the 
suppression of translation, which has been proposed by others to function as the 
switch from translation to replication (Herold & Andino, 2001; Paul et al., 2000). 
Further deletions may help ‘map’ which protein is responsible for this effect. 
Perhaps when the 5’-end is not authentic, the RNA is predominantly translated, 
and following removal of non-viral nucleotides (or 3BVPg during infection) triggers 
replication.  
The molecular biology of FMDV replication is largely unexplained. Limited studies 
have been performed and many analogies have to made with the enteroviruses. 
The findings described within this thesis may help to elucidate the fundamentals 
of RNA replication, or, at least help to gain more insight into this process. Strand-
specific RT-qPCR could be used to compare levels of negative- and positive-
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strand RNA produced by both polymerase deletion and WT replicons. This would 
require sequencing of isolated genomes to determine authenticity of the viral 5’-
end. 
 
The use of Pt.GFP within the FMDV replicon not only allows for GFP 
fluorescence to be measured without cleavage by Lpro, but will aid in studies 
which focus on persistence due to the increased fluorescent properties of this FP. 
FMDV readily establishes persistent infections, but very little is known about this 
process at the molecular level.  
Experiments at St Andrews will consist of passaging RNA isolated from cells 
post-transfection. It is proposed that persistent cells will be expressing Pt.GFP at 
lower levels, and will therefore be easier to detect due to the intrinsic brightness 
exhibited by this GFP. Cells will be collected by FACS or via antibiotic selection, 
RNA extracted, and introduced into fresh cell monolayers. RNA isolated at each 
subsequent passage will be sequenced by colleagues at Pirbright and any 
changes observed will be investigated. Colleagues at Pirbright will also attempt to 
establish persistently infected cell cultures. Both sets of persistent cultures will be 
analysed using SILAC analysis (by colleagues at Dundee University) to 
determine the relative abundance/ subcellular localisation of viral proteins within 
these cells. 
mCherry replicons generated during this work will assist in competition 
experiments between mutant replicons using the IncuCyte microscope. They will 
also aid in trans-complementation assays to ‘rescue’ replicons which have 
decreased rates of replication. Such experiments have been performed by 
colleagues at both Leeds University and the Pirbright Instuitue, where 
mutations/deletions within proteins have been complemented with mCherry 
replicons and replication has been improved. Virus work will supplement any 
analyses utilising competition or trans-complementation assays. 
 
The observation that replicons encoding BEV 2Apro were attenuated in 
comparison to WT replicons requires in-depth investigation, not only to rescue 
virus from corresponding infectious copies, but to elucidate regulation of FMDV 
2A ‘ribosome-skipping’ in further detail. In vitro transcription/translation 
experiments on newly generated BEV replicons will identify whether the ratio of 
proteins up-and downstream of BEV 2Apro is altered in comparison to replicons 
encoding FMDV 2A. Further examination will include western blotting with anti-
eEF2 and phospho-specific anti-eEF2 antibodies. The loss of fluorescence 
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detected for some of the replicons analysed may have been due to incomplete 
processing at either of the junctions surrounding BEV 2Apro. To clarify this, 
extracts will be probed with anti-GFP and anti-FMDV antibodies, as well as anti-
eIF4G to examine if BEV 2Apro is active within all constructs generated. 
Polyprotein processing will be improved by passaging of virus/RNA, with 
sequencing at the C-terminus of Δ1D to observe any key changes which increase 
fitness. TaV 2A will be removed and various 3Cpro dipeptides will be inserted at 
the C-terminus of BEV 2A in an attempt to induce cleavage at this junction. 
Particle yields from corresponding infectious copies of BEV replicons will be 
determined and compared to IncuCyte and protein analysis performed at St 
Andrews. It is anticipated that these data will correlate and show that reduced 
protein synthesis from the BEV replicon lowers particle yield. 
Studies into the innate immune system (comparison or replicons containing Lpro 
vs BEV 2Apro, mainly NF-κB due to published data; de los Santos et al., 2006, 
2007) and host-cell shut-off by the two viral proteinases will commence in the 
future once the avenues above have been investigated. 
 
Confirmation that increasing dinucleotide frequencies, and not CPB, was the 
basis of attenuation will greatly facilitate the synthetic biology design process 
used to create the next generation of attenuated FMDV replicon genomes. Work 
has already been undertaken to create such replicons, and preliminary data has 
demonstrated that these genomes are indeed attenuated (experiments 
performed by Dr E. Minskaia). Work will commence shortly to rescue the 
corresponding infectious copies, expanding these findings.  
Replicons encoding Pt.GFP displayed a stable decline in GFP fluorescence from 
12 hr onwards when compared to replicons encoding Aq.GFP (Figure 5.8 vs 
Figure 4.3B) which could be explained by the composition of CpG/UpA 
dinucleotides between these replicons. It is possible that replicons encoding 
Aq.GFP have a higher frequency of these dinucleotides, and therefore increase 
cell death due to enhanced detection by an unknown pathway of the innate 
immune system; postulated previously as the underlying mechanism of 
attenuation (Atkinson et al., 2014). The GFP signal generated by the pPt.GFP 
replicon decreases less rapidly than those encoding Aq.GFP, therefore rather 
than increased stability of Pt.GFP (which was proposed during Chapter 5), 
perhaps a reduced frequency of these dinucleotides allows for the viral RNA to 
escape detection by the immune system, allowing for increased replication and 
limited cell death. All relevant replicons generated during this thesis will be 
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analysed using the SSE software developed by Prof. P. Simmonds (Simmonds, 
2012) to determine the frequency of CpG/UpA dinucleotides within each genome. 
Any major differences will be rectified using gene blocks with an ‘optimised’ 
sequence. 
 
Hence, the data generated during the construction of this FMDV replicon system 
highlights the possibilities for the use of this approach and how it will allow us to 
investigate the fundamentals of FMDV RNA replication. Publications from other 
groups have resulted from the use of the replicon (Forrest et al., 2014),  with 
collaborators from various institutes using  these constructs to study aspects of 
FMDV biology. Okapi Biosciences (Belgium) are also using this replicon system 
to screen for small molecule inhibitors of FMDV.  
In conclusion, this system will help to produce a step-change in our 
understanding of how this virus grows and interacts in cells. The work carried out 
during this project will aid in the development of 
 
 a new generation of more effective vaccines 
 new, more biosecure, methods of vaccine production and 
 more effective diagnosis. 
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Appendices 
 
A.1 Primers used throughout this study for cloning purposes 
 
Table A.1 Oligonucleotides used during vector construction. Primer 
sequences are shown in the 5’- 3’ direction with the name and description listed. 
All primers were designed to maintain a correct ORF. 
Primer 
Name 
Primer sequence (5’- 3’) and description 
JN7 
CCCGGGTGGCACCGGGCTTGCGGGTCATGC 
Reverse primer encoding the C-terminus of Puromycin-N-acetyl-transferase (PAC) 
JN9 
TTATAACCACTGAACACATGGATATCGTGTCCAAAGGGGAAGAGCTG 
Forward primer encoding the N-terminus of GFP, with a PsiI site (underlined) 
JN10 
TACGTAATCGATATCGTGTCCAAAGGGGAAGAGCTG 
Forward primer encoding the N-terminus of GFP, containing a SnaBI site (underlined) 
GFP_fwd 
AATACTATGCATATGGATATCGTGTCCAAAGGG 
Forward primer encoding the N-terminus of GFP, containing an EcoRV site 
(underlined) 
GFP_rev 
_SmaI 
CCCGGGCTTATACAGCTCGTCCATG 
Reverse primer encoding the C-terminus of GFP, containing a SmaI site  (underlined) 
PMR for 
2 
CGGACCCAACATGTGTGCAA 
Forward primer encoding region of the 5'-UTR from FMDV 
PMR for 
14 
GTTGCAACCCTGATGTTGAT 
Forward primer encoding region of 3D
pol
 from FMDV 
HDVrbz_
5nt_AscI 
rev 
GGCGCGCCTGGCTCTCCCTTAGCCATCCGA 
Reverse primer encoding HDV ribozyme with 5 extra nucleotides (bold) and an AscI 
site (underlined) 
Pt.GFP_ 
BamHI 
fwd 
GGCCGCGGATCCAGATGCATATGAACCGCAACGT 
Forward primer encoding Pt.GFP and a BamHI site (underlined) 
Pt.GFP_ 
PstI_rev 
CGCGGCCTGCAGCACCCACTCGTGCAG 
Reverse primer encoding Pt.GFP and a PstI site (underlined) 
Pt.GFP 
Δ1A_ 
BamHI 
fwd 
GCGCGCGGATCCCCTTTTATAACCACTGAA 
Forward primer encoding Δ1A and a BamHI site (underlined) 
PMR rev 
8 
CCGACGTTAGGTCGAACTTC 
Reverse primer encoding 5'-end of 2B 
EM234 
CTACGGGGTCTGACGCTCAGTGGAAC 
Forward primer encoding region of pUC ori 
EM235 
GTTCCACTGAGCGTCAGACCCCGTAG 
Reverse primer encoding region of pUC ori 
GFPmut 
fwd 
CCGCATCGAGCTGCNCGGCATCGACTTCAAGGAGG 
Forward primer encoding L
pro
- GFP cleavage site with mutated Lysine (bold and 
underlined) 
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GFPmut 
rev 
CCTCCTTGAAGTCGATGCCGNGCAGCTCGATGCGG 
Reverse primer encoding L
pro
- GFP cleavage site with mutated Lysine (bold and 
underlined) 
PMR rev 
9 
GTCCTCCTGCATCTGGTTGAT 
Reverse primer encoding 5'-end of 2B 
mCherry 
fwd_NsiI 
ATGCATATGGATATCGTGAGCAAGGGCGAGGAG 
Forward primer encoding 5'-end of mCherry and a NsiI site (underlined) 
mCherry 
fwd_PsiI 
TTATAACCACTGAACACATGGTGAGCAAGGGCGAGGAGGAT 
Forward primer encoding 5'-end of mChery and a PsiI site (underlined) 
La-
mCherry 
fwd_PsiI 
TTATAACCACTGAACACATGAATACAACTGACTGTTTTATCGCTTTGGTACAGGCTA
TCAGAGAGATTAAAGCACTTTTTCTATCACGCACCACAGGGAAAATGGTGAGCAAGG
GCGAGGAGGATAACATGGCC 
Forward primer encoding the ‘spacer’ region of L
pro
, the 5’-end of mCherry (bold) and a 
PsiI site (underlined) 
mCherry 
rev_XmaI 
CCCGGGTTTTGTACAATTCATCCAT 
Reverse primer encoding mCherry and a XmaI site (underlined) 
BEV_ 
Δ1D fwd 
CCGCGCCCCGGGGGATTTGTTCTAACAGAGCCAGCTTGACTAGCTATGGACCCTTTG
GGCAGCAGCAGGGT 
Forward primer encoding BEV Δ1D and a region of BEV 2A with a XmaI site 
(underlined) 
BEV_ 
Δ1D rev 
CCGCGCGGGCCCGTCACGTGCTTTGAGCTGTTCCAT 
Reverse primer encoding region of BEV 2A with an ApaI site (underlined) 
BEV_Tav
2A fwd 
CCGCGCCCCGGGTCACCGAGTTGCTTTACCGG 
Forward primer encoding region of BEV 2A with a XmaI site (underlined) 
BEV_Tav
2A rev 
CGCGCCGGGCCCAGGATTTTCCTCCACGTCCCCGCATGTTAGAAGACTTCCCCTGCC
CTCCAGATGTTCCATGGCGTCATCCTC 
Reverse primer encoding TaV 2A and a region of BEV 2A with an ApaI site 
(underlined) 
BEV_Δ1
D fwd_2 
CGCGGCCCCGGGGGATTTGTTCTAACAGA 
Forward primer encoding region of BEV Δ1D with a XmaI site (underlined) 
R1 OS 
CCCAATTTGATGTAACACCACACATGG 
Forward primer used to amplify region1 of E7 for competition assays 
R1 OAS 
CCCATACTCGGATGTGCTTGGG 
Reverse primer used to amplify region1 of E7 for competition assays 
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A.2 pGFP-PAC replicon sequence 
 
 
Replicon O1K pGFP-PAC 
 
1    TTTACTTTCACCAGCGTTTCTGGGTGAGCAAAAACAGGAAGGCAAAATGCCGCAAAAAAG 
                                                       SspI 
61   GGAATAAGGGCGACACGGAAATGTTGAATACTCATACTCTTCCTTTTTCAATATTATTGA 
121  AGCATTTATCAGGGTTATTGTCTCATGAGCGGATACATATTTGAATGTATTTAGAAAAAT 
181  AAACAAATAGGGGTTCCGCGCACATTTCCCCGAAAAGTGCCACCTGACGTCTAAGAAACC 
241  ATTATTATCATGACATTAACCTATAAAAATAGGCGTATCACGAGGCCCTTTCGTCTCGCG 
301  CGTTTCGGTGATGACGGTGAAAACCTCTGACACATGCAGCTCCCGGAGACGGTCACAGCT 
361  TGTCTGTAAGCGGATGCCGGGAGCAGACAAGCCCGTCAGGGCGCGTCAGCGGGTGTTGGC 
421  GGGTGTCGGGGCTGGCTTAACTATGCGGCATCAGAGCAGATTGTACTGAGAGTGCACCAT 
481  TCGACGCTCTCCCTTATGCGACTCCTGCATTAGGAAGCAGCCCAGTAGTAGGTTGAGGCC 
                                  SphI 
541  GTTGAGCACCGCCGCCGCAAGGAATGGTGCATGCAAGGAGATGGCGCCCAACAGTCCCCC 
601  GGCCACGGGGCCTGCCACCATACCCACGCCGAAACAAGCGCTCATGAGCCCGAAGTGGCG 
661  AGCCCGATCTTCCCCATCGGTGATGTCGGCGATATAGGCGCCAGCAACCGCACCTGTGGC 
 
       SgrAI                                          SpeI -> T7  
721  GCCGGTGATGCCGGCCACGATGCGTCCGGCGTAGAGGATCTGGCTAGGACTAGTAATACG 
 
 promoter  -> FMDV 
781  ACTCACTATAGGTTTGAAAGGGGGCATTAGGGTCTCACCCCTAGTAAGCCAACGACAGTC 
841  CCTGCGTTGCACTCCACACTTACGTTGTACACACGCGGGACCCGATGGGCTATCGTTCAC 
             
   PvuII 
901  CCACCTACAGCTGGACTCACGGCGCCGCGTGGCCATTTAGCTGGATTGTGCGGACGAACA 
961  CGCTTGCGCACCTCGCGTGACCGGTTAGTACTCTTACCACTCTCCGCCTACTTGGTCGTT 
1021 AGCGCTGTCTTGGGCATTCCTGTGGGGGCCGTTCGACGCTCCACGGGAACTCTCCTGTGT 
1081 GACATCTACGGTGATGGGGCCGTTTCGCGTGGGCTGGTCGTTTGGACTGCTTCGGCTGTC                       
 NheI     
1141 ACCCGGCGCCCGCCTTTCAGCTAGCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCC 
1201 CCCCCCCCCCCCCCGCTCCCCCCCCCCCAAGTTTTACCGTCGTTCCCGACGTAAAAGGGA 
              HinDIII                                    HinDIII 
1261 GGTAACCACAAGCTTGAAACCGTCCGGCCCGACGTAAAAGGGTGGTAACCACAAGCTTAC 
1321 TGCCGTCTTTCCCGACGTTAAAGGGATGAAACCACAAGACTTACCTTCGCTCGGAAGTAA 
1381 AACGACAAACACACACAGTTTTGCCCGTTTTCATGAGAAATGGGACGTCTGCGCACGAAA 
1441 CGCGCCGTCGCTTGAGGAGGACTTGTACAAACACGATCTATGCAGGTTTCCCCAACTGAC 
1501 ACAAACCGTGCAACTTGAAACTCCGCCTGGTCTTTCCAGGTCTAGAGGGGTAACATTTTG 
1561 TACTGTGTTTGACTCCACGCTCGATCCACTAGCGAGTGTTAGTAGCGGTACTGCTGTCTC 
1621 GTAGCGGAGCATGTTGGCCGTGGGAACACCTCCTTGGTAACAAGGACCCACGGGGCCGAA 
1681 AGCCATGTCCTAACGGACCCAACATGTGTGCAACCCCAGCACGGCAGCTTTACTGTGAAA 
1741 CCCACTTCAAGGTGACATTGATACTGGTACTCAAACACTGGTGACAGGCTAAGGATGCCC 
          KpnI 
1801 TTCAGGTACCCCGAGGTAACAAGCGACACTCGGGATCTGAGAAGGGGACTGGGACTTCTT 
                        HinDIII 
1861 TAAAGTGCCCAGTTTAAAAAGCTTCTACGCCTGAATAGGTGACCGGAGGCCGGCACCTTT 
 
          PsiI              Lab 
1921 CCTTTTATAACCACTGAACACATGAATACAACTGACTGTTTTATCGCTTTGGTACAGGCT 
1                          M  N  T  T  D  C  F  I  A  L  V  Q  A  
 
                                                    Lb 
1981 ATCAGAGAGATTAAAGCACTTTTTCTATCACGCACCACAGGGAAAATGGAACTGACACTG 
14    I  R  E  I  K  A  L  F  L  S  R  T  T  G  K  M  E  L  T  L   
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2041 TACAACGGTGAGAAGAAGACCTTTTACTCCAGGCCCAACAACCACGACAACTGCTGGTTG 
34    Y  N  G  E  K  K  T  F  Y  S  R  P  N  N  H  D  N  C  W  L   
 
2101 AACGCCATCCTCCAGTTGTTCAGGTACGTTGAAGAACCATTCTTCGACTGGGTCTACAGT 
54    N  A  I  L  Q  L  F  R  Y  V  E  E  P  F  F  D  W  V  Y  S   
 
2161 TCGCCTGAGAACCTCACGCTTGAAGCCATCAAGCAGTTGGAGGATCTCACAGGACTTGAA 
74    S  P  E  N  L  T  L  E  A  I  K  Q  L  E  D  L  T  G  L  E   
 
2221 CTGCATGAGGGTGGACCACCTGCTCTCGTGATCTGGAACATCAAGCACTTGCTCCACACC 
94    L  H  E  G  G  P  P  A  L  V  I  W  N  I  K  H  L  L  H  T   
 
2281 GGCATCGGCACCGCCTCGCGACCCAGCGAGGTGTGCATGGTGGATGGTACGGACATGTGC 
114   G  I  G  T  A  S  R  P  S  E  V  C  M  V  D  G  T  D  M  C   
                                 AflII     
2341 TTGGCTGATTTCCATGCTGGCATTTTCCTTAAGGGGCAAGAACACGCTGTGTTTGCGTGT 
134   L  A  D  F  H  A  G  I  F  L  K  G  Q  E  H  A  V  F  A  C   
 
2401 GTCACCTCCAACGGGTGGTACGCGATTGACGATGAGGACTTCTACCCCTGGACGCCGGAC 
154   V  T  S  N  G  W  Y  A  I  D  D  E  D  F  Y  P  W  T  P  D   
 
2461 CCGTCCGACGTTCTGGTGTTTGTCCCGTACGATCAAGAACCACTCAACGGGGAATGGAAA 
174   P  S  D  V  L  V  F  V  P  Y  D  Q  E  P  L  N  G  E  W  K   
 
                               1A 
2521 GCCAAGGTTCAACGCAAGCTCAAAGGGGCTGGACAATCCAGTCCAGCGACCGGCTCGCAG 
194   A  K  V  Q  R  K  L  K  G  A  G  Q  S  S  P  A  T  G  S  Q   
 
                               GFP 
                        NsiI  NdeI  EcoRV     
2581 AACCAATCTGGCAATACTATGCATATGGATATCGTGTCCAAAGGGGAAGAGCTGTTCACC 
214   N  Q  S  G  N  T  M  H  M  D  I  V  S  K  G  E  E  L  F  T   
 
2641 GGGGTGGTGCCCATCCTGGTCGAGCTGGACGGCGACGTAAACGGCCACAAGTTCAGCGTG 
234   G  V  V  P  I  L  V  E  L  D  G  D  V  N  G  H  K  F  S  V   
 
eGFP active site residues 
2701 TCCGGCGAGGGCGAGGGCGATGCCACCTACGGCAAGCTGACCCTGAAGTTCATCTGCACC 
254   S  G  E  G  E  G  D  A  T  Y  G  K  L  T  L  K  F  I  C  T   
 
2761 ACCGGCAAGCTGCCCGTGCCCTGGCCCACCCTCGTGACCACCCTGACCTACGGCGTGCAG 
274   T  G  K  L  P  V  P  W  P  T  L  V  T  T  L  T  Y  G  V  Q   
 
2821 TGCTTCAGCCGCTACCCCGACCACATGAAGCAGCACGACTTCTTCAAGTCCGCCATGCCC 
294   C  F  S  R  Y  P  D  H  M  K  Q  H  D  F  F  K  S  A  M  P   
 
2881 GAAGGCTACGTCCAGGAGCGCACCATCTTCTTCAAGGACGACGGCAACTACAAGACCCGC 
314   E  G  Y  V  Q  E  R  T  I  F  F  K  D  D  G  N  Y  K  T  R  
  
       
possible Lpro cleavage site 
2941 GCCGAGGTGAAGTTCGAGGGCGACACCCTGGTGAACCGCATCGAGCTGAAGGGCATCGAC 
334   A  E  V  K  F  E  G  D  T  L  V  N  R  I  E  L  K  G  I  D   
 
3001 TTCAAGGAGGACGGCAACATCCTGGGGCACAAGCTGGAGTACAACTACAACAGCCACAAC 
354   F  K  E  D  G  N  I  L  G  H  K  L  E  Y  N  Y  N  S  H  N   
 
3061 GTCTATATCATGGCCGACAAGCAGAAGAACGGCATCAAGGTGAACTTCAAGATCCGCCAC 
374   V  Y  I  M  A  D  K  Q  K  N  G  I  K  V  N  F  K  I  R  H   
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3121 AACATCGAGGACGGCAGCGTGCAGCTCGCCGACCACTACCAGCAGAACACCCCCATCGGC 
394   N  I  E  D  G  S  V  Q  L  A  D  H  Y  Q  Q  N  T  P  I  G   
 
3181 GACGGCCCCGTGCTGCTGCCCGACAACCACTACCTGAGCACCCAGTCCGCCCTGAGCAAA 
414   D  G  P  V  L  L  P  D  N  H  Y  L  S  T  Q  S  A  L  S  K   
 
3241 GACCCCAACGAGAAGCGCGATCACATGGTCCTGCTGGAGTTCGTGACCGCCGCCGGGATC 
434   D  P  N  E  K  R  D  H  M  V  L  L  E  F  V  T  A  A  G  I   
 
                                     PAC 
                                 ApaI 
3301 ACTCTCGGCATGGACGAGCTGTATAAGGGGCCCCACCACCACCACCACCACACCGAGTAC 
454   T  L  G  M  D  E  L  Y  K  G  P  H  H  H  H  H  H  T  E  Y   
 
3361 AAGCCCACGGTGCGCCTCGCCACCCGCGACGACGTCCCCAGGGCCGTACGCACCCTCGCC 
474   K  P  T  V  R  L  A  T  R  D  D  V  P  R  A  V  R  T  L  A   
                                              BspEI       
                                              AccIII       
3421 GCCGCGTTCGCCGACTACCCCGCCACGCGCCACACCGTCGATCCGGACCGCCACATCGAG 
494   A  A  F  A  D  Y  P  A  T  R  H  T  V  D  P  D  R  H  I  E   
 
3481 CGGGTCACCGAGCTGCAAGAACTCTTCCTCACGCGCGTCGGCCTCGACATCGGGAAGGTG 
514   R  V  T  E  L  Q  E  L  F  L  T  R  V  G  L  D  I  G  K  V   
 
3541 TGGGTCGCGGACGACGGCCCCGCGGTGGCGGTCTGGACCACGCCGGAGAGCGTCGAAGCG 
534   W  V  A  D  D  G  P  A  V  A  V  W  T  T  P  E  S  V  E  A   
 
3601 GGGGCGGTGTTCGCCGAGATCGGCCCGCGCATGGCCGAGTTGAGCGGTTCCCGGCTGGCC 
554   G  A  V  F  A  E  I  G  P  R  M  A  E  L  S  G  S  R  L  A   
                       StuI 
3661 GCGCAGCAACAGATGGAAGGCCTCCTGGCGCCGCACCGGCCCAAGGAGCCCGCGTGGTTC 
574   A  Q  Q  Q  M  E  G  L  L  A  P  H  R  P  K  E  P  A  W  F   
 
3721 CTGGCCACCGTCGGCGTCTCGCCCGACCACCAGGGCAAGGGTCTGGGCAGCGCCGTCGTG 
594   L  A  T  V  G  V  S  P  D  H  Q  G  K  G  L  G  S  A  V  V   
                       EagI 
3781 CTCCCCGGAGTGGAGGCGGCCGAGCGCGCCGGGGTGCCCGCCTTCCTGGAGACCTCCGCG 
614   L  P  G  V  E  A  A  E  R  A  G  V  P  A  F  L  E  T  S  A   
 
3841 CCCCGCAACCTCCCCTTCTACGAGCGGCTCGGCTTCACCGTCACCGCCGACGTCGAGGTG 
634   P  R  N  L  P  F  Y  E  R  L  G  F  T  V  T  A  D  V  E  V   
 
                                                    1D 
                                                    SmaI 
3901 CCCGAAGGACCGCGCACCTGGTGCATGACCCGCAAGCCCGGTGCCACCCGGGTCACCGAG 
654   P  E  G  P  R  T  W  C  M  T  R  K  P  G  A  T  R  V  T  E   
 
3961 TTGCTTTACCGGATGAAGAGGGCCGAAACATACTGTCCAAGGCCCTTGCTGGCAATCCAC 
674   L  L  Y  R  M  K  R  A  E  T  Y  C  P  R  P  L  L  A  I  H   
 
                                         SgrAI 
                                         AgeI             2A 
4021 CCAACTGAAGCCAGACACAAACAGAAAATTGTGGCACCGGTGAAACAGACTTTGAATTTT 
694   P  T  E  A  R  H  K  Q  K  I  V  A  P  V  K  Q  T  L  N  F   
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 2B 
                                             ApaI 
4081 GACCTTCTCAAGTTGGCGGGAGACGTCGAGTCCAACCCTGGGCCCTTCTTTTTCTCCGAC 
714   D  L  L  K  L  A  G  D  V  E  S  N  P  G  P  F  F  F  S  D   
 
4141 GTTAGGTCGAACTTCTCCAAACTGGTGGAAACCATCAACCAGATGCAGGAGGACATGTCA 
734   V  R  S  N  F  S  K  L  V  E  T  I  N  Q  M  Q  E  D  M  S   
 
4201 ACAAAACACGGGCCTGACTTTAACCGGTTAGTGTCCGCATTTGAGGAGTTGGCCATTGGA 
754   T  K  H  G  P  D  F  N  R  L  V  S  A  F  E  E  L  A  I  G   
                                                  HinDIII 
4261 GTGAAAGCCATCAGAACCGGTCTCGACGAAGCCAAACCCTGGTACAAGCTTATCAAGCTC 
774   V  K  A  I  R  T  G  L  D  E  A  K  P  W  Y  K  L  I  K  L   
 
4321 CTAAGCCGCCTGTCGTGCATGGCCGCTGTGGCAGCACGGTCCAAGGACCCAGTCCTTGTG 
794   L  S  R  L  S  C  M  A  A  V  A  A  R  S  K  D  P  V  L  V   
 
4381 GCCATCATGCTGGCCGACACCGGTCTCGAGATTCTGGACAGCACCTTCGTCGTGAAGAAG 
814   A  I  M  L  A  D  T  G  L  E  I  L  D  S  T  F  V  V  K  K   
 
4441 ATCTCCGACTCGCTCTCCAGTCTCTTTCACGTGCCGGCCCCCGTCTTCAGTTTCGGAGCA 
834   I  S  D  S  L  S  S  L  F  H  V  P  A  P  V  F  S  F  G  A   
 
4501 CCGGTCCTGTTGGCCGGGTTGGTCAAAGTTGCCTCGAGTTTCTTCCGGTCCACACCCGAA 
854   P  V  L  L  A  G  L  V  K  V  A  S  S  F  F  R  S  T  P  E   
 
                          2C 
4561 GACCTTGAGAGAGCAGAGAAACAGCTCAAAGCACGTGACATCAACGACATCTTCGCCATT 
874   D  L  E  R  A  E  K  Q  L  K  A  R  D  I  N  D  I  F  A  I   
 
4621 CTCAAGAACGGCGAGTGGCTGGTCAAACTGATCCTTGCCATCCGCGACTGGATTAAGGCT 
894   L  K  N  G  E  W  L  V  K  L  I  L  A  I  R  D  W  I  K  A   
 
4681 TGGATCGCCTCAGAAGAGAAGTTTGTCACCATGACAGACTTGGTGCCTGGCATCCTTGAA 
914   W  I  A  S  E  E  K  F  V  T  M  T  D  L  V  P  G  I  L  E   
 
4741 AAGCAGCGGGACCTGAACGACCCGAGCAAGTACAAGGAAGCCAAGGAGTGGCTCGACAAC 
934   K  Q  R  D  L  N  D  P  S  K  Y  K  E  A  K  E  W  L  D  N   
 
4801 GCGCGCCAAGCGTGTTTGAAGAGCGGGAACGTCCACATTGCCAACCTGTGCAAAGTGGTC 
954   A  R  Q  A  C  L  K  S  G  N  V  H  I  A  N  L  C  K  V  V   
 
4861 GCACCAGCACCCAGCAAGTCGAGGCCCGAACCCGTGGTTGTTTGCCTCCGCGGCAAATCT 
974   A  P  A  P  S  K  S  R  P  E  P  V  V  V  C  L  R  G  K  S   
 
4921 GGCCAGGGCAAGAGCTTCCTTGCAAACGTGCTTGCACAGGCAATTTCCACCCACTTCACC 
994   G  Q  G  K  S  F  L  A  N  V  L  A  Q  A  I  S  T  H  F  T   
 
4981 GGCAGAATCGACTCAGTGTGGTACTGCCCACCTGACCCTGACCACTTCGACGGTTACAAC 
1014  G  R  I  D  S  V  W  Y  C  P  P  D  P  D  H  F  D  G  Y  N   
 
5041 CAGCAAACCGTTGTTGTGATGGATGATTTGGGCCAGAACCCTGACGGCAAGGACTTCAAA 
1034  Q  Q  T  V  V  V  M  D  D  L  G  Q  N  P  D  G  K  D  F  K   
 
5101 TACTTTGCCCAAATGGTCTCGACCACAGGGTTTATCCCGCCCATGGCATCACTCGAGGAC 
1054  Y  F  A  Q  M  V  S  T  T  G  F  I  P  P  M  A  S  L  E  D   
 
5161 AAAGGTAAACCTTTCAACAGCAAAGTCATCATCGCGACCACCAACTTGTACTCGGGCTTC 
1074  K  G  K  P  F  N  S  K  V  I  I  A  T  T  N  L  Y  S  G  F   
 
 
174 
 
5221 ACCCCGAGGACCATGGTATGTCCCGACGCACTGAACCGGAGGTTTCACTTTGACATCGAT 
1094  T  P  R  T  M  V  C  P  D  A  L  N  R  R  F  H  F  D  I  D   
 
 
5281 GTGAGTGCTAAGGATGGGTACAAAATTAACAGCAAATTGGACATTATCAAAGCACTCGAA 
1114  V  S  A  K  D  G  Y  K  I  N  S  K  L  D  I  I  K  A  L  E   
5341 GACACCCACGCCAACCCAGTGGCAATGTTTCAATACGACTGTGCCCTTCTCAACGGCATG 
1134  D  T  H  A  N  P  V  A  M  F  Q  Y  D  C  A  L  L  N  G  M   
 
5401 GCCGTTGAAATGAAGAGAATGCAACAAGACATGTTCAAGCCTCAACCACCCCTCCAGAAT 
1154  A  V  E  M  K  R  M  Q  Q  D  M  F  K  P  Q  P  P  L  Q  N   
 
5461 GTGTACCAGCTTGTTCAGGAGGTGATCGATCGGGTCGAGCTCCACGAGAAAGTGTCGAGT 
1174  V  Y  Q  L  V  Q  E  V  I  D  R  V  E  L  H  E  K  V  S  S   
 
                     3A 
5521 CACCCGATCTTCAAGCAGATCTCAATTCCTTCTCAAAAATCTGTGTTGTACTTTCTCATT 
1194  H  P  I  F  K  Q  I  S  I  P  S  Q  K  S  V  L  Y  F  L  I   
                            MfeI EcoRI 
5581 GAGAAGGGCCAACATGAGGCAGCAATTGAATTCTTTGAGGGCATGGTCCACGACTCCATC 
1214  E  K  G  Q  H  E  A  A  I  E  F  F  E  G  M  V  H  D  S  I   
 
5641 AAAGAGGAACTCCGACCCCTCATCCAACAAACTTCATTTGTGAAACGCGCTTTCAAGCGC 
1234  K  E  E  L  R  P  L  I  Q  Q  T  S  F  V  K  R  A  F  K  R   
 
5701 CTGAAGGAAAATTTTGAGATTGTTGCTCTGTGTTTAACGCTTTTGGCAAACATTGTGATC 
1254  L  K  E  N  F  E  I  V  A  L  C  L  T  L  L  A  N  I  V  I   
 
5761 ATGATCCGTGAGACTCGCAAGAGGCAGAAAATGGTGGATGATGCAGTGAATGAGTACATT 
1274  M  I  R  E  T  R  K  R  Q  K  M  V  D  D  A  V  N  E  Y  I   
                                                             XbaI 
5821 GAGAAAGCAAACATCACCACAGATGACAAGACTCTTGACGAGGCGGAGAAGAGCCCTCTA 
1294  E  K  A  N  I  T  T  D  D  K  T  L  D  E  A  E  K  S  P  L   
                                                             SphI 
5881 GAGACCAGCGGCGCCAGCACCGTTGGCTTTAGAGAGAGAACTCTCCCAGGTCAAAAGGCA 
1314  E  T  S  G  A  S  T  V  G  F  R  E  R  T  L  P  G  Q  K  A   
   
 3B1 
5941 TGCGATGACGTGAACTCCGAGCCTGCCCAACCTGTTGAGGAGCAACCACAAGCTGAAGGA 
1334  C  D  D  V  N  S  E  P  A  Q  P  V  E  E  Q  P  Q  A  E  G   
 
6001 CCCTACGCCGGACCACTCGAGCGTCAGAAACCTCTGAAAGTGAGAGCCAAGCTCCCACAG 
1354  P  Y  A  G  P  L  E  R  Q  K  P  L  K  V  R  A  K  L  P  Q   
 
            3B2 
6061 CAGGAGGGGCCTTACGCTGGTCCGATGGAGAGACAAAAACCGCTAAAAGTGAAAGCAAAA 
1374  Q  E  G  P  Y  A  G  P  M  E  R  Q  K  P  L  K  V  K  A  K   
 
                        3B3 
6121 GCCCCGGTCGTGAAGGAAGGACCTTACGAGGGACCGGTGAAGAAGCCTGTCGCTTTGAAA 
1394  A  P  V  V  K  E  G  P  Y  E  G  P  V  K  K  P  V  A  L  K   
 
                              3Cpro 
6181 GTGAAAGCTAAGAACCTGATTGTCACTGAGAGTGGTGCCCCACCGACCGACTTGCAAAAG 
1414  V  K  A  K  N  L  I  V  T  E  S  G  A  P  P  T  D  L  Q  K   
 
 
6241 ATGGTCATGGGCAACACAAAGCCTGTTGAGCTCATCCTTGACGGGAAGACGGTAGCCATC 
1434  M  V  M  G  N  T  K  P  V  E  L  I  L  D  G  K  T  V  A  I   
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6301 TGCTGCGCTACTGGAGTGTTTGGCACTGCTTACCTCGTGCCTCGTCATCTCTTCGCAGAG 
1454  C  C  A  T  G  V  F  G  T  A  Y  L  V  P  R  H  L  F  A  E   
 
6361 AAGTATGACAAGATCATGGTGGACGGCAGAGCCATGACAGACAGTGACTACAGAGTGTTT 
1474  K  Y  D  K  I  M  V  D  G  R  A  M  T  D  S  D  Y  R  V  F   
6421 GAGTTTGAGATCAAAGTAAAAGGACAGGACATGCTCTCAGACGCCGCGCTCATGGTGCTC 
1494  E  F  E  I  K  V  K  G  Q  D  M  L  S  D  A  A  L  M  V  L   
 
6481 CACCGTGGGAACCGTGTGAGGGACATCACGAAGCACTTTCGTGACACAGCAAGAATGAAG 
1514  H  R  G  N  R  V  R  D  I  T  K  H  F  R  D  T  A  R  M  K   
 
6541 AAAGGCACCCCCGTTGTCGGTGTGATTAATAACGCCGATGTCGGGAGACTGATTTTCTCT 
1534  K  G  T  P  V  V  G  V  I  N  N  A  D  V  G  R  L  I  F  S   
 
6601 GGTGAGGCCCTTACTTACAAGGACATTGTGGTTTGCATGGACGGAGACACCATGCCTGGC 
1554  G  E  A  L  T  Y  K  D  I  V  V  C  M  D  G  D  T  M  P  G   
 
6661 CTCTTTGCCTACAGAGCCGCCACCAAGGCTGGTTACTGCGGAGGAGCCGTTCTTGCCAAA 
1574  L  F  A  Y  R  A  A  T  K  A  G  Y  C  G  G  A  V  L  A  K   
                                         PstI 
6721 GACGGAGCTGACACTTTCATCGTCGGCACTCACTCTGCAGGAGGCAACGGAGTTGGATAC 
1594  D  G  A  D  T  F  I  V  G  T  H  S  A  G  G  N  G  V  G  Y   
 
6781 TGCTCATGCGTTTCCAGGTCCATGCTTCTTAAAATGAAGGCACACATTGACCCCGAACCA 
1614  C  S  C  V  S  R  S  M  L  L  K  M  K  A  H  I  D  P  E  P   
 
               3Dpol 
6841 CACCACGAGGGGTTGATTGTGGACACCAGAGATGTGGAAGAGCGCGTTCACGTGATGCGC 
1634  H  H  E  G  L  I  V  D  T  R  D  V  E  E  R  V  H  V  M  R   
            HinDIII                                        ApaI 
6901 AAAACCAAGCTTGCACCCACCGTTGCACACGGTGTGTTCAACCCCGAGTTTGGGCCCGCT 
1654  K  T  K  L  A  P  T  V  A  H  G  V  F  N  P  E  F  G  P  A   
 
6961 GCCTTGTCCAACAAGGACCCGCGTCTGAACGAGGGTGTTGTCCTCGACGAAGTCATCTTC 
1674  A  L  S  N  K  D  P  R  L  N  E  G  V  V  L  D  E  V  I  F   
 
7021 TCCAAACACAAGGGAGACACAAAGATGTCTGAGGAGGACAAAGCGCTGTTCCGCCGCTGC 
1694  S  K  H  K  G  D  T  K  M  S  E  E  D  K  A  L  F  R  R  C   
                 MluI 
7081 GCTGCTGACTACGCGTCACGCTTGCACAGCGTGTTGGGCACAGCAAATGCCCCACTGAGC 
1714  A  A  D  Y  A  S  R  L  H  S  V  L  G  T  A  N  A  P  L  S   
 
7141 ATCTACGAGGCAATCAAGGGTGTCGACGGACTCGACGCCATGGAACCAGACACTGCGCCC 
1734  I  Y  E  A  I  K  G  V  D  G  L  D  A  M  E  P  D  T  A  P   
                ApaI 
7201 GGCCTCCCCTGGGCCCTCCAGGGTAAACGCCGCGGCGCGCTCATCGACTTCGAGAACGGC 
1754  G  L  P  W  A  L  Q  G  K  R  R  G  A  L  I  D  F  E  N  G   
 
7261 ACGGTCGGACCCGAAGTTGAGGCTGCCCTGAAGCTCATGGAGAAGAGAGAATACAAATTT 
1774  T  V  G  P  E  V  E  A  A  L  K  L  M  E  K  R  E  Y  K  F   
 
7321 GTTTGTCAGACCTTCCTGAAGGACGAGATTCGCCCGTTGGAGAAAGTACGTGCCGGTAAG 
1794  V  C  Q  T  F  L  K  D  E  I  R  P  L  E  K  V  R  A  G  K   
 
7381 ACTCGCATTGTCGACGTCCTGCCCGTTGAGCACATTCTTTACACCAGGATGATGATTGGC 
1814  T  R  I  V  D  V  L  P  V  E  H  I  L  Y  T  R  M  M  I  G   
 
7441 AGATTTTGTGCACAGATGCACTCAAATAACGGACCGCAAATTGGCTCAGCGGTCGGTTGC 
1834  R  F  C  A  Q  M  H  S  N  N  G  P  Q  I  G  S  A  V  G  C   
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7501 AACCCTGATGTTGATTGGCAGAGATTTGGCACACACTTCGCCCAGTACAGAAACGTGTGG 
1854  N  P  D  V  D  W  Q  R  F  G  T  H  F  A  Q  Y  R  N  V  W   
 
7561 GATGTGGACTATTCGGCCTTTGATGCTAATCACTGTAGTGATGCCATGAACATCATGTTT 
1874  D  V  D  Y  S  A  F  D  A  N  H  C  S  D  A  M  N  I  M  F   
                                                    
   BamHI     
7621 GAGGAGGTGTTTCGCACGGAGTTCGGCTTCCACCCGAATGCTGAGTGGATCCTGAAGACT 
1894  E  E  V  F  R  T  E  F  G  F  H  P  N  A  E  W  I  L  K  T   
 
7681 CTTGTGAACACGGAACACGCCTATGAGAACAAACGCATCACTGTTGGAGGCGGAATGCCG 
1914  L  V  N  T  E  H  A  Y  E  N  K  R  I  T  V  G  G  G  M  P   
 
7741 TCTGGTTGCTCCGCAACAAGCATCATCAACACAATTTTGAACAACATCTACGTGCTCTAC 
1934  S  G  C  S  A  T  S  I  I  N  T  I  L  N  N  I  Y  V  L  Y   
 
7801 GCCCTGCGTAGACACTATGAGGGAGTTGAGCTGGACACATACACCATGATCTCCTACGGA 
1954  A  L  R  R  H  Y  E  G  V  E  L  D  T  Y  T  M  I  S  Y  G   
 
7861 GACGACATCGTGGTGGCAAGTGATTATGATTTGGACTTCGAGGCTCTCAAGCCCCACTTT 
1974  D  D  I  V  V  A  S  D  Y  D  L  D  F  E  A  L  K  P  H  F   
                              PvuII 
7921 AAATCCCTTGGCCAAACCATCACTCCAGCTGACAAAAGCGACAAAGGTTTTGTTCTTGGT 
1994  K  S  L  G  Q  T  I  T  P  A  D  K  S  D  K  G  F  V  L  G   
 
7981 CACTCCATTACCGATGTCACTTTCCTCAAAAGGCACTTCCACATGGACTATGGAACTGGG 
2014  H  S  I  T  D  V  T  F  L  K  R  H  F  H  M  D  Y  G  T  G   
 
8041 TTTTACAAACCTGTGATGGCCTCAAAGACCCTTGAGGCTATCCTCTCCTTTGCACGCCGT 
2034  F  Y  K  P  V  M  A  S  K  T  L  E  A  I  L  S  F  A  R  R   
 
8101 GGGACCATACAGGAGAAGTTGATCTCCGTGGCAGGACTCGCCGTCCACTCTGGACCAGAC 
2054  G  T  I  Q  E  K  L  I  S  V  A  G  L  A  V  H  S  G  P  D   
 
8161 GAGTACCGGCGTCTCTTTGAGCCTTTCCAAGGTCTCTTTGAGATTCCAAGCTACAGATCA 
2074  E  Y  R  R  L  F  E  P  F  Q  G  L  F  E  I  P  S  Y  R  S   
                                        MluI 
8221 CTTTACCTGCGTTGGGTGAACGCCGTGTGCGGTGACGCGTAATCCCTCAGAGGCCACGAC 
2094  L  Y  L  R  W  V  N  A  V  C  G  D  A  *                     
 
8281 AGCCGGGCTCTGAGGCGTGCGACACCGTAGGAGTGAAAATCCCGAAAGGGTTTTTCCGCT 
8341 TCCTTAATCCAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAA 
8401 AAAAAAAAAAAAAAA                 HpaI 
                    CCCCCCCCCCCCCCCCGTTAACGGCCCCCAAAAAACCCCCCTCCC 
                               SfiI 
8461 TACTTCGGGAATACCTCAAAGGCCAAGGGGGCCTCGGCCTCTGCATAAATAAAAAAAATT 
8521 ATTCACCCTTGGGGCGAAAAAGGGGCGGAATGGGGCGGATTTAGGGGCGGGAGGGGCGGA 
8581 TTTAGGGGCGGAACTATGGTTGCGGACTAATTGAAATGCAGGCTTTGCTTACTTCGGCCT 
8641 GCTGGGGGACCGGGGAACTTTC 
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A.3 pRbz_5nts replicon sequence 
 
 
New FMDV Replicon: pRbz_5nts replicon (pCDNA3.1(+) backbone) 
 
 
           SalI            BglII 
1   GTCGACGGATCGGGAGATCTCCCGATCCCCTATGGTGCACTCTCAGTACAATCTGCTCTG 
 
61  ATGCCGCATAGTTAAGCCAGTATCTGCTCCCTGCTTGTGTGTTGGAGGTCGCTGAGTAGT 
 
121 GCGCGAGCAAAATTTAAGCTACAACAAGGCAAGGCTTGACCGACAATTGCATGAAGAATC 
                                                                                                                                
CMV Promoter -> 
                                                       MluI 
181 TGCTTAGGGTTAGGCGTTTTGCGCTGCTTCGCGATGTACGGGCCAGATATACGCGTTGAC 
                SpeI 
241 ATTGATTATTGACTAGTTATTAATAGTAATCAATTACGGGGTCATTAGTTCATAGCCCAT 
 
301 ATATGGAGTTCCGCGTTACATAACTTACGGTAAATGGCCCGCCTGGCTGACCGCCCAACG 
 
361 ACCCCCGCCCATTGACGTCAATAATGACGTATGTTCCCATAGTAACGCCAATAGGGACTT 
 
421 TCCATTGACGTCAATGGGTGGAGTATTTACGGTAAACTGCCCACTTGGCAGTACATCAAG 
          NdeI 
481 TGTATCATATGCCAAGTACGCCCCCTATTGACGTCAATGACGGTAAATGGCCCGCCTGGC 
                   CMV primer 2 
541 ATTATGCCCAGTACATGACCTTATGGGACTTTCCTACTTGGCAGTACATCTACGTATTAG 
 
601 TCATCGCTATTACCATGGTGATGCGGTTTTGGCAGTACATCAATGGGCGTGGATAGCGGT 
 
661 TTGACTCACGGGGATTTCCAAGTCTCCACCCCATTGACGTCAATGGGAGTTTGTTTTGGC 
                                                       CMV primer 
721 ACCAAAATCAACGGGACTTTCCAAAATGTCGTAACAACTCCGCCCCATTGACGCAAATGG                                                                                                                       
 
                                          SacI    T7 Promoter->         
781 GCGGTAGGCGTGTACGGTGGGAGGTCTATATAAGCAGAGCTCTAATACGACTCACTATAG 
 
Hammerhead ribozyme    FMDV ->  
         SmaI (Oligo=PMRfor17)                                                              
841 GGCCTTTCAACTGATGAGGCCGAAAGGCCGAAAACCCGGTATCCCGGGTTCTTGAAAGGG 
 
901 GGCATTAGGGTCTCACCCCTAGTAAGCCAACGACAGTCCCTGCGTTGCACTCCACACTTA 
 
    (Oligo=PMRrev1) 
961 CGTTGTACACACGCGGGACCCGATGGGCTATCGTTCACCCACCTACAGCTGGACTCACGG 
 
1021 CGCCGCGTGGCCATTTAGCTGGATTGTGCGGACGAACACGCTTGCGCACCTCGCGTGACC 
 
           ScaI        (Oligo=PMRrev3) 
1081 GGTTAGTACTCTTACCACTCTCCGCCTACTTGGTCGTTAGCGCTGTCTTGGGCATTCCTG 
 
1141 TGGGGGCCGTTCGACGCTCCACGGGAACTCTCCTGTGTGACATCTACGGTGATGGGGCCG 
                                                             NheI 
1201 TTTCGCGTGGGCTGGTCGTTTGGACTGCTTCGGCTGTCACCCGGCGCCCGCCTTTCAGCT 
 
1261 AGCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCGCTCCCCC 
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(Oligo=PMRrev2)      (Oligo=PMRfor1) 
1321 CCCCCCAAGTTTTACCGTCGTTCCCGACGTAAAAGGGAGGTAACCACAAGCTTGAAACCG 
 
1381 TCCGGCCCGACGTAAAAGGGTGGTAACCACAAGCTTACTGCCGTCTTTCCCGACGTTAAA 
 
1441 GGGATGAAACCACAAGACTTACCTTCGCTCGGAAGTAAAACGACAAACACACACAGTTTT 
              BspHI  
1501 GCCCGTTTTCATGAGAAATGGGACGTCTGCGCACGAAACGCGCCGTCGCTTGAGGAGGAC 
 
1561 TTGTACAAACACGATCTATGCAGGTTTCCCCAACTGACACAAACCGTGCAACTTGAAACT 
                        XbaI 
1621 CCGCCTGGTCTTTCCAGGTCTAGAGGGGTAACATTTTGTACTGTGTTTGACTCCACGCTC 
 
1681 GATCCACTAGCGAGTGTTAGTAGCGGTACTGCTGTCTCGTAGCGGAGCATGTTGGCCGTG 
 
(Oligo=PMRrev7)       (Oligo=PMRfor2) 
1741 GGAACACCTCCTTGGTAACAAGGACCCACGGGGCCGAAAGCCATGTCCTAACGGACCCAA 
 
1801 CATGTGTGCAACCCCAGCACGGCAGCTTTACTGTGAAACCCACTTCAAGGTGACATTGAT 
                                                  KpnI 
1861 ACTGGTACTCAAACACTGGTGACAGGCTAAGGATGCCCTTCAGGTACCCCGAGGTAACAA 
 
1921 GCGACACTCGGGATCTGAGAAGGGGACTGGGACTTCTTTAAAGTGCCCAGTTTAAAAAGC 
                                NaeI             PsiI 
1981 TTCTACGCCTGAATAGGTGACCGGAGGCCGGCACCTTTCCTTTTATAACCACTGAACACA 
 
     Labpro -> 
2041 TGAATACAACTGACTGTTTTATCGCTTTGGTACAGGCTATCAGAGAGATTAAAGCACTTT 
1    M  N  T  T  D  C  F  I  A  L  V  Q  A  I  R  E  I  K  A  L    
 
                             Lbpro -> 
2101 TTCTATCACGCACCACAGGGAAAATGGAACTGACACTGTACAACGGTGAGAAGAAGACCT 
21   F  L  S  R  T  T  G  K  M  E  L  T  L  Y  N  G  E  K  K  T    
 
2161 TTTACTCCAGGCCCAACAACCACGACAACTGCTGGTTGAACGCCATCCTCCAGTTGTTCA 
41   F  Y  S  R  P  N  N  H  D  N  C  W  L  N  A  I  L  Q  L  F    
 
2221 GGTACGTTGAAGAACCATTCTTCGACTGGGTCTACAGTTCGCCTGAGAACCTCACGCTTG 
61   R  Y  V  E  E  P  F  F  D  W  V  Y  S  S  P  E  N  L  T  L    
 
2281 AAGCCATCAAGCAGTTGGAGGATCTCACAGGACTTGAACTGCATGAGGGTGGACCACCTG 
81   E  A  I  K  Q  L  E  D  L  T  G  L  E  L  H  E  G  G  P  P    
                                                           NruI 
2341 CTCTCGTGATCTGGAACATCAAGCACTTGCTCCACACCGGCATCGGCACCGCCTCGCGAC 
101  A  L  V  I  W  N  I  K  H  L  L  H  T  G  I  G  T  A  S  R    
                                                      (Oligo=PMRfor3) 
2401 CCAGCGAGGTGTGCATGGTGGATGGTACGGACATGTGCTTGGCTGATTTCCATGCTGGCA 
121  P  S  E  V  C  M  V  D  G  T  D  M  C  L  A  D  F  H  A  G    
           AflII 
2461 TTTTCCTTAAGGGGCAAGAACACGCTGTGTTTGCGTGTGTCACCTCCAACGGGTGGTACG 
141  I  F  L  K  G  Q  E  H  A  V  F  A  C  V  T  S  N  G  W  Y    
 
2521 CGATTGACGATGAGGACTTCTACCCCTGGACGCCGGACCCGTCCGACGTTCTGGTGTTTG 
161  A  I  D  D  E  D  F  Y  P  W  T  P  D  P  S  D  V  L  V  F    
       BsiWI/SunI 
2581 TCCCGTACGATCAAGAACCACTCAACGGGGAATGGAAAGCCAAGGTTCAACGCAAGCTCA 
181  V  P  Y  D  Q  E  P  L  N  G  E  W  K  A  K  V  Q  R  K  L    
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       Δ1A ->        NsiI/ 
2641 AAGGGGCTGGACAATCCAGTCCAGCGACCGGCTCGCAGAACCAATCTGGCAATACTATGC 
201  K  G  A  G  Q  S  S  P  A  T  G  S  Q  N  Q  S  G  N  T  M    
 
       GFP -> 
     NdeI/EcoRV 
2701 ATATGGATATCGTGTCCAAAGGGGAAGAGCTGTTCACCGGGGTGGTGCCCATCCTGGTCG 
221  H  M  D  I  V  S  K  G  E  E  L  F  T  G  V  V  P  I  L  V    
 
2761 AGCTGGACGGCGACGTAAACGGCCACAAGTTCAGCGTGTCCGGCGAGGGCGAGGGCGATG 
241  E  L  D  G  D  V  N  G  H  K  F  S  V  S  G  E  G  E  G  D    
 
2821 CCACCTACGGCAAGCTGACCCTGAAGTTCATCTGCACCACCGGCAAGCTGCCCGTGCCCT 
261  A  T  Y  G  K  L  T  L  K  F  I  C  T  T  G  K  L  P  V  P    
 
        eGFP active site residues 
2881 GGCCCACCCTCGTGACCACCCTGACCTACGGCGTGCAGTGCTTCAGCCGCTACCCCGACC 
281  W  P  T  L  V  T  T  L  T  Y  G  V  Q  C  F  S  R  Y  P  D    
 
2941 ACATGAAGCAGCACGACTTCTTCAAGTCCGCCATGCCCGAAGGCTACGTCCAGGAGCGCA 
301  H  M  K  Q  H  D  F  F  K  S  A  M  P  E  G  Y  V  Q  E  R    
 
3001 CCATCTTCTTCAAGGACGACGGCAACTACAAGACCCGCGCCGAGGTGAAGTTCGAGGGCG 
321  T  I  F  F  K  D  D  G  N  Y  K  T  R  A  E  V  K  F  E  G   
  
        possible Lpro cleavage site 
3061 ACACCCTGGTGAACCGCATCGAGCTGAAGGGCATCGACTTCAAGGAGGACGGCAACATCC 
341  D  T  L  V  N  R  I  E  L  K  G  I  D  F  K  E  D  G  N  I    
 
3121 TGGGGCACAAGCTGGAGTACAACTACAACAGCCACAACGTCTATATCATGGCCGACAAGC 
361  L  G  H  K  L  E  Y  N  Y  N  S  H  N  V  Y  I  M  A  D  K    
 
3181 AGAAGAACGGCATCAAGGTGAACTTCAAGATCCGCCACAACATCGAGGACGGCAGCGTGC 
381  Q  K  N  G  I  K  V  N  F  K  I  R  H  N  I  E  D  G  S  V    
 
3241 AGCTCGCCGACCACTACCAGCAGAACACCCCCATCGGCGACGGCCCCGTGCTGCTGCCCG 
401  Q  L  A  D  H  Y  Q  Q  N  T  P  I  G  D  G  P  V  L  L  P    
 
3301 ACAACCACTACCTGAGCACCCAGTCCGCCCTGAGCAAAGACCCCAACGAGAAGCGCGATC 
421  D  N  H  Y  L  S  T  Q  S  A  L  S  K  D  P  N  E  K  R  D    
 
3361 ACATGGTCCTGCTGGAGTTCGTGACCGCCGCCGGGATCACTCTCGGCATGGACGAGCTGT 
441  H  M  V  L  L  E  F  V  T  A  A  G  I  T  L  G  M  D  E  L    
 
              PAC -> 
           ApaI 
3421 ATAAGGGGCCCCACCACCACCACCACCACACCGAGTACAAGCCCACGGTGCGCCTCGCCA 
461  Y  K  G  P  H  H  H  H  H  H  T  E  Y  K  P  T  V  R  L  A    
                            BsiWI 
3481 CCCGCGACGACGTCCCCAGGGCCGTACGCACCCTCGCCGCCGCGTTCGCCGACTACCCCG 
481  T  R  D  D  V  P  R  A  V  R  T  L  A  A  A  F  A  D  Y  P    
                         BspEI 
3541 CCACGCGCCACACCGTCGATCCGGACCGCCACATCGAGCGGGTCACCGAGCTGCAAGAAC 
501  A  T  R  H  T  V  D  P  D  R  H  I  E  R  V  T  E  L  Q  E    
 
3601 TCTTCCTCACGCGCGTCGGGCTCGACATCGGCAAGGTGTGGGTCGCGGACGACGGCCCCG 
521  L  F  L  T  R  V  G  L  D  I  G  K  V  W  V  A  D  D  G  P    
 
3661 CGGTGGCGGTCTGGACCACGCCGGAGAGCGTCGAAGCGGGGGCGGTGTTCGCCGAGATCG 
541  A  V  A  V  W  T  T  P  E  S  V  E  A  G  A  V  F  A  E  I    
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                                                             StuI 
3721 GCCCGCGCATGGCCGAGTTGAGCGGTTCCCGGCTGGCCGCGCAGCAACAGATGGAAGGCC 
561  G  P  R  M  A  E  L  S  G  S  R  L  A  A  Q  Q  Q  M  E  G    
 
3781 TCCTGGCGCCGCACCGGCCCAAGGAGCCCGCGTGGTTCCTGGCCACCGTCGGCGTCTCGC 
581  L  L  A  P  H  R  P  K  E  P  A  W  F  L  A  T  V  G  V  S    
                                                            EagI 
3841 CCGACCACCAGGGCAAGGGTCTGGGCAGCGCCGTCGTGCTCCCCGGAGTGGAGGCGGCCG 
601  P  D  H  Q  G  K  G  L  G  S  A  V  V  L  P  G  V  E  A  A    
 
3901 AGCGCGCCGGGGTGCCCGCCTTCCTGGAGACCTCCGCGCCCCGCAACCTCCCCTTCTACG 
621  E  R  A  G  V  P  A  F  L  E  T  S  A  P  R  N  L  P  F  Y    
 
3961 AGCGGCTCGGCTTCACCGTCACCGCCGACGTCGAGGTGCCCGAAGGACCGCGCACCTGGT 
641  E  R  L  G  F  T  V  T  A  D  V  E  V  P  E  G  P  R  T  W    
 
                                 (Δ1D ->) 
                               SmaI 
4021 GCATGACCCGCAAGCCCGGTGCCACCCGGGTCACCGAGTTGCTTTACCGGATGAAGAGGG 
661  C  M  T  R  K  P  G  A  T  R  V  T  E  L  L  Y  R  M  K  R    
                                         (Oligo=PMRfor6) 
4081 CCGAAACATACTGTCCAAGGCCCTTGCTGGCAATCCACCCAACTGAAGCCAGACACAAAC 
681  A  E  T  Y  C  P  R  P  L  L  A  I  H  P  T  E  A  R  H  K    
                               2A ->                       
                 SgrAI  
4141 AGAAAATTGTGGCACCGGTGAAACAGACTTTGAATTTTGACCTTCTCAAGTTGGCGGGAG 
701  Q  K  I  V  A  P  V  K  Q  T  L  N  F  D  L  L  K  L  A  G   
  
                         2B -> 
                        ApaI 
4201 ACGTCGAGTCCAACCCTGGGCCCTTCTTTTTCTCCGACGTTAGGTCGAACTTCTCCAAAC 
721  D  V  E  S  N  P  G  P  F  F  F  S  D  V  R  S  N  F  S  K    
 
4261 TGGTGGAAACCATCAACCAGATGCAGGAGGACATGTCAACAAAACACGGGCCTGACTTTA 
741  L  V  E  T  I  N  Q  M  Q  E  D  M  S  T  K  H  G  P  D  F    
 
4321 ACCGGTTAGTGTCCGCATTTGAGGAGTTGGCCATTGGAGTGAAAGCCATCAGAACCGGTC 
761  N  R  L  V  S  A  F  E  E  L  A  I  G  V  K  A  I  R  T  G    
 
4381 TCGACGAAGCCAAACCCTGGTACAAGCTTATCAAGCTCCTAAGCCGCCTGTCGTGCATGG 
781  L  D  E  A  K  P  W  Y  K  L  I  K  L  L  S  R  L  S  C  M    
 
4441 CCGCTGTGGCAGCACGGTCCAAGGACCCAGTCCTTGTGGCCATCATGCTGGCCGACACCG 
801  A  A  V  A  A  R  S  K  D  P  V  L  V  A  I  M  L  A  D  T    
                                          BglII 
4501 GTCTCGAGATTCTGGACAGCACCTTCGTCGTGAAGAAGATCTCCGACTCGCTCTCCAGTC 
821  G  L  E  I  L  D  S  T  F  V  V  K  K  I  S  D  S  L  S  S    
 
4561 TCTTTCACGTGCCGGCCCCCGTCTTCAGTTTCGGAGCACCGGTCCTGTTGGCCGGGTTGG 
841  L  F  H  V  P  A  P  V  F  S  F  G  A  P  V  L  L  A  G  L   
    (oligo=PMRfor7)                                                                                                                                       
4621 TCAAAGTTGCCTCGAGTTTCTTCCGGTCCACACCCGAAGACCTTGAGAGAGCAGAGAAAC 
861  V  K  V  A  S  S  F  F  R  S  T  P  E  D  L  E  R  A  E  K    
 
        2C -> 
4681 AGCTCAAAGCACGTGACATCAACGACATCTTCGCCATTCTCAAGAACGGCGAGTGGCTGG 
881  Q  L  K  A  R  D  I  N  D  I  F  A  I  L  K  N  G  E  W  L    
 
4741 TCAAACTGATCCTTGCCATCCGCGACTGGATTAAGGCTTGGATCGCCTCAGAAGAGAAGT 
901  V  K  L  I  L  A  I  R  D  W  I  K  A  W  I  A  S  E  E  K    
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4801 TTGTCACCATGACAGACTTGGTGCCTGGCATCCTTGAAAAGCAGCGGGACCTGAACGACC 
921  F  V  T  M  T  D  L  V  P  G  I  L  E  K  Q  R  D  L  N  D    
 
4861 CGAGCAAGTACAAGGAAGCCAAGGAGTGGCTCGACAACGCGCGCCAAGCGTGTTTGAAGA 
941  P  S  K  Y  K  E  A  K  E  W  L  D  N  A  R  Q  A  C  L  K    
 
4921 GCGGGAACGTCCACATTGCCAACCTGTGCAAAGTGGTCGCACCAGCACCCAGCAAGTCGA 
961  S  G  N  V  H  I  A  N  L  C  K  V  V  A  P  A  P  S  K  S    
 
4981 GGCCCGAACCCGTGGTTGTTTGCCTCCGCGGCAAATCTGGCCAGGGCAAGAGCTTCCTTG 
981  R  P  E  P  V  V  V  C  L  R  G  K  S  G  Q  G  K  S  F  L    
                                            (Oligo=PMRfor8) 
5041 CAAACGTGCTTGCACAGGCAATTTCCACCCACTTCACCGGCAGAATCGACTCAGTGTGGT 
1001 A  N  V  L  A  Q  A  I  S  T  H  F  T  G  R  I  D  S  V  W    
 
5101 ACTGCCCACCTGACCCTGACCACTTCGACGGTTACAACCAGCAAACCGTTGTTGTGATGG 
1021 Y  C  P  P  D  P  D  H  F  D  G  Y  N  Q  Q  T  V  V  V  M    
 
5161 ATGATTTGGGCCAGAACCCTGACGGCAAGGACTTCAAATACTTTGCCCAAATGGTCTCGA 
1041 D  D  L  G  Q  N  P  D  G  K  D  F  K  Y  F  A  Q  M  V  S    
 
5221 CCACAGGGTTTATCCCGCCCATGGCATCACTCGAGGACAAAGGTAAACCTTTCAACAGCA 
1061 T  T  G  F  I  P  P  M  A  S  L  E  D  K  G  K  P  F  N  S    
                NruI 
5281 AAGTCATCATCGCGACCACCAACTTGTACTCGGGCTTCACCCCGAGGACCATGGTATGTC 
1081 K  V  I  I  A  T  T  N  L  Y  S  G  F  T  P  R  T  M  V  C    
 
5341 CCGACGCACTGAACCGGAGGTTTCACTTTGACATCGATGTGAGTGCTAAGGATGGGTACA 
1101 P  D  A  L  N  R  R  F  H  F  D  I  D  V  S  A  K  D  G  Y    
                                            (Oligo=PMRfor9) 
5401 AAATTAACAGCAAATTGGACATTATCAAAGCACTCGAAGACACCCACGCCAACCCAGTGG 
1121 K  I  N  S  K  L  D  I  I  K  A  L  E  D  T  H  A  N  P  V    
 
5461 CAATGTTTCAATACGACTGTGCCCTTCTCAACGGCATGGCCGTTGAAATGAAGAGAATGC 
1141 A  M  F  Q  Y  D  C  A  L  L  N  G  M  A  V  E  M  K  R  M    
 
5521 AACAAGACATGTTCAAGCCTCAACCACCCCTCCAGAATGTGTACCAGCTTGTTCAGGAGG 
1161 Q  Q  D  M  F  K  P  Q  P  P  L  Q  N  V  Y  Q  L  V  Q  E    
 
                                                           3A -> 
         PvuI       SacI                                   BglII 
5581 TGATCGATCGGGTCGAGCTCCACGAGAAAGTGTCGAGTCACCCGATCTTCAAGCAGATCT 
1181 V  I  D  R  V  E  L  H  E  K  V  S  S  H  P  I  F  K  Q  I    
 
5641 CAATTCCTTCTCAAAAATCTGTGTTGTACTTTCTCATTGAGAAGGGCCAACATGAGGCAG 
1201 S  I  P  S  Q  K  S  V  L  Y  F  L  I  E  K  G  Q  H  E  A    
      MfeI / EcoRI 
5701 CAATTGAATTCTTTGAGGGCATGGTCCACGACTCCATCAAAGAGGAACTCCGACCCCTCA 
1221 A  I  E  F  F  E  G  M  V  H  D  S  I  K  E  E  L  R  P  L    
 
5761 TCCAACAAACTTCATTTGTGAAACGCGCTTTCAAGCGCCTGAAGGAAAATTTTGAGATTG 
1241 I  Q  Q  T  S  F  V  K  R  A  F  K  R  L  K  E  N  F  E  I    
                                          BspHI 
5821 TTGCTCTGTGTTTAACGCTTTTGGCAAACATTGTGATCATGATCCGTGAGACTCGCAAGA 
1261 V  A  L  C  L  T  L  L  A  N  I  V  I  M  I  R  E  T  R  K    
                  (Oligos = PCRAph2rev / PCRAph2for)(Oligo=PMRfor10) 
5881 GGCAGAAAATGGTGGATGATGCAGTGAATGAGTACATTGAGAAAGCAAACATCACCACAG 
1281 R  Q  K  M  V  D  D  A  V  N  E  Y  I  E  K  A  N  I  T  T    
                                         XbaI 
5941 ATGACAAGACTCTTGACGAGGCGGAGAAGAGCCCTCTAGAGACCAGCGGCGCCAGCACCG 
1301 D  D  K  T  L  D  E  A  E  K  S  P  L  E  T  S  G  A  S  T    
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                                         SphI 
6001 TTGGCTTTAGAGAGAGAACTCTCCCAGGTCAAAAGGCATGCGATGACGTGAACTCCGAGC 
1321 V  G  F  R  E  R  T  L  P  G  Q  K  A  C  D  D  V  N  S  E    
 
                                         3B1-> 
6061 CTGCCCAACCTGTTGAGGAGCAACCACAAGCTGAAGGACCCTACGCCGGACCACTCGAGC 
1341 P  A  Q  P  V  E  E  Q  P  Q  A  E  G  P  Y  A  G  P  L  E    
 
                                                  3B2-> 
6121 GTCAGAAACCTCTGAAAGTGAGAGCCAAGCTCCCACAGCAGGAGGGGCCTTACGCTGGTC 
1361 R  Q  K  P  L  K  V  R  A  K  L  P  Q  Q  E  G  P  Y  A  G    
 
                                                            3B3-> 
6181 CGATGGAGAGACAAAAACCGCTAAAAGTGAAAGCAAAAGCCCCGGTCGTGAAGGAAGGAC 
1381 P  M  E  R  Q  K  P  L  K  V  K  A  K  A  P  V  V  K  E  G    
                                                                           
6241 CTTACGAGGGACCGGTGAAGAAGCCTGTCGCTTTGAAAGTGAAAGCTAAGAACCTGATTG 
1401 P  Y  E  G  P  V  K  K  P  V  A  L  K  V  K  A  K  N  L  I   
 
 3Cpro->     (Oligo=PMRfor11) 
6301 TCACTGAGAGTGGTGCCCCACCGACCGACTTGCAAAAGATGGTCATGGGCAACACAAAGC 
1421 V  T  E  S  G  A  P  P  T  D  L  Q  K  M  V  M  G  N  T  K    
           SacI 
6361 CTGTTGAGCTCATCCTTGACGGGAAGACGGTAGCCATCTGCTGCGCTACTGGAGTGTTTG 
1441 P  V  E  L  I  L  D  G  K  T  V  A  I  C  C  A  T  G  V  F    
 
6421 GCACTGCTTACCTCGTGCCTCGTCATCTCTTCGCAGAGAAGTATGACAAGATCATGGTGG 
1461 G  T  A  Y  L  V  P  R  H  L  F  A  E  K  Y  D  K  I  M  V    
 
6481 ACGGCAGAGCCATGACAGACAGTGACTACAGAGTGTTTGAGTTTGAGATCAAAGTAAAAG 
1481 D  G  R  A  M  T  D  S  D  Y  R  V  F  E  F  E  I  K  V  K    
 
6541 GACAGGACATGCTCTCAGACGCCGCGCTCATGGTGCTCCACCGTGGGAACCGTGTGAGGG 
1501 G  Q  D  M  L  S  D  A  A  L  M  V  L  H  R  G  N  R  V  R    
 
6601 ACATCACGAAGCACTTTCGTGACACAGCAAGAATGAAGAAAGGCACCCCCGTTGTCGGTG 
1521 D  I  T  K  H  F  R  D  T  A  R  M  K  K  G  T  P  V  V  G    
         VspI 
6661 TGATTAATAACGCCGATGTCGGGAGACTGATTTTCTCTGGTGAGGCCCTTACTTACAAGG 
1541 V  I  N  N  A  D  V  G  R  L  I  F  S  G  E  A  L  T  Y  K    
                                            (Oligo=PMRfor12) 
6721 ACATTGTGGTTTGCATGGACGGAGACACCATGCCTGGCCTCTTTGCCTACAGAGCCGCCA 
1561 D  I  V  V  C  M  D  G  D  T  M  P  G  L  F  A  Y  R  A  A    
 
6781 CCAAGGCTGGTTACTGCGGAGGAGCCGTTCTTGCCAAAGACGGAGCTGACACTTTCATCG 
1581 T  K  A  G  Y  C  G  G  A  V  L  A  K  D  G  A  D  T  F  I    
                   PstI 
6841 TCGGCACTCACTCTGCAGGAGGCAACGGAGTTGGATACTGCTCATGCGTTTCCAGGTCCA 
1601 V  G  T  H  S  A  G  G  N  G  V  G  Y  C  S  C  V  S  R  S    
 
                                                     3Dpol -> 
6901 TGCTTCTTAAAATGAAGGCACACATTGACCCCGAACCACACCACGAGGGGTTGATTGTGG 
1621 M  L  L  K  M  K  A  H  I  D  P  E  P  H  H  E  G  L  I  V    
 
6961 ACACCAGAGATGTGGAAGAGCGCGTTCACGTGATGCGCAAAACCAAGCTTGCACCCACCG 
1641 D  T  R  D  V  E  E  R  V  H  V  M  R  K  T  K  L  A  P  T   
                                    ApaI 
7021 TTGCACACGGTGTGTTCAACCCCGAGTTTGGGCCCGCTGCCTTGTCCAACAAGGACCCGC 
1661 V  A  H  G  V  F  N  P  E  F  G  P  A  A  L  S  N  K  D  P    
 
183 
 
7081 GTCTGAACGAGGGTGTTGTCCTCGACGAAGTCATCTTCTCCAAACACAAGGGAGACACAA 
1681 R  L  N  E  G  V  V  L  D  E  V  I  F  S  K  H  K  G  D  T   
 
                                        (Oligo=PMRfor13)  MluI 
7141 AGATGTCTGAGGAGGACAAAGCGCTGTTCCGCCGCTGCGCTGCTGACTACGCGTCACGCT 
1701 K  M  S  E  E  D  K  A  L  F  R  R  C  A  A  D  Y  A  S  R    
 
7201 TGCACAGCGTGTTGGGCACAGCAAATGCCCCACTGAGCATCTACGAGGCAATCAAGGGTG 
1721 L  H  S  V  L  G  T  A  N  A  P  L  S  I  Y  E  A  I  K  G    
                                                      ApaI 
7261 TCGACGGACTCGACGCCATGGAACCAGACACTGCGCCCGGCCTCCCCTGGGCCCTCCAGG 
1741 V  D  G  L  D  A  M  E  P  D  T  A  P  G  L  P  W  A  L  Q    
 
7321 GTAAACGCCGCGGCGCGCTCATCGACTTCGAGAACGGCACGGTCGGACCCGAAGTTGAGG 
1761 G  K  R  R  G  A  L  I  D  F  E  N  G  T  V  G  P  E  V  E    
 
7381 CTGCCCTGAAGCTCATGGAGAAGAGAGAATACAAATTTGTTTGTCAGACCTTCCTGAAGG 
1781 A  A  L  K  L  M  E  K  R  E  Y  K  F  V  C  Q  T  F  L  K    
 
7441 ACGAGATTCGCCCGTTGGAGAAAGTACGTGCCGGTAAGACTCGCATTGTCGACGTCCTGC 
1801 D  E  I  R  P  L  E  K  V  R  A  G  K  T  R  I  V  D  V  L   
                                                   Alw44I 
7501 CCGTTGAGCACATTCTTTACACCAGGATGATGATTGGCAGATTTTGTGCACAGATGCACT 
1821 P  V  E  H  I  L  Y  T  R  M  M  I  G  R  F  C  A  Q  M  H   
 
   EspI          (Oligo=PMRfor14) 
7561 CAAATAACGGACCGCAAATTGGCTCAGCGGTCGGTTGCAACCCTGATGTTGATTGGCAGA 
1841 S  N  N  G  P  Q  I  G  S  A  V  G  C  N  P  D  V  D  W  Q    
 
7621 GATTTGGCACACACTTCGCCCAGTACAGAAACGTGTGGGATGTGGACTATTCGGCCTTTG 
1861 R  F  G  T  H  F  A  Q  Y  R  N  V  W  D  V  D  Y  S  A  F    
 
7681 ATGCTAATCACTGTAGTGATGCCATGAACATCATGTTTGAGGAGGTGTTTCGCACGGAGT 
1881 D  A  N  H  C  S  D  A  M  N  I  M  F  E  E  V  F  R  T  E    
                              BamHI 
7741 TCGGCTTCCACCCGAATGCTGAGTGGATCCTGAAGACTCTTGTGAACACGGAACACGCCT 
1901 F  G  F  H  P  N  A  E  W  I  L  K  T  L  V  N  T  E  H  A    
 
7801 ATGAGAACAAACGCATCACTGTTGGAGGCGGAATGCCGTCTGGTTGCTCCGCAACAAGCA 
1921 Y  E  N  K  R  I  T  V  G  G  G  M  P  S  G  C  S  A  T  S    
 
7861 TCATCAACACAATTTTGAACAACATCTACGTGCTCTACGCCCTGCGTAGACACTATGAGG 
1941 I  I  N  T  I  L  N  N  I  Y  V  L  Y  A  L  R  R  H  Y  E    
 
7921 GAGTTGAGCTGGACACATACACCATGATCTCCTACGGAGACGACATCGTGGTGGCAAGTG 
1961 G  V  E  L  D  T  Y  T  M  I  S  Y  G  D  D  I  V  V  A  S    
                                            (Oligo=PMRfor15) 
7981 ATTATGATTTGGACTTCGAGGCTCTCAAGCCCCACTTTAAATCCCTTGGCCAAACCATCA 
1981 D  Y  D  L  D  F  E  A  L  K  P  H  F  K  S  L  G  Q  T  I    
 
8041 CTCCAGCTGACAAAAGCGACAAAGGTTTTGTTCTTGGTCACTCCATTACCGATGTCACTT 
2001 T  P  A  D  K  S  D  K  G  F  V  L  G  H  S  I  T  D  V  T    
 
8101 TCCTCAAAAGGCACTTCCACATGGACTATGGAACTGGGTTTTACAAACCTGTGATGGCCT 
2021 F  L  K  R  H  F  H  M  D  Y  G  T  G  F  Y  K  P  V  M  A    
 
8161 CAAAGACCCTTGAGGCTATCCTCTCCTTTGCACGCCGTGGGACCATACAGGAGAAGTTGA 
2041 S  K  T  L  E  A  I  L  S  F  A  R  R  G  T  I  Q  E  K  L    
 
8221 TCTCCGTGGCAGGACTCGCCGTCCACTCTGGACCAGACGAGTACCGGCGTCTCTTTGAGC 
2061 I  S  V  A  G  L  A  V  H  S  G  P  D  E  Y  R  R  L  F  E            
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EcoNI 
8281 CTTTCCAAGGTCTCTTTGAGATTCCAAGCTACAGATCACTTTACCTGCGTTGGGTGAACG 
2081 P  F  Q  G  L  F  E  I  P  S  Y  R  S  L  Y  L  R  W  V  N    
 
MluI                    (Oligo=PMRfor16) 
8341 CCGTGTGCGGTGACGCGTAATCCCTCAGAGGCCACGACAGCCGGGCTCTGAGGCGTGCGA 
2101 A  V  C  G  D  A  *                                           
 
8401 CACCGTAGGAGTGAAAATCCCGAAAGGGTTTTTCCCGCTTCCTTAATCCAAAAAAAAAAAA 
 
8461 AAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAGGGTCGGC 
 
                         Hepatitis Delta Ribozyme 
8521 ATGGCATCTCCACCTCCTCGCGGTCCGACCTGGGCATCCGAAGGAGGACGCACGTCCACTC 
 
     5nts   AscI  
8581 GGATGGCTAAGGGAGAGCCAGGCGCGCCTGCTAACAAAGCCCGAAAGGAAGCTGAGTTGGC 
       
                EspI                      T7Φ terminator 
8641 TGCTGCCACCGCTGAGCAATAACTAGCATAACCCCTTGGGGCCTCTAAACGGGTCTTGAGG 
                           (BspEI /XmaI)      
8701 GGTTTTTTGCTGAAAGGAGGAACTATATCCGGGAGCTTGTATATCCATTTTCGGATCTGAT 
 
                                    Neomycin 
8761 CAAGAGACAGGATGAGGATCGTTTCGCATGATTGAACAAGATGGATTGCACGCAGGTTCT 
8821 GGCCGCTTGGGTGGAGAGGCTATTCGGCTATGACTGGGCACAACAGACAATCGGCTGCTC 
8881 TGATGCCGCCGTGTTCCGGCTGTCAGCGCAGGGGCGCCCGGTTCTTTTTGTCAAGACCGA 
8941 CCTGTCCGGTGCCCTGAATGAACTGCAGGACGAGGCAGCGCGGCTATCGTGGCTGGCCAC 
9001 GACGGGCGTTCCTTGCGCAGCTGTGCTCGACGTTGTCACTGAAGCGGGAAGGGACTGGCT 
9061 GCTATTGGGCGAAGTGCCGGGGCAGGATCTCCTGTCATCTCACCTTGCTCCTGCCGAGAA 
9121 AGTATCCATCATGGCTGATGCAATGCGGCGGCTGCATACGCTTGATCCGGCTACCTGCCC 
9181 ATTCGACCACCAAGCGAAACATCGCATCGAGCGAGCACGTACTCGGATGGAAGCCGGTCT 
9241 TGTCGATCAGGATGATCTGGACGAAGAGCATCAGGGGCTCGCGCCAGCCGAACTGTTCGC 
9301 CAGGCTCAAGGCGCGCATGCCCGACGGCGAGGATCTCGTCGTGACCCATGGCGATGCCTG 
9361 CTTGCCGAATATCATGGTGGAAAATGGCCGCTTTTCTGGATTCATCGACTGTGGCCGGCT 
9421 GGGTGTGGCGGACCGCTATCAGGACATAGCGTTGGCTACCCGTGATATTGCTGAAGAGCT 
9481 TGGCGGCGAATGGGCTGACCGCTTCCTCGTGCTTTACGGTATCGCCGCTCCCGATTCGCA 
               BstBI 
9541 GCGCATCGCCTTCTATCGCCTTCTTGACGAGTTCTTCTGAGCGGGACTCTGGGGTTCGAA 
9601 ATGACCGACCAAGCGACGCCCAACCTGCCATCACGAGATTTCGATTCCACCGCCGCCTTC 
9661 TATGAAAGGTTGGGCTTCGGAATCGTTTTCCGGGACGCCGGCTGGATGATCCTCCAGCGC 
                                             SV40 polyA 
9721 GGGGATCTCATGCTGGAGTTCTTCGCCCACCCCAACTTGTTTATTGCAGCTTATAATGGT 
9781 TACAAATAAAGCAATAGCATCACAAATTTCACAAATAAAGCATTTTTTTCACTGCATTCT 
                                                        SalI 
9841 AGTTGTGGTTTGTCCAAACTCATCAATGTATCTTATCATGTCTGTATACCGTCGACCTCT 
9901 AGCTAGAGCTTGGCGTAATCATGGTCATAGCTGTTTCCTGTGTGAAATTGTTATCCGCTC 
9961 ACAATTCCACACAACATACGAGCCGGAAGCATAAAGTGTAAAGCCTGGGGTGCCTAATGA 
10021 GTGAGCTAACTCACATTAATTGCGTTGCGCTCACTGCCCGCTTTCCAGTCGGGAAACCTG 
10081 TCGTGCCAGCTGCATTAATGAATCGGCCAACGCGCGGGGAGAGGCGGTTTGCGTATTGGG 
10141 CGCTCTTCCGCTTCCTCGCTCACTGACTCGCTGCGCTCGGTCGTTCGGCTGCGGCGAGCG 
10201 GTATCAGCTCACTCAAAGGCGGTAATACGGTTATCCACAGAATCAGGGGATAACGCAGGA 
   pUC Ori 
10261 AAGAACATGTGAGCAAAAGGCCAGCAAAAGGCCAGGAACCGTAAAAAGGCCGCGTTGCTG 
10321 GCGTTTTTCCATAGGCTCCGCCCCCCTGACGAGCATCACAAAAATCGACGCTCAAGTCAG 
10381 AGGTGGCGAAACCCGACAGGACTATAAAGATACCAGGCGTTTCCCCCTGGAAGCTCCCTC 
10441 GTGCGCTCTCCTGTTCCGACCCTGCCGCTTACCGGATACCTGTCCGCCTTTCTCCCTTCG 
10501 GGAAGCGTGGCGCTTTCTCATAGCTCACGCTGTAGGTATCTCAGTTCGGTGTAGGTCGTT 
10561 CGCTCCAAGCTGGGCTGTGTGCACGAACCCCCCGTTCAGCCCGACCGCTGCGCCTTATCC 
10621 GGTAACTATCGTCTTGAGTCCAACCCGGTAAGACACGACTTATCGCCACTGGCAGCAGCC 
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10681 ACTGGTAACAGGATTAGCAGAGCGAGGTATGTAGGCGGTGCTACAGAGTTCTTGAAGTGG 
10741 TGGCCTAACTACGGCTACACTAGAAGAACAGTATTTGGTATCTGCGCTCTGCTGAAGCCA 
10801 GTTACCTTCGGAAAAAGAGTTGGTAGCTCTTGATCCGGCAAACAAACCACCGCTGGTAGC 
10861 GGTTTTTTTGTTTGCAAGCAGCAGATTACGCGCAGAAAAAAAGGATCTCAAGAAGATCCT 
10921 TTGATCTTTTCTACGGGGTCTGACGCTCAGTGGAACGAAAACTCACGTTAAGGGATTTTG 
10981 GTCATGAGATTATCAAAAAGGATCTTCACCTAGATCCTTTTAAATTAAAAATGAAGTTTT 
                                                           Amp 
11041 AAATCAATCTAAAGTATATATGAGTAAACTTGGTCTGACAGTTACCAATGCTTAATCAGT 
11101 GAGGCACCTATCTCAGCGATCTGTCTATTTCGTTCATCCATAGTTGCCTGACTCCCCGTC 
11161 GTGTAGATAACTACGATACGGGAGGGCTTACCATCTGGCCCCAGTGCTGCAATGATACCG 
11221 CGAGACCCACGCTCACCGGCTCCAGATTTATCAGCAATAAACCAGCCAGCCGGAAGGGCC 
11281 GAGCGCAGAAGTGGTCCTGCAACTTTATCCGCCTCCATCCAGTCTATTAATTGTTGCCGG 
11341 GAAGCTAGAGTAAGTAGTTCGCCAGTTAATAGTTTGCGCAACGTTGTTGCCATTGCTACA 
11401 GGCATCGTGGTGTCACGCTCGTCGTTTGGTATGGCTTCATTCAGCTCCGGTTCCCAACGA 
11461 TCAAGGCGAGTTACATGATCCCCCATGTTGTGCAAAAAAGCGGTTAGCTCCTTCGGTCCT 
11521 CCGATCGTTGTCAGAAGTAAGTTGGCCGCAGTGTTATCACTCATGGTTATGGCAGCACTG 
11581 CATAATTCTCTTACTGTCATGCCATCCGTAAGATGCTTTTCTGTGACTGGTGAGTACTCA 
11641 ACCAAGTCATTCTGAGAATAGTGTATGCGGCGACCGAGTTGCTCTTGCCCGGCGTCAATA 
11701 CGGGATAATACCGCGCCACATAGCAGAACTTTAAAAGTGCTCATCATTGGAAAACGTTCT 
11761 TCGGGGCGAAAACTCTCAAGGATCTTACCGCTGTTGAGATCCAGTTCGATGTAACCCACT 
11821 CGTGCACCCAACTGATCTTCAGCATCTTTTACTTTCACCAGCGTTTCTGGGTGAGCAAAA 
11881 ACAGGAAGGCAAAATGCCGCAAAAAAGGGAATAAGGGCGACACGGAAATGTTGAATACTC 
        SspI 
11941 ATACTCTTCCTTTTTCAATATTATTGAAGCATTTATCAGGGTTATTGTCTCATGAGCGGA 
12001 TACATATTTGAATGTATTTAGAAAAATAAACAAATAGGGGTTCCGCGCACATTTCCCCGA 
12061 AAAGTGCCACCTGAC 
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A.4 Accession numbers of 3Dpol sequences of the genus type species of the 
twenty six picornavirus genera 
 
NCBI Accession number Type species 
EU142040 Aquamavirus A 
JQ316470 Pasivirus A 
L02971 Human parechovirus 
DQ226541 Duck hepatitis A virus 
KC465954 Avisivirus A 
AJ225173 Avian encephalomyelitis virus 
M14707 Hepatitis A virus 
JF973686 Rosavirus A 
JN819202 Cadicivirus A 
HM751199 Melegrivirus A 
GQ179640 Salivirus A 
GU182408 Oscivirus A 
AB040749 Aichivirus A 
GU182406 Passerivirus A 
JQ691613 Gallivirus A 
AF406813 Porcine sapelovirus 
J02281 Enterovirus C 
JF973687 Mosavirus A 
JQ941880 Hunnivirus A 
AF231769 Porcine teschovirus 
X96871 Equine rhinitis B virus 
AAT01781 Foot-and-mouth disease virus_SAT 1 
AAT01791 Foot-and-mouth disease virus_SAT 2 
AAT01793 Foot-and-mouth disease virus_SAT 3 
AY593829 Foot-and-mouth disease virus_O 
PO33062 Foot-and-mouth disease virus_A 
AAT01747 Foot-and-mouth disease virus_C 
ABM66096 Foot-and-mouth disease virus_Asia 1 
FJ438902 Cosavirus A 
JQ814851 Mischivirus A 
DQ641257 Seneca Valley virus 
M81861 Encephalomyocarditis virus 
